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The Sox genes are a large group of transcription factors with representatives in all 
animal species and initial investigations have demonstrated the importance of many 
members of this family during embryogenesis.
The expression pattern of Sox2 was surveyed in the second half of gestation by 
examining the X-gal staining pattern of Sox2P̂ °̂'̂ '̂  embryos in wholemount and section 
immunohistochemistry using a SOX2 specific polyclonal antibody. Particular attention 
was given to the pattern in the developing inner ear and in the hair follicle. Expression 
suggests that Sox2 plays significant roles in a diverse range of tissues throughout 
embryogenesis.
The null mutation of Sox2 demonstrates a critical requirement for this gene in 
embryogenesis but early lethality of Sox2^^^°' '̂ embryos precludes study at later stages. A 
strategy to produce a conditionally null allele of Sox2 was devised to circumvent the early 
lethality and allow functional investigation of Sox2 in a tissue specific and/or time 
dependent manner throughout embryogenesis and post-natally. Initial attempts to target 
the Sox2 allele were unsuccessful but redesigning the targeting vector resulted in the 
production of correctly targeted ES cells. Targeted clones were used to produce high 
percentage chimeras but the ES cell component did not contribute to subsequent 
generations.
Two mouse mutants, Lee and Ysb, display abnormalities in inner ear and coat 
formation. Expression analysis and physical mapping implicate Sox2 as a strong candidate 
affected by these alleles. The creation of mice carrying combinations of SoxTP̂ '' ,̂ Lee and 
Ysb mutations showed that they are allelic and that inner ear and coat abnormalities are 
caused predominantly by the loss of expression of Sox2. Congenic breeding of Sox2!̂ ^̂ °
X
mice onto a C3H/He background revealed heterozygous coat phenotypes confirming an 
important role for Sox2 in hair formation.
The closely related gene S o xl is co-expressed along with Sox2 during CNS 
development and physical similarities between their protein products suggest overlapping 
functions able to compensate for the loss of either gene. Breeding experiments 
demonstrate an increase in the rate of mortality far greater than that expected by the 
addition of individual phenotypes. Immunohistochemical analysis reveals aberrant cell 
behaviour in CNS progenitor cell populations carrying the most severe genotype and 
suggests some common function between these genes during CNS development.
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Chapter 1 Introduction.
1.2 Sox Proteins and genes - Classification and phvlogenv
The identification of members of the Sox gene family grew from the 
discovery of the mammalian sex determining factor SRY reported in 1990 (Gubbay et 
al., 1990; Sinclair et al., 1990). SRY, which is found on the Y chromosome in mice 
and humans, has a DNA binding domain similar to the non-histone chromosomal 
proteins HMG-1 and HMG-2. The HMG domain or box can be found in a large 
number of genes although few positions in the 70-80 amino acid long region are 
conserved throughout the superfamily (Laudet et al., 1993)). The broadest division of 
the HMG-box proteins separates members of the HMG/UBF families from those of 
the SOX/TCF/MATA genes (Soullier et al., 1999). HMG/UBF genes are found in 
the three major eukaryotic phyla (fungi, plants and animals) and generally contain 
multiple DNA binding domains that associate with DNA with low to moderate 
affinity and little sequence specificity (Soullier et al., 1999). The SOX/TCF/MATA 
family usually have a single HMG domain that binds specifically to target sequences. 
This family appears to be younger, with MATA and SOX/TCF genes found 
exclusively in yeast and animals respectively. Significant diversification is restricted 
to the SOX/TCF genes in animals with the SOX family having more than thirty 
members. The human and mouse genomes each contain twenty SOX genes with 
further genome duplication thought to be responsible for additional family members 
found in other vertebrates such as zebrafish and Xenopus (Bowles et al., 2000; Pevny 
and Lovell-Badge, 1997; Schepers et al., 2002; Soullier et al., 1999; Wegner, 1999).
Conventionally, as the family name indicates, the SOX gene family is based
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on the criterion of at least 50% identity to Sry within the HMG box (Collignon et al.,
1996). However, homology with Sry, a gene which is exclusive to mammals, is not 
necessarily the most accurate method of classifying the whole Sox family. Recent 
analysis, benefiting from the complete HMG domain sequence of over seventy SOX 
genes isolated from nematodes, insects, amphibians, reptiles, fish, birds, and 
mammals, suggests an improved method of classification based on the conservation 
of particular HMG domain motifs (Bowles et al., 2000). This includes genes such as 
human-SOX30 and Caenorhabditis elegans-SOXS, which have approximately 45% 
identity in their HMG box to Sry but would exclude the Zebrafish gene casanova 
(Dickmeis et al., 2001; Kikuchi et al., 2001; Sakaguchi et al., 2001). Casanova is one 
of the few family members that does not contain the exact protein motif 
RPMNAFMVW in its HMG box although substitutions are conservative (Dickmeis et 
al., 2001). This amino acid sequence represents those residues that confer specificity 
by having direct base contact as well as those that intercalate with the minor groove 
of the DNA helix facilitating architectural changes (Dailey and Basilico, 2001). It is 
clear that, as further related genes are discovered, only a more flexible definition will 
include all the Sox family members.
1.3 Sox gene subgrouping
Sequence data from many Sox family members in diverse species also helps to 
confirm their sub-grouping into categories of greatest similarly. In 1993, by 
comparison of the HMG domain amino acid sequence of the fifteen mouse Sox genes 
identified, members with more than eighty percent amino acid identity were grouped 
together, resulting in seven sub-divisions of the Sox gene family
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Figure 1.1 An unrooted phylogeny for the SOX HMG domain.
This diagram (adapted from Bowles 2000) demonstrates the clustering o f Sox genes from  
diverse species on the basis o f similarities in the HMG domain. Branch lengths represent 
the extent o f divergence and colours highlight membership o f a particular subgroup. A 
single mammalian representative o f each gene is included where numerous orthologues 
exist (except group A). The close conservation amongst group B genes requires a 
magnified view, ce, nematode, Caenorhabditis elegans; dr, fruit-fly. Drosophila 
melanogaster; hu, human. Homo sapiens; mo or m, mouse. Mus musculus; or, orangutan, 
Pongo pygmaeus; pi, pig. Sus scrofa ; tw, tammar wallaby (marsupial). Macropus eugenii; 






(Wright et al., 1993). This classification was subsequently extended as further genes 
were discovered leading Bowles et al to propose that there should be ten sub-groups 
(A-J). Three of these groups have only a single member at present with orthologues 
perhaps awaiting discovery (Fig. 1.1).
Except for group B, which may show a relatively recent divergence, 
invertebrate SOX  genes have a single representative for each sub-group and 
phylogenetic analysis indicates that the numerous vertebrate subgroup members are 
the products of duplication events (Cremazy et al., 2001). Five Sox group B genes 
have been identified in vertebrates and the gene pairs S0X 1/S0X 21 and 
SOX2/SOX14 show conserved synteny in chicken and human indicating that 
duplications that gave rise to these genes pre-date the divergence of birds and 
mammals 310 million years ago (Kdrby et al., 2002; Kuroiwa et al., 2002). It is 
therefore possible that the seven or so invertebrate Sox genes were duplicated in two 
steps perhaps corresponding to the proposed genome duplications that gave rise to the 
four HOX gene clusters in early vertebrate development (Amores et al., 1998; Kirby 
et al., 2002).
Amongst the vertebrate genes discovered, comparison of non-HMG domains 
within sub-groups generally upholds current classification even though sequence 
identity is much lower (Fig. 1.2). Functional studies have also revealed similarities 
between the closest relatives within species but although grossly these proteins are 
extremely similar more subtle differences may account for their conservation over 
such a long period of evolution (Kamachi et al., 1998; Kuhlbrodt et al., 1998a). It is 
tempting to speculate that greater complexity in vertebrates can, in part, be attributed
16
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Figure 1.2 Schematic representation of SOX proteins.
This diagram (adapted from Bowles 2000) highlights the gross similarities and differences 
between the SOX proteins when they are arranged in groups according to their HMG 
domain sequence. Various structural features, motifs, and functional regions 
(demonstrated or putative) are shown along with intron positions and sizes where known. 
Genomic structures are known in some cases indicates that an intronless structure has 
been reported. Abbreviations as for fig. 1.1.
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to the development of more elaborate non-HMG domains of this large family of DNA 
binding proteins.
1.4 Sox genes are transcription factors.
The HMG domain that defines the Sox family facilitates the association of 
members with DNA where their primary function appears to be to regulate gene 
expression (Kamachi et ah, 1998; Ng et ah, 1997; Wiebe et ah, 2003; Yuan et ah, 
1995). A gene is expressed when an RNA copy of it is produced by the action of the 
basal transcription machinery. The activity of this complex is often controlled by 
numerous cw-regulatory elements that might be located flanking the gene or perhaps 
within intronic sequence. Each regulatory element allows the binding of specific 
transcription factors which in turn modify the activity of the transcriptional 
machinery. Individual regulators may effect several genes and a gene may require 
the coordinated action of several transcription factors to ensure appropriate 
expression that is usually dynamic quantitatively spatially and temporally. 
Interaction of these proteins produces a regulatory network that dictates the overall 
expression profile and thus the identity of any given cell.
1.5 The ability of the SOX  proteins to bind to and bend DNA.
The resolution of the crystal structure of the Sox type HMG domain reveals 
that the amino acids most highly conserved across the group contribute to a twisted 
L-shape DNA binding region and a hydrophobic core that maintains its shape. Target 
DNA lies across the concave surface of the ‘L ’ that partially intercalates into the 
minor groove inducing a bend in the DNA of between 70° and 85°. Sox proteins 
show some capacity to bind particular DNA conformations without sequence
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specificity in vitro but this ability has not yet been demonstrated in vivo and therefore 
may not be functionally important (Travers, 2000; Wegner, 1999). Instead, the 
function of Sox factors appears to be dependent upon a specific relationship with 
variants of the core consensus motif %  %  CAA%  G (Mertin et al., 1999).
Conformational change upon binding of a specific target sequence is a characteristic 
of Sox proteins and has been hypothesised to play a significant role in gene regulation 
by this family (Pevny and Lovell-Badge, 1997). When the group B proteins, SOXl 
and SOX2, were compared to S0X9, a Group E protein, in vitro binding and bending 
assays gave almost indistinguishable results (Kamachi et al., 1999).
1.6 Transcriptional regulation bv the Sox proteins.
The specific association of Sox proteins with DNA suggests a role in gene 
regulation and several family members display an activation capacity that is 
independent of cell type or SOX DNA binding domain. Discrete regions from the C 
terminus of several Sox proteins have been shown to possess an ability to activate 
reporter genes in vitro (Sox2 (Kamachi et ah, 1998; Nowling et al., 2000), Sox9 (Ng 
et al., 1997), Soxll (Kuhlbrodt et al., 1998a), Soxl8 (Hosking et al., 1995; Ng et al.,
1997)). Others displayed no autonomous transcriptional activity in these assays 
(Sox5 (Denny et al., 1992), SoxlO (Kuhlbrodt et al., 1998b), Soxl4 & Sox21 
(Uchikawa et al., 1999)) but when natural promotors were used with full length 
proteins regulatory capacity was observed demonstrating the importance of 
promotor/enhancer context for appropriate activity in vivo.
Modification of the local DNA geometry of enhancer sequences in vitro has 
various effects upon reporter expression but this is only one of the ways in which
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these proteins are able to influence gene activity. Mutations introduced into the 
promotor of the myelin protein zero gene (Pq) increased the bending angle that bound 
SoxlO was able to induce (by 20 degrees) but this had little effect on transcriptional 
activity in vitro unless homodimer formation was also interrupted (Schlierf et al.,
2002). Cooperation is also key to the optimal activation of the Fgf4 enhancer by 
SOX2 and OCT3/4 although mutations that reduced the bending angle by half 
actually increased reporter activation three fold. Abolishing the bendability of the 
DNA itself did not interfere with the ability of SOX2 to bind its target but did abolish 
transactivation activity. The authors argued that the absolute angle of bend is not as 
important as the direction (phase) of the bend (Scaffidi and Bianchi, 2001). In both 
these cases a particular geometric arrangement of promotor/enhancer DNA is likely 
to aid cooperative interaction between proteins that associate with it and in this way 
facilitate an optimal level of gene regulation.
1.7 Strategies have evolved to ensure selective regulation despite binding 
similarities.
Binding of Sox family members to the same consensus sequence creates the 
possibility that any Sox protein might bind to another’s target. The primary 
mechanism that limits the effect of transciptional regulators is to restrict the sites 
where these genes are expressed. Sox genes are expressed in highly ordered patterns 
in diverse tissues in many organisms and restricted patterns of expression during 
development, in particular, indicate that these proteins have important roles in cell 
fate decisions. However expression of several Sox proteins in the same cells at the 
same time is often observed (Cheung et al., 2000; Lefebvre et al., 1998; Montero et
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al., 2002; S hen and Ingraham, 2002; Uwanogho et al., 1995). Where there is 
overlapping expression of Sox genes from the same sub-group questions of functional 
redundancy arise whilst an overlap of more diverse Soxes may suggest some 
differential regulation of the same targets mediated through common consensus 
sequences.
To achieve meaningful and effective regulation of target genes, selective 
mechanisms exist so that any single family member only influences a relevant set of 
genes and these proteins employ a number of strategies in order to restrict any 
promiscuous influence upon gene expression. Auto-inhibitory activity, that prevents 
the close association of protein to target and cooperative binding with other 
transcription factors play significant roles in curbing out of context regulation (Wiebe 
et ah, 2003). SO X ll is unable to bind the Sox consensus sequence unless an auto- 
inhibitory acidic region in its C terminus is first neutralized, but this mechanism is 
perhaps limited to group C genes that also have an acidic domain (Wiebe et ah,
2003). In the same assay, S0X2 was able to bind target DNA but needed to 
cooperatively bind OCT3/4 for maximal activation of the reporter, thus 
demonstrating a more common mechanism of target specification (Kamachi et ah, 
2000). Similarly in vivo, S0X9 activates Col2al, during chondrogenesis, however 
ectopic expression of Sox9 only results in the activation of Col2al in a subset of the 
extra sites indicating that further factors must be necessary for selective expression of 
Sox9 targets (Bell et ah, 1997).
In vitro the affinity of Sox proteins for their DNA targets is not especially 
strong (Kd 10 ^-lO^M) when compared with good activators such as GAL4 that binds
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to its target two or three magnitudes stronger (Kd 10 “M) (Kamachi et ah, 2000). 
Although in vitro binding to consensus sequences of many of the Sox proteins can be 
achieved this may not represent the in vivo situation where specific partnerships with 
other DNA binding proteins not only play a crucial role in stabilizing their 
association with target elements, but may also dictate their regulatory influence 
(Wilson and Koopman, 2002).
There is a strong association with members of homeobox containing gene 
families such as Pax and POU domain proteins (Wilson and Koopman, 2002). The 
combination of these two classes of sequence specific transcription factors is perhaps 
one that has been conserved and refined over a very long period as their ancestral 
genes also show synergistic DNA binding and activation activity (Dailey and 
Basilico, 2001). Zappavigna et al. 1996showed that the direct interaction of HMGl 
with HOX proteins (sequence specific homeobox genes) was able to increase the 
amount of HOX-DNA complex formed in vitro and HOX mediated transcriptional 
activation in vivo (Zappavigna et al, 1996). Fgf4 was one of the first genes shown to 
be synergistically regulated by the specific interaction of SOX2 and the POU domain 
protein OCT3/4, which bind to adjacent sites of its enhancer (Yuan et al., 1995) with 
similar associations subsequently found necessary for the regulation of other genes 
such as UTFl (Nishimoto et al., 1999), HOXbl-ARE (Di Rocco et al., 2001), Fbxl5  
(Tokuzawa et al., 2003) and osteopontin (Botquin et al., 1998).
Specific partnerships not only offer a mechanism for selective regulation of 
target genes by Sox proteins (reviewed by Kamachi 2000) but also a way in which 
alternative levels of gene expression may be achieved through the same regulatory
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element (Kamachi et al., 2000). S o x ll  and Brn-2 have overlapping patterns of 
expression with Sox2 particularly in the developing CNS (Uwanogho et ah, 1995). In 
an assay similar to that employed to show a specific partnership between SOX2 and 
OCT3/4 that confirmed their activation potential, SO X ll was demonstrated to be a 
sixty times more potent activator of the same reporter, either alone or when co­
expressed with OCT3/4 (Wiebe et ah, 2003). Activation of this reporter by SO X ll 
was increased further when BRN-2, another POU protein, was introduced instead of 
OCT3/4 (Wiebe et ah, 2003). This along with other examples demonstrates in vitro 
how differential regulation through a common regulatory element might be achieved 
by the association of alternative partners and how this might recapitulate the situation 
in vivo (Kuhlbrodt et ah, 1998a; Kuhlbrodt et ah, 1998b).
In some instances partners may be other Sox proteins. Homodimerization of 
SOX 10 (group E) ensures that it can stably associate with a pair of target sequences 
that an undimerized SOX protein is unable to bind and in this way restricts the 
activation of the myelin gene protein zero (Peirano et ah, 2000). Homo or hetero 
dimerization also appears to be important for the regulation of the Col2al gene by L- 
SOX5/SOX6 (group D) (Lefebvre et ah, 1998).
An important question, however, is what happens in vivo where several 
possible combinations of partners may occur simultaneously and so context is 
therefore extremely important. SOX21 represses SOXl activation of the DC5 
crystallin reporter in lens cells and has no intrinsic activation potential, whilst in a 
neuroblastoma cell line, SOX21 was able to activate a reporter containing a distal
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regulatory element of the popioid receptor (Hwang et al., 2003; Uchikawa et al., 
1999).
Different modes of transcriptional regulation may be achieved by the 
assembly of multi-protein regulatory complexes. Differential regulation of a gene via 
the same regulatory element reflects the makeup and/or stability of the multi-protein 
complexes that assemble on it which is perhaps why even very similar (Sox) proteins 
may elicit different responses in the same context (Kamachi et al., 1998). 
Cooperative interaction between the Soxes and other DNA binding proteins dictates a 
specific association with DNA. This perhaps provides a foundation for the 
recruitment of accessory factors through direct protein interaction or architectural 
changes to the DNA. This offers a mechanism whereby significantly more complex 
regulatory networks may have arisen by the alteration or addition of relatively few 
components and is perhaps why there is an association between the evolution and 
expansion of families of regulatory genes, such as the Soxes, and the increased 
complexity and diversity of organisms.
1.8 Gene duplication and the evolution of complex regulatory networks
In 1970 Ohno proposed that diversity and complexity was facilitated by gene 
duplication and functional redundancy arguing that this enables genes to accumulate 
modifications that would otherwise be deleterious (Ohno, 1970). In the case of the 
invertebrate Sox family, one level of complexity seems to have been achieved by the 
evolution of a small group of transcription factors with diverse function but united by 
a common DNA binding domain. Vertebrates however have a far more extensive set
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of Sox genes often with numerous orthologues to each of the invertebrate Sox genes 
(Fig. 1.1 & Fig. 1.2).
The conservation of similar transcription factors offers the possibility of a 
wide range of responses by any given cell in which they are expressed. A single 
transcription factor is likely to regulate a cohort of targets through its association with 
a number of other factors. Whilst its closest relatives may be capable of regulating a 
very similar group of targets the slight differences between them are likely to produce 
altered affinities with certain cofactors which in turn may alter various aspects of 
target gene regulation. In combination, these factors have the potential to produce a 
wide range of regulatory outcomes but the fine tuning of a cells regulatory network, 
and thus its ideal identity, may be key to their evolutionary conservation.
The classical model for the evolution of duplicated genes describes how once 
duplicated one of the pair will rapidly accumulate deleterious mutations (within a few 
million years) and will only be conserved if it acquires a novel function. But this 
does not explain why so many duplicated genes seem to have been conserved in 
higher organisms. The duplication-degeneration-complementation (DDC) model, 
however, describes how gene duplicates may be conserved if regulatory mutations 
render each copy essential so overall their expression is (at least) equal to that of the 
ancestral gene (Fig. 1.3) (Force et al., 1999). In time this could either result in 
functionally identical genes being expressed in mutually exclusive sites or very 
similar, but perhaps not identical, genes being expressed in the same cells at the same 
time. In the latter case these genes, which in a given context, encode essentially the
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same proteins may achieve an optimal dose through regulatory mutation but subtle 
functional differences could also account for simultaneous expression.
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Figure 1.3 Duplication and evolution of gene families
The DDC model after Force 1999. When a gene is duplicated it is released from the 
normal pressures that conserve its sequence. Gene pairs accumulate mutations in 
regulatory (orange boxes) and functional sequence (blue boxes) as long as the overall role 
of the ancestral gene is maintained. Mutations imparting novel function (green boxes) or 
expression sites (yellow lozenges) may also be accumulated resulting in a pair o f closely 
related but unique proteins that may have some overlapping function. (Regulatory 
elements may possibly be assimilated during the duplication event).
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Within the Sox family there are examples of different strategies of specialisation 
acquired following duplication events this includes diversification of function of 
similar proteins expressed in the same cells. L-S0X5 and SOX6 are in sub-group D 
and are 67% identical to each other and 94%identical in the HMG domain (Kamachi 
et al., 2000; Smits and Lefebvre, 2003). Both are expressed in all cartilages and they 
can dimerize alone or in combination. Because of their similarity, it was 
hypothesised that there might be functional redundancy between these two genes. In 
vivo, a severe disruption in chondrogenesis was seen only when mice were null for 
both of these genes, being lethal at 16.5 days post coitum (dpc). The individual 
knockout animals survived past birth but each had slightly different phenotypes that 
caused lethality before they were weaned, whereas compound heterozygotes were 
viable and fertile (Smits and Lefebvre, 2003). This suggests that although some 
aspects of chondrogenesis can be performed by the remaining protein not all 
functions can be fulfilled, even by a very similar counterpart.
A different resolution appears to have been attained in the case of the group E 
genes Sox9 and SoxlO that are very similar to each other (72% amino acid similarity 
(Schepers et al., 2000)) but are expressed in mutually exclusive patterns. Null 
mutation of either of these genes in mice results in severe developmental phenotypes. 
However, another group B gene Sox8 is expressed in a pattern that is essentially the 
sum of that of Sox9 and Soxl 0, but it does not seem to have a similar level of 
functional responsibility as only relatively mild phenotypes are observed when it is 
deleted (Sock et al., 2001). Sox8 may demonstrate the importance of more subtle 
contributions as deletion does lead to minor phenotypes that affect an individuals 
ability to thrive. Whilst some phenotypes could be attributed to absence from cells
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where there is no overlapping expression of other group E genes there are 
abnormalities in other structures, such as the tarsals of the hind limbs, where there is 
overlapping expression of Sox9. These data suggest that whilst some functional 
conservation is exhibited between subgroup members certain activities clearly 
provide a unique contribution to an individual.
Where there is overlapping expression of a gene with that of very similar family 
members, redundancy is often heralded as the reason for the apparent lack of obvious 
phenotypes from the null mutation. However, there are at least two alternative 
explanations. First, the phenotypes may only be revealed by minute analysis of 
specific regions and molecular markers. Secondly phenotypes may not be manifest 
under normal laboratory conditions. This can be demonstrated in yeast whose 
environment can be readily manipulated. In this system an examination of the effect 
of null mutation reveals that increasing the number of growing conditions decreases 
the chance that any given null mutation will have little or no effect (Gu et al., 2003). 
In higher animals, such as mice, this effect is more difficult to ascertain and it may be 
necessary to devise specific assays in order to reveal the function of certain genes.
1.9 Sox group B  genes;similarities & differences.
SoxB genes were the first members of the Sox family to be discovered and 
represent the subgroup that has been most extensively studied across a range of 
animals (Gubbay et al., 1990). As well as sharing sequence similarity, all group B 
genes so far isolated are expressed in the developing nervous system although 
individual members can also be detected in a spectrum of other tissues during 
development. Similar sequence and expression characteristics observed between
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distantly related species indicates that certain regulatory roles and relationships may 
have also been conserved and highlight the importance of functional analysis in lower 
organisms.
1.10 Vertebrate versus Invertebrate Sox genes functional similarities.
In the fruit fly, Drosophila, the SoxB gene Dichaete (SOX70D, fish, fish-hook 
or SoxB l.l) is required for the correct formation of the midline structures and 
phenotypes arising from its disruption can be rescued by expression of mouse Sox2 
(Soriano and Russell, 1998). Dichaete shares 88% identity in its HMG domain to 
SOX2 as well as limited identity within the C terminal domain but may actually 
represent an ancestral form of the entire sub-group B. Removal of C terminal 
sequence produces a truncated form of Dichaete that is able to rescue midline 
phenotypes as efficiently as the full length protein but lacks activity when ectopically 
expressed in other sites of Dichaete expression, such as eye-antennal or wing 
imaginai disks (Mukherjee et al., 2000; Soriano and Russell, 1998). This suggests 
that D ichaete has discrete functional characteristics with context dependent 
importance. Midline structures rely most heavily upon some property of the Sox 
HMG domain but the C terminal domain possesses significant but uncharacterised 
functional properties highlighted during gain of function experiments.
Conserved interaction with POUpartners
Correct formation of midline structures, especially midline glia, is also 
dependent upon the POU domain protein Ventral veinless and genetic experiments 
implicate interaction with Dichaete in the regulation of target genes (Soriano and 
Russell, 1998). These experiments further support an ancient relationship between
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s o x  and POU proteins that have been shown to cooperate via interaction between 
their DNA binding domains (Kamachi et al., 2000). Sox genes do display partner 
preference but can cooperate with other proteins of the same class that, at least in 
vitro, can result in different activation levels of the same reporter constructs (Wiebe 
et al., 2003).
A second Drosophila gene SoxNeuro (SoxN, SoxB2.1) is even more similar to 
mouse Sox2 than Dichaete with 92% amino acid identity in the HMG domain 
although again there is limited similarity in flanking regions (Sasai, 2001). Like 
Dichaete, SoxN is also expressed in the developing nervous system with a degree of 
overlap between these two related proteins and SoxN mutants have the strongest 
phenotypes in lateral CNS where its expression does not overlap with Dichaete 
(Cremazy et al., 2001; Overton et al., 2002). In areas where there is overlapping 
expression, neural phenotypes are fairly mild in both SoxN  and Dichaete mutants. 
Not surprisingly simultaneous disruption of both Drosophila SoxB genes results in 
general neural hypoplasia and indicates a degree of functional equivalence in some 
contexts. However in other situations these proteins have different activities and 
even antagonistic effects. This apparent contradiction may be explained by 
differences in the nature of the cooperative interactions required for target selection 
and regulatory activity. Where this depends upon partner interaction via the HMG 
domain, Dichaete, SoxN and even mouse Sox2 may functionally compensate for each 
other. Targets where there is a requirement for interactions not involving the HMG 
domain are likely to recruit more specific combinations of factors that will in turn 
elicit different regulatory activities. Cell identity may even depend upon competition 
for common targets and may explain some of the peculiar responses to ectopically
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expressed protein (Soriano and Russell, 1998). The evolution of higher organisms 
may have exploited some of these regulatory principals with the creation of larger 
groups of similar proteins providing the opportunity of further, subtle, modification 
of the regulatory network.
1.11 Vertebrate group B sequence similarities and differences.
Within the HMG box vertebrate group B proteins, from the mouse and 
chicken, are greater than 94% similar to each other, but a further subdivision 
separates group B1 {Soxl Sox2 and Sox3) from group B2 {Soxl4 and Sox21 ) as there 
is only limited similarity between them in non HMG domains (Kamachi et al., 1998; 
Uchikawa et al., 1999) (Fig. 1.2).
When non-HMG domain sequence from the three mouse B1 genes is 
compared it is clear that despite significant similarity each has a unique combination 
of structural motifs (Collignon et al., 1996). A PRD-type repeat (His-Pro) is a unique 
feature present only in SOXl, whilst polyalanine repeats, two of which are in similar 
positions, punctuate regions of homology in SOXl and S0X3. Comparison with 
chicken sequence reveals conservation of domain arrangements except that poly­
alanine repeats are absent in chicken S0X3. When homologues from chicken and 
mouse are compared then identity is much higher with SOXl, S0X2 and S0X3 
sharing 87%, 93% and 70% amino acid identity respectively despite the closest 
common relative occurring more than 310 million years ago (Kamachi et al., 1998). 
Chicken S0X14 and 21 also show a high degree of non-HMG box homology (about 
50%) and again regions of homology are separated by stretches of poly alanine 
repeats (Uchikawa et al., 1999).
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Such extensive similarities would suggest functional conservation between the 
most closely related genes. Indeed SOXl, S0X2 and S0X3 have all been implicated 
in the in the consolidation of neural fate and are able to activate a luciferase reporter 
via the ôl-crystallin enhancer in lens cells (Graham et al., 2003; Kamachi et al., 1999; 
Kamachi et al., 1998; Uchikawa et al., 1999). However there is almost a three fold 
difference in the level of activation of this reporter construct by these different 
proteins indicating that the differences that do exist significantly effect their activity 
(Kamachi et al., 1999; Kamachi et al., 1998).
Two group B2 genes SoxM  and Sox21 have been shown, in similar assays, to 
act as repressors, however, their levels of repressive activity differ (Uchikawa et al., 
1999). Repressive activity is conferred by their carboxyl terminal domains and can 
also specifically interfere, in vitro, with SOXl activation of the DC5 region of the 
crystallin enhancer in lens cells (Uchikawa et al., 1999). In vivo, Soxl4  expression 
phenocopies the effect of a dominant negative form of Sox2 in the chick neural tube 
further supporting a repressive role (Graham et al., 2003). It would be misleading to 
label the Sox B2 genes exclusively as repressors since Sox21 was subsequently 
isolated in a one hybrid screen using the distal promotor of the popiod receptor as 
bait and in this context shown to be a transcriptional activator (Hwang et al., 2003).
1.12 Expression of Sox group B1 genes
As well as displaying significant sequence similarity Soxl, Sox2 and Sox3 
display considerable overlap in their expression patterns. These genes are expressed 
predominantly in the developing nervous system. However de-novo RNA expression 
has also been detected in other tissues in the developing embryo and adult, although
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most analysis has only been carried out on embryos up to mid gestation. Expression 
is detected in a variety of cells with different developmental potential, but in general 
it is suggestive of a role in pluripotent or undifferentiated cell types. Sox2 RNA is the 
first to be detected, at about 3.5dpc, in the inner cell mass of preimplantation embryos 
(Avilion et al., 2003). At the pre-streak stage (6.5dpc) Sox2 and Sox3 are expressed 
throughout the epiblast and extraembryonic ectoderm then in the initial stages of 
gastrulation expression becomes restricted to anterior ectoderm and the chorion. 
Sox3 expression is rapidly down regulated in the extraembryonic component whilst 
Sox2 continues to be expressed at the headfold stage (Wood and Episkopou, 1999). 
Beginning at the late streak stage, Sox3 ectoderm expression spreads toward the 
posterior so that by the headfold stage Sox2 and Sox3 have formed complementary 
anterior posterior gradients. It is at this stage when a low level of Soxl expression 
can first be detected in the neural plate ectoderm. All three genes are expressed in the 
neuroectoderm from the onset of somitogenesis and show varying degrees of 
overlapping expression (Collignon, 1992; Wood and Episkopou, 1999). Sox2 appears 
to have an expression pattern which almost entirely encompasses that of the sum 
Soxl and Sox3 except for a few areas of the hindbrain where some complementary 
expression patterns are seen. There are a few regions, however, such as the floor 
plate and future roof plate of the neural tube that have unique expression of Sox2. 
Cells of the peripheral nervous system display expression of Sox2 but no expression 
has been observed in neural crest cells that give rise to it (Wood and Episkopou, 
1999). In the spinal cord at 13.5dpc, overlapping expression of Soxl and Sox2 
continues to be confined to the ventricular zone, with Sox2 alone being expressed in
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the floor and roof plate regions Sox3 expression is also largely confined to the 
ventricular zone (Rizzotti, unpublished data).
Until midgestation Soxl and Sox2 expression is restricted to neuroectoderm 
but from about the six somite stage, Sox2 is also observed in a broad region of surface 
ectoderm from which all sensory placodes will derive. Within the latter, it becomes 
restricted to the individual placodes as they appear (Collignon, 1992). Overlapping 
expression of Sox3 can be seen in ectoderm adjacent to the hindbrain and overlying 
the second branchial arch at these early stages. Slightly later both Sox2 and Sox3 can 
be detected in the nasal placodes but only Sox2 alone is seen in the otic placode 
(Wood and Episkopou, 1999). Sox2 is expressed in the earliest stages of lens 
formation but then gives way to Soxl as the predominant gene expressed whilst Sox3 
is not observed in this structure (Kamachi et al., 1998). Sox2 displays de-novo 
expression throughout the endoderm of the gut and lung with a partially overlapping 
expression pattern with Sox3 that is detected in the posterior part of the foregut 
(Collignon, 1992; Kamachi et al., 1998; Wood and Episkopou, 1999).
In chick, expression of the three Sox group B1 genes is largely similar to that 
of the mouse although there a few notable differences where opposite patterns appear 
to have been adopted by Sox2 and Sox3 such as the epiblast and germ cell lineage 
(Uchikawa et al., 1999). This might indicate a random evolutionary choice between 
two very similar genes or perhaps reflect subtle functional differences with different 
suitability in the respective species. Comparing SoxB expression in the developing 
chick CNS reveals a complicated pattern of expression where different levels and 
combinations of these genes mark discrete regions (Uchikawa et al., 1999). It is
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therefore possible that proper development of particular populations of cells depends 
on the correct ratio of these factors despite their apparent similarity to each other.
1.13 Disruption of the SoxBl genes.
In mice, null mutations in all the members of the Sox group B1 genes (Soxl 
Sox2 and Sox3), have been produced with all three models displaying distinct 
phenotypes upon complete removal of the respective gene. Although there is 
extensive overlap in the expression pattern of these three genes the most severe 
phenotypes are observed in tissues where only a single SoxBl gene is normally 
detected. This suggests that in the sites where there is overlapping expression there is 
some degree of functional compensation with normal expression of other closely 
related proteins sufficient to support the basic integrity of the regulatory network. It 
is likely, however, that although these closely related genes share some common 
function, additional roles have evolved that have assured their continued existence 
and co-expression.
1.13.1 Mouse knockouts to date -  Soxl
Soxl does not appear to be essential for embryonic viability in mice but the 
targeted deletion of Soxl (Soxl"^ '̂ '̂) causes malformations in both eye and brain 
development (Malas et al., 2003; Nishiguchi et al., 1998). Micropthalmia is observed 
in mutant animals and is a result of the failure of lens fibre cells to elongate properly, 
probably as a result of the almost complete absence of y-crystallins. CNS 
development appears grossly normal despite widespread expression throughout the 
neuroepithelium but a major developmental defect in the ventral telencephalon is 
observed in SOXl deficient animals. Malformation of the ventral striatum and the
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olfactory cortex appear responsible for spontaneous seizures in animals over six 
weeks and result in secondary malformations of the hippocampus and the CAl 
pyramidal cell layer and premature death (Malas et ah, 2003).
1.13.2 Mouse knockouts to date -  Sox3
Targeting of the X-linked Sox3 gene in XY ES cells produced clones that 
were completely null as the only copy of the gene present was mutated (Parsons, 
1997). The production of chimeras from these cells results in embryonic lethality 
when the ES cell contribution is over about 10%. Embryos recovered at 9.5dpc 
showed severe aberrant morphology with posterior, mesodermally derived structures 
most severely affected. Sox3 is not expressed in these tissues and it is thought that 
these phenotypes are a consequence of an abnormality in cells as they pass through 
the primitive streak. More recently a conditionally null mutation of Sox3 has been 
produced which does not show the same phenotypes. Instead, mice completely null 
for Sox3 can be viable but often display a range of abnormalities associated with 
abnormal formation and function of the pituitary gland (Rizzoti et al., 2004).
1.13.3 Mouse knockouts to date -  Sox2
The null mutation of Sox2 was created in ES cells by replacing the coding 
region of this gene with the selection/reporter cassette figeo  (Avilion et al., 2003; 
Friedrich and Soriano, 1991). Heterozygous mice produced from targeted
clones are usually viable and show little phenotype, whilst the homozygous null 
mutation (Sox2!̂ ^̂ °'̂ ') is always lethal at the peri-implantation stage at around 5.5dpc. 
Survival to this stage may be the consequence of a pool of stable, maternally derived, 
S0X2 which appears to persist in pre-implantation embryos and suggests that one
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contribution this protein makes is to help maintain the pluripotency of embryonic 
progenitor cells. Chimera rescue experiments revealed a cell-autonomous 
requirement for zygotic S0X2 around 5.5dpc by cells of the epiblast, but rescued 
embryos then died shortly after 7.5dpc due to an extraembryonic defect (Avilion et 
al., 2003). A similar failure of inner cell mass/epiblast lineages is observed in 
embryos null for the POU protein OCT3/4 supporting evidence of cooperative 
interaction between these two proteins in the regulation of a number of genes 
expressed at these stages including Fgf4 (Ambrosetti et al., 1997), osteopontin 
(Botquin et al., 1998), UTFl (Nishimoto et al., 1999) and FbxlS  (Tokuzawa et al., 
2003) and maybe Sox2 itself (Tomioka et al., 2002). Failure at these stages of 
development makes phenotypic analysis technically demanding and it is impossible 
to obtain information about the role of S0X2 at other sites later in development.
These data demonstrate the significant role for Sox2 in a number of tissues 
prior to 7.5dpc. Isolation of purified neural precursors on the basis of Sox2  
expression (Li et al., 1998), as well as the detection of further Sox2 expression sites 
throughout mouse development suggest a significant role for Sox2 not only in these 
stages but throughout embryogenesis, but early lethality precludes the use of Sox2P̂ °̂' 
'' embryos to investigate contributions later in development.
1.13.4 Summarv of the SoxBl null mutations in mice
An examination of the mice null for SoxB genes indicates that aberrant 
phenotypes are most commonly manifest in tissues that do not have overlapping 
expression of Soxl, Sox2 or Sox3. Lens malformation, observed in Soxl"^^''' mice, 
seems to coincide with a stage in normal lens development when Soxl is up-regulated
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and Sox2 is down-regulated (Nishiguchi et al., 1998). The mutant embryos produced 
with Sox3 null ES cells are indicative of an abnormality in ectodermal cells that are 
destined to form mesoderm but no longer express Sox2 and have never expressed 
Soxl. Sox2 is the first of these genes to be expressed in the embryo and so mice null 
for this gene show the earliest abnormal phenotype of all, resulting in lethality. 
Rescue of this phenotype reveals further abnormalities resulting from a different site 
of unique Sox2 expression (Avilion et al., 2003). Together these data suggest all three 
genes have critical functions in development, but that there is likely to be some 
degree of overlapping function.
Expression analysis and functional studies in other organisms suggest that the 
SoxBl genes have important roles in the early stages of neuronal development. In 
order to reveal these roles in mice, null mutations have been created, but these models 
throw little light on gene function due to early lethality or possible compensation by 
the overlapping expression of closely related genes. The complete disruption of Sox2
or Sox3 specifically in the developing nervous system and avoiding early lethality is
b
now technically possible but may still expose little of their function due to 
compensation by the remaining wild-type SoxBl alleles. If these genes do have 
equivalent function the role of the SoxBl genes will only be revealed by the overall 
reduction in SoxBl dose. The disruption of multiple alleles may therefore be able to 
reveal some of the functions these genes have to play in neuronal development.
1.13.5 Human mutations involving SOXBl genes: S0X2.
Evidence regarding the role of the SoxB genes can also be elucidated by 
studying the effects of genetic lesions in humans. Fantes et al. 2003 show four
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patients with anophthalmia (two bilateral and two unilateral anophthalmia with 
contralateral micropthalmia) that are heterozygous for de novo truncation mutations 
in Sox2. Interestingly the more severe of the patients have non sense mutations in the 
C-terminal of S0X2  whereas the slightly less severe mutations in the middle of the 
DNA binding domain and should disrupt all binding. It may be possible that the 
more severe mutations are also acting in a dominant negative fashion that interferes 
with the function of other SOX proteins.
1.13.6 Human mutations involving SOXBl genes: S0X3.
A  number of human patients have been characterised as having some degree 
of X linked mental retardation (XLMR) in connection with the Xq26-Xq27 region 
where (the X linked gene) S0X3  is located (Laumonnier et al., 2002). Patients 
carrying a chromosomal inversion, including S0X3 are mentally retarded but display 
no significant physical abnormalities. Short stature and mental retardation in N3 
patients is linked to a S0X3 with eleven additional alanines in one polyalanine tract 
(711-783 dup (33bp)) roughly doubling its length. Two patients (from the same 
family) carrying the T84 mutation, where nine alanines are deleted from the same 
tract (718 del 27), were severely mentally retarded. Their maternal grandfather 
however carried the same mutation but showed no signs of similar mental retardation 
suggesting an additional mutation carried by the boys. Alanine expansions have been 
found in a number of other genes linked with human disease with a suggestion that 
they may cause a suppression of transcriptional activity (Han and Manley, 1993). 
T19 were short, microcephalic with mild mental retardation and peculiar facies but
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had no obvious abnormality in S0X3, although XLMR was mapped to the Xq26- 
Xq27 region (Laumonnier et al., 2002).
1.14 Scope of thesis
When one is confronted by a large group of similar regulatory genes that 
display overlapping expression patterns it is important to elucidate the role that each 
one plays. Three reasons why coexpression may be found are the following. Firstly 
redundancy. In this instance there is expression surplus to requirement and removal 
of one gene will have no effect in regions of overlapping expression. Secondly all 
members of the group are functionally equivalent but an optimal level of activity is 
achieved by the cumulative contribution of the expressed genes. Finally the slight 
differences in gene sequence between each of the members dictate distinct regulatory 
activities that could allow differential regulation of the same or discrete targets.
A suitable strategy to distinguish between each of these possibilities would 
comprise several experimental steps. In this instance I have analysed the expression 
of Sox2 in the mouse embryo as well as carrying out comparative analysis with Soxl 
and Sox3 in specific regions. This will highlight the areas most likely to be affected 
by the null mutation of any one of these genes. Phenotypes arising from the null 
mutation of individual SoxBl genes tend to be exhibited in sites where there is unique 
expression and in the case of the Sox2 null precludes any investigation after 5.5dpc. 
In order to study Sox2 by null mutation at later stages a strategy avoiding early 
lethality must be adopted. I attempted to achieve this by both the creation of a 
targeted mutation allowing a temporally and spatially specific ablation of Sox2, as 
well as identifying randomly generated Sox2 regulatory mutants. In order to address
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the role of SoxBl proteins in regions of overlapping expression the null mutation of 
individual genes is a difficult starting point, therefore I created mice carrying 
compound null mutations using the existing animal models. By the creation of 
animals harbouring all the various combinations of available SoxBl null alleles an 
idea of their relative contributions may be ascertained. The introduction of multiple 
null alleles will reduce the overall SoxBl dose to a level that might reveal more 
obvious phenotypes and illuminate the contribution these genes make during 
development. From this an assay may be developed sensitive enough to examine the 
role the individual genes might have in these sites of overlapping expression. A 
reduction in the overall dose of these genes does not, however, allow that one to 
distinguish between the second hypothesis of functional equivalence and the third 
hypothesis of distinct regulatory activity. In order to achieve this in vivo a series of 
targeted replacement experiments would be necessary to see if each gene under the 
control of another’s regulation can perform in exactly the same way.
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Chapter 2 Expression of Sox2 during mouse embryogenesis.
2.2 Introduction.
There is reiterative use of specific critical signalling molecules throughout 
development. Notable examples would be fetal growth factor 4 (Fgf4) and sonic 
hedgehog (Shh) which make significant contributions during CNS development and 
morphogenesis of the limb. The influence that such molecules have on a given cell is 
mediated via further proteins such as membrane receptors and transcription factors, 
the exact combination of which will dictate a particular cellular response. Further 
analysis might reveal diverse regulatory strategies that are built around a foundation 
of common components. It is unlikely that a single transcription factor might elicit 
an identical response from all its targets at different spatial and/or temporal points. 
Rather, a contribution is made to an overall response that is unique to a given cell 
type or even individual cell. This is achieved by the interaction of regulatory proteins 
producing a network flexible enough to provide the subtlety and diversity of gene 
expression that organisms require, especially those with greater complexity. 
Although similar mechanisms may be employed in the regulatory networks of diverse 
cell types, expression and functional data indicate that, it is the particular combination 
of all these components that defines cellular identity. It may also be true that similar 
regulatory proteins, like those within highly related families, might offer a 
mechanism whereby gene expression levels and thus cell behaviour can be modified 
in a subtle way without drastically disrupting the core regulatory network. 
Expression data is thus vital in order to understand some of the complexities of gene 
regulation within a particular cell type and will consequently help to identify common
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or unique interactions providing the individual response that defines the identity of 
any given cell.
The expression pattern of group B Sox genes has been widely investigated in 
the early stages of both mouse and chick development but only a few specific sites of 
expression have been described at later stages (Avilion et al., 2003; Cheung et al., 
2000; Collignon, 1992; Ishii et al., 1998; Pevny and Rao, 2003; Uchikawa et al., 
1999; Wood and Episkopou, 1999). A comprehensive description of the expression 
pattern of these genes, including Sox2, throughout development is thus important to 
fully understand how these proteins function and in order to decipher the phenotypes 
that arise from manipulating Sox expression in vivo or in vitro. Further analysis of 
the Sox2 expression pattern after mid-gestation was carried out in order to extend the 
current description and to establish whether there are any uncharacterised sites of 
expression.
2.2.1 Sox2P̂ °̂''̂  can be used as a tool to study Sox2 expression.
When the Sox2 allele was originally targeted with a null mutation, mice were 
produced carrying the reporter/selection fusion protein figeo  that replaced 3.5 
kilobases (kb) of one of the Sox2 alleles including the entire coding region (Avilion et 
al.. Fig. 3.2a). figeo is a fusion between the bacterial gene beta galactosidase (figal) 
and the antibiotic resistance gene neomycin (neo) (Friedrich and Soriano, 1991). 
This strategy provided an efficient way in which to isolate correctly targeted 
embryonic stem cells but had the added benefit that animals made from these cells 
should express the figeo protein under the control of the endogenous Sox2 promoter. 
Although some regulatory function could potentially have been lost expression from
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Figure 2.1 Bgeo expression in a embryo at 9.5dpc.
X-gal staining o f Sox2^^ °̂'^  ̂ embryos compares favourably with the published expression 
pattern o f Sox2 at 9.5dpc (see Avilion et. al. 2003 figure IF). Sectioning o f stained 
samples reveals the detail o f the expression but reconstruction and three dimensional 
modelling gives a much clearer impression o f staining patterns.
(a), figeo expression is revealed by X-gal staining of9.5dpc Sox2f̂ °̂'̂ '̂  embryos. The figeo 
selection cassette, under the control o f endogenous Sox2 regulatory elements, produces 
staining throughout the neural tube as well as in the gut endoderm and sensory placodes 
that are difficult to visualise in wholemount. Bar is 100pm.
(h). Three-dimensional reconstruction o f the X-gal staining pattern o f a 9.5dpc embryo 
with pseudo-colouring highlights different components o f the Sox2 expression pattern. 
This model shows only the parts o f the embryo that are expressing figeo (and are also 
positive fo r  S0X2 expression) at 9.5dpc. The most extensive staining is seen in the neural 
tube (transparent cyan) and in the oropharyangeal and gut endoderm (solid green). 
Staining is seen in all the sensory placodes at this stage. Olfactory epithelium (oe) is solid 
cyan and surrounds the anterior end o f the neural tube. Otic placode (op) lies adjacent to 
the olfactory epithelium and is coloured solid yellow. Staining in the otic vesicle (ov) is 




this cassette should reliably mimic the expression pattern of Sox2 and so can be used 
to indicate sites of Sox2 expression that warrant further investigation (Avilion et al., 
2003; Tomioka et al., 2002).
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2.3 Results
The expression of the figeo  fusion protein was visualised using the 
chromagenic substrate 5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside (X-gal) 
in partially fixed tissue (materials and methods). Visualisation of the
coloured product of X-gal is a robust and sensitive method that can be used to rapidly 
assess expression patterns in embryos that are otherwise not accessible to analysis by 
wholemount mRNA in situ hybridisation or immunohistochemistry. Whole mount 
detection of figal activity was carried out in staged embryos between
9.5dpc and 17.5dpc (Fig. 2.1 & 2.2a-h). These samples were then serial sectioned to 
reveal the detail of this staining.
Although the detection of figal activity is a useful tool for preliminary 
analysis, the stability of this bacterial enzyme means that the X-gal staining pattern 
produced may not be exactly representative of either the transcript or protein of 
interest. In order to control for the possibility that X-gal staining might be 
misrepresenting both the spatial and temporal expression pattern of S0X2 a number 
of sites showing figal activity were examined by section immunohistochemistry using 
a S0X2 specific polyclonal antibody.
At 9.5dpc, X-gal stained embryos have an expression pattern closely 
resembling the mRNA in situ hybridisation pattern of Sox2 as previously reported 
(Avilion et al., 2003; Collignon, 1992; Wood and Episkopou, 1999). This assures 
confidence that X-gal staining does indeed accurately represent the actual expression 
pattern of S0X2 in developing embryos. At this stage, the X-gal staining
pattern reveals a number of developing organs that have some degree of Sox2
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Figure 2.1 bgeo expression in embryos between ll.Sdpc and 13.5dpc.
Sox2P̂ °̂''* embryos were harvested at various stages between 11.5dpc and 15.5dpc and 
subjected to whole mount figal staining (materials and methods). Lateral (a,c,e,g) and 
ventral (b,dfih) views o f stained embryos are shown. Bar is 1mm in adjacent pairs o f 
pictures.
(a), (b). 11.5dpc: The majority o f staining is in the developing CNS. Endodermal staining 
o f the oesophagus and branching lung shows the initial development o f these organs (e).
(c), (d). lld p c : At this stage the dermal papilla o f the vibrissae are just starting to 
condense from the surrounding mesenchyme and can be clearly seen lateral to the strong 
staining in the nasal epithelium (arrowhead).
(^)y (/)• 12.5dpc: A few hours later, as the previously induced vibrissal follicles develop, 
staining o f cells in the barrel region o f the developing follicles as well as further dermal 
papillae can be seen. Ganglia o f the PNS that will innervate the hind limbs are 
prominently displayed lateral to the posterior spinal cord. The crescent shaped stomach 
epithelium marks the posterior limit o f gut staining (s).
(s)> (h)> 13.5dpc: Staining o f the CNS is much weaker as cells differentiate. Most o f the 
vibrissae present in an adult mouse have been induced with lines o f whisker follicles 
marked clearly by blue staining. Follicles o f the whisker like hairs above the eye have 
started to form and are also stained. Spots o f staining in the abdominal skin mark 
condensations o f mesodermal cells that are the dermal papillae o f the first wave o f follicle 






expression that persists throughout embryonic development. The two most 
significant components of the expression pattern can be seen in Fig. 2.1)
with extensive staining of the developing central nervous system (CNS) and the 
endoderm of the emergent gut and lung.
2.3.2 Sox2 expression in the developing nervous system
Sox2 is expressed throughout the nervous system from the earliest stages of 
development (Avilion et al., 2003) and persists in the majority of CNS cells until mid 
gestation (Avilion et al., 2003; Collignon, 1992).
During the second half of embryonic development there is an elaboration on 
the basic CNS plan resulting from proliferation and differentiation. At 10.5dpc, in 
whole-mount preparations, X-gal expression is observed throughout the CNS and in 
the ganglia of the peripheral nervous system (PNS) (Fig. 2.2a,b). figal expression 
becomes increasingly restricted from this stage onwards commencing coincidently 
with the differentiation of the embryonic CNS (Collignon, 1992). Expression is lost 
first from the ventral neural tube throughout the region of the post-mitotic (motor) 
neurons. By 13.5dpc a signal is still present but it becomes more refined as further 
neurons of both the central and peripheral nervous systems differentiate and cease to 
divide. However, there continues to be populations of cells that maintain Sox2 
expression in the brain and spinal cord up to and after birth (Fig. 2.2g,h).
As the complexity of the developing CNS increases it is necessary to identify 
the sites of S0X2 localisation on a cellular level. Hence immunohistochemistry was 
performed on serial sections of mid to late gestation brain, using the SOX2 antibody.
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which emulates the pattern of mRNA in situ hybridisation results (Collignon, 1992) 
and figal staining in the early stages of CNS development.
At 10.5dpc the S0X2 antibody marks the majority of neuroepithelial cells of 
the developing CNS where neuro and gliogenesis is taking place (Fig. 2.4a). At later 
stages staining remains associated with populations of undifferentiated and dividing 
cells that line the ventricles but further populations are also marked by S0X2 
expression. At 16.5dpc S0X2 is predominantly visualised in the ventricular and sub- 
ventricular layers. In the forebrain, cells travelling to the olfactory bulb from the 
lateral ventricles form a structure called the rostral migratory stream (RMS) that 
continues to contain neuronal precursors into adulthood (Hartfuss et al., 2001). 
S0X2 is detected in cells of the RMS but also in those migrating from the ventricular 
zones of the lateral ganglionic eminence to populate the nucleus accumbens and the 
olfactory tubercle. The most closely related Sox proteins SOXl and SOX3 were also 
detected in serial sections showing that in this region there is extensive overlap in 
their expression patterns. In the forebrain, staining in the ventricular zones and RMS 
always appeared very similar, but SOXl staining in the olfactory tubercle appeared to 
be slightly more extensive than either S0X2 or S0X3 (Fig. 2.3a-c) (Malas et al., 
2003).
2.3.3 Sox2 expression in gut and lung.
Staining in the endodermally derived epithelial tissue of the lung, gut and 
oropharyangeal area is clearly seen in X-gal stained embryos up to 13.5dpc (Fig. 
2.2a-h &2.1b(green)). Immunohistochemistry confirms this pattern and reveals that 
S0X2 protein is localised to the nucleus. SOX2 is detected from the earliest stages
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Figure 2.3 SOXBl expression in the forbrain of 16.5 dpc embryos.
Serial sagittal sections o f the anterior portion o f 16.5dpc mouse embryo brain. SOXl, 
S0X2, and S0X3 proteins were detected using specific polyclonal antibodies (materials 
and methods). Bar is 200pm.
The staining pattern reveals a very similar expression pattern in these structures with cells 
from the same populations positive for each antibody. New cells are ’bom ’ in the regions 
surrounding the lateral ventricle (Iv) and then migrate away from this site to populate 
other regions o f the developing brain. Much o f this migration is radial (such as for the 
cortex) where as other specific structures are populated by streams o f migration o f 
relatively undifferentiated cells such as in the rostral migratory stream (rms) that leads to 
the olfactory bulbs and migrating cells o f the lateral ganglionic eminence that populate the 












examined but as the lung develops only the larger of the branching vessels remain 
positive (Fig. 2.4g,h). Samples of adult lung stained for figeo activity show that, even 
at these stages, there continues to be a strong signal in the larger bronchial vessels. 
Strong staining is seen in the oesophagus and stomach (Fig. 2.4i,k) reiterating the 
figal expression observed in embryos (Fig. 2.2). S0X2 is expressed in the
oropharyangeal epithelium, including the invagination that forms Rathke’s pouch 
(Kamachi et al., 1998). Patches of staining seen on the tongue of 13.5dpc embryos 
stained with X-gal indicate that Sox2 is likely to be expressed in the clusters of cells 
that will eventually form the taste buds (fungiform papillae) (Fig. 2.41).
2.3.4 Sox2 expression in sensory epithelial structures
Sox2 expression has been described as marking the earliest cell populations in 
sense organ development (Collignon, 1992; Wood and Episkopou, 1999). From 
9.5dpc, whole mount staining is unable to clearly show the extent of figeo expression, 
but reconstruction of the X-gal pattern from serial sections with pseudo colouring 
gives a much better indication as to the extent of staining in the developing sense 
organs (Fig. 2.1b). X-gal staining clearly marks the first stages of eye development 
with expression at this stage marking optic cup and prospective lens tissue. The 
expression of SoxB l genes has already been described in some detail in the 
developing eye (Collignon, 1992; Kamachi et al., 1998; Nishiguchi et al., 1998) and 
expression of figeo in Sox2f̂ °̂'̂ '̂  embryos closely matches this pattern.
At 9.5dpc the olfactory epithelium covers the most anterior aspect of the 
embryo and Sox2̂ "̂°'̂ '̂  samples show figeo expression throughout this area; a pattern 
again matched by mRNA in situ hybridisation results (see fig 7a and 7b in
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Figure 2.4 S0X2 expression in embryonic mouse sections.
S0X2 expression in various sections taken from mouse embryos between 10.5 and 13.5 
dpc.
(a). Transverse section through the head region o f a 10.5dpc embryo showing staining in 
neural epithelium o f the CNS, optic cup (o), neural epithelium (nh) o f hindbrain (sorry 
about the bubble). Bar is 100pm.
(h). Transverse section through hindbrain region o f an 11.5dpc embryo showing staining 
in the ependymal layer (el) but not the post-mitotic mantle layer (ml). Bar is 100pm.
(c). Sagittal section through ear o f a 13.5dpc embryo showing staining in thickened 
epithelium o f the prospective sensory patches, saccule (s), vestibulocochlea Vlll ganglion 
(g). Bar is 50pm. f  Close up o f saccule staining in c. Bar is 20pm.
(d). Sagittal section o f 13.5dpc embryo showing the cytoplasmic staining o f dorsal root 
ganglia cells. Bar is 100pm. e Close up ofd. Bar is 20pm.
(g). Sagittal section through the lung o f a 13.5dpc embryo showing staining in the 
epithelial layer o f bronchus (b). Bar is 100pm. h Close up ofg. Bar is 20pm.
(i). Transverse section at the mouth level o f an 11.5dpc embryo showing nuclear staining 
o f the epithelium o f the pharangeal region o f the foregut (f) and the laryngeal orifice (la). 
Bar is 20pm.
(j). Sagittal section through stomach o f a 13.5dpc embryo showing staining in the 
epithelial lining. Bar is 200pm. k  close up ofj. Bar is 50pm.
(I). Sagittal section o f 13.5dpc tongue showing epithelial staining, particularly in the 
fungiform papillae (arrow). Bar is 50pm.
(m). Fluroescence immunohistochemistry to detect S0X2 (red) in the olfactory epithelium 
o f a 14.5dpc embryo. This section was then subject to S0X3 immunohistochemistry shown 
in n. Arrow marks midline. Bar is 20pm.
(n). Fluorescence immunohistochemistry showing that S0X3 (green) is not present in the 
olfactory epithelium. This is the same section as m. Sequential immunohistochemistry was 
performed as described in materials and methods. As an internal control S0X3 was 











(Collignon, 1992; Kamachi et al., 1998)). Wholemount X-gal staining of 
embryos indicates the continued expression of Sox2 in the nasal epithelium (Fig. 
2.2a-h). By 14.5dpc the S0X2 antibody detects protein in the medial portion of the 
epithelium lining the nasal cavity whilst no SOX3 (or SOXl) can be detected at this 
stage (Fig. 2.4m,n) despite earlier overlapping expression in these endodermally 
derived tissues ((Collignon, 1992; Wood and Episkopou, 1999) and Brunelli 
unpublished data).
Sox2 expression in the developing Ear
Sox2 is detected during the formation of the embryonic ear from the earliest 
stages of otic placode formation (Collignon, 1992; Wood and Episkopou, 1999). X- 
gal staining of the developing ear in Sox2P^ °̂''  ̂ embryos matches that observed with 
the antibody and shows a pattern marking the prospective sensory epithelia that 
becomes increasingly restricted as this complex structure develops.
The ear is an elegantly complex organ responsible for the senses of hearing 
and of motion and position. The molecular mechanisms dictating the morphogenesis 
and differentiation of the mammalian ear are largely unknown although a number of 
genes have been linked to both syndromic and non-syndromic deafness in humans 
(Steel and Kros, 2001). Further genes have been implicated in various aspects of ear 
development through null mutations and expression studies in mouse, chick and frog 
(Torres and Giraldez, 1998).
Sensory cells responsible for detecting sound or motion and transmitting them 
to the brain are located in the inner most part of the ear structure. Mammals have a
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Figure 2.5 X-gal staining of S embryos marks Sox2 expression in the inner ear.
(a). Whole mount X-gal staining o f a 11.5 dpc Sox2®®̂ °’̂  ̂embryo. The outline o f the otic 
vesicle is difficult to visualise against the background o f staining in the CNS but is marked 
in the high magnification view where some blue staining can be seen. For orientation 
purposes D is dorsal, L is lateral and A is anterior. Bar is 200pm.
(b). After wax embedding and sectioning staining o f the otocyst can be clearly seen in the 
thickened epithelium o f the developing inner ear. Computer reconstruction o f from  
sections shows how staining relates to the entire structure. Example sections below 
correspond approximately to the regions marked on the model. Light blue corresponds to 
space within the otocyst. Green, yellow and red mark low to high intensities o f X-gal 
staining respectively. Reconstruction o f this structure from sections shows how the figeo 
expressing cells are wrapped around the lumen o f the developing inner ear and mark 
regions where sensory epithelium will develop in both the prospective cochlea and 
vestibular components. Bar is 200pm.
(c). Computer reconstruction o f the developing inner ear o f S0x2̂ ^̂ °'̂  ̂ embryo at 9.5dpc 
showing X-gal staining. Yellow and red colour marks X-gal staining with transparent grey 
indicating the shape o f the otic epithelium. Bar is 100pm.
(d), (e). Similar to (c) but with the inner ear o f a 10.5dpc and 12.5dpc Sox2P̂ °̂'̂ * embryo 
shown respectively. Bars are 100pm.
(f). Immunohistochemistry using a S0X2 specific antibody marks the prospective sensory 
epithelial cells o f the cristae in a 13.5dpc mouse embryo. Bar is 20pm.
(g). Schematic representation o f the inner ear structure at 14.5dpc showing the 
localisation o f sensory epithelia. cO cochlea, c cristae, mu macula utriculi, ms macula 
sacculae. (Fekete, 1999).
(h-j). Serial section immunohistochemistry using antibodies specific for  SOXl (h), S0X2
(i) and S0X 3 (j) only detects the presence o f S 0 X 2  protein in the mouse inner ear at 
14.5dpc. Staining is observed in the prospective sensory epithelia o f both the cochlea and 
vestibular halves o f this structure. Success o f the immunohistochemical procedure where 
no inner ear staining was detected was determined by observing appropriate staining in 
other structures on the same section (data not shown). Labels as for (g). Bars are 100pm.
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pair of ears and each of these derives from an area of epithelium adjacent to the 
neural epithelium of the headfold. By 9.5dpc these otic placodes invaginate forming 
hollow epithelial spheres, the otic vesicles, lateral to rhombomere four of the 
hindbrain. Almost all of the cellular components of the inner ear derive from the otic 
vesicle although there is a small contribution from a neural crest derived melanocyte 
population (Roydon-Price and Fisher, 2001). From a simple structure at this stage 
cells divide and differentiate to produce a highly complex and organised form capable 
of sensing sound as well as changes in position in space. Both auditory and motion 
senses rely upon the endolymphatic fluid which fills the inner ear. External sound or 
change in aspect causes movement of this fluid, stimulating hair cells of the 
respective sensory epithelia. The cochlea is the component of the inner ear that is 
responsible for the detection of sound whereas the vestibular sensory cells of the 
macula sacculae, macula utriculi and the cristae record changes in gravity or angular 
acceleration. Sound waves collected through the outer ear are transduced and 
amplified mechanically through the middle ear and are finally converted into 
vibrations of the endolymph of the inner ear. The spiral shaped cochlea has an array 
of auditory hair cells aligned along its length, collectively called the organ of corti. 
Different amplitudes and frequencies of vibration will stimulate particular sets of hair 
cells in the cochlea to different extents and in this way a wide range of sounds can be 
detected and then interpreted by the brain.
Three-dimensional reconstruction from serial sections of these embryonic 
inner ears make it easier to visualise areas that express figeo  in the initial stages of 
otocyst formation, between 9.5 and 12.5dpc (Fig. 2.5a-e). This expression pattern is 
confirmed by anti-S0X 2 immunohistochemistry (Fig. 2.5f,i). Models and section
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data indicate that Sox2 is expressed in all the cells from which the sensory epithelium 
derives as well as in the ganglia that innervate them (Fig. 2.5).
It has already been reported that Sox2 marks the prospective otic placodes at 
8.5dpc, but at 9.5dpc Sox2 is detected only in the ventral half of the otic vesicle 
(Chapter 1) (Fig. 2.5c). By 11.5dpc the otic vesicle has begun to resolve its final 
structure with a clear division between the auditory and vestibular halves of the inner 
ear. The 3D model representing the expression pattern of Sox2 at this stage shows the 
protein localising to the developing cristae and maculae at the base of the vertical 
canal plate and extending along the side of the cochlea anlagen that will develop into 
the organ of corti. At 13.5dpc and 14.5dpc immunohistochemistry confirms that 
S0X2 is present only in the prospective sensory cells of the vestibular and auditory 
components of the inner ear and that both SOXl and S0X3 are absent (Fig. 2.5h-j). 
Staining observed in thickened regions of the otic epithelia confirms that they are 
likely to be prospective sensory cells. A signal is also detected in cells of the 
facioacoustic (VII-VIII) ganglion complex that will eventually innervate the fully 
formed inner ear (Fig. 2.5i).
2.3.5 Sox2 expression in the hair follicles of the vibrissae and pelage.
A site of Sox2 expression that has not been described previously is the 
developing hair follicle. Sox2 mRNA expression is detectable at 13.5dpc just under 
the epithelial layer adjacent to the nostrils. Radioactive mRNA in situ hybridisation 
indicates that there is expression of Sox2 in some component of the developing 
vibrissae but because this procedure has no cellular resolution it is impossible to 
accurately ascertain exactly which cells these are (Fig. 2.9h) (Collignon). Various
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stages of follicle development were therefore analysed in order to clarify the 
expression pattern of Sox2 and to elucidate how it might be contributing to follicle 
development.
The hair follicle is just one of a number of epithelial appendages in diverse 
species that require a series of reciprocal inductive interactions between the 
epithelium and the mesenchyme for their correct formation, the first steps of which 
appear to be evolutionarily conserved. In mice four discrete waves of follicle 
induction occur, each giving rise to a particular type of hair but the general processes 
involved in induction of all hair follicles appear to be the same (Hardy, 1969; Slee, 
1962). Two main phases are involved in follicle induction, initially the number and 
spacing of placodes is determined and then this is followed by cellular differentiation 
that facilitates the formation of one of a myriad of possible structures.
Follicle induction
The first of these signals defines areas that are competent to form appendages 
and tissue recombination experiments demonstrate that they derive from the 
mesenchyme (Fig. 2.6a) (Hardy, 1992; Oro and Scott, 1998; Reddy et al., 2001). 
Focal points of appendage formation are defined, possibly through a reaction- 
diffusion mechanism (Slack, 1991), and cause regions of epithelium to thicken 
forming placodes. From these points a second, epidermally derived, signal instructs a 
small group of underlying mesenchyme cells to condense (Fig. 2.6b). From this 
group of cells the third message instructs epithelial differentiation and proliferation to 
produce an appendage appropriate to its class of origin, whether that be scale, feather
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Figure 2.6 Epithelial-mesenchymal interactions during follicle development.
Figure adapted from M.H. Hardy (1992) showing the flow o f signals in the early stages of 
follicle development.
(a). First, mesenchymal, signal indicating ‘make an appendage \
(b). Second, epithelial, signal defining point at which appendage is to be made.
(c). Third, mesenchymal, signal directing what sort o f appendage to make.
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or hair (Fig. 2.6c). It has become clear that there is a range of factors and 
collaborations involved in the formation of these epithelial appendages that may 
throw light on developmental processes common to other sites of organogenesis.
Pathways involved in the signalling interplay between mesodermal and 
epidermally derived structures appear to be complex but a few genes have been 
shown to play important roles in this process. The initial patterning of placodal fields 
appears to rely on the interplay between several factors such as Wnts, FGFs, BMPs, 
Notch and Delta and Noggin (Millar, 2002).
WNT signalling and platelet derived growth factor-A (PDGF-A) contribute to 
the second (epithelial) signal triggering the induction of the dermal condensate. 
Sonic hedgehog (Shh) expression depends upon the WNT signal and is required for 
the development of the dermal condensate into the dermal papilla. In Shh deficient 
mice there is no down growth of the follicular epithelium and so it is likely to be 
involved in initiating the third signal from the dermal condensate which might 
involve the production of activins/BMPs and their inhibitors (Millar, 2002).
Follicle growth
The progression of epithelial proliferation in hair development produces a 
plug that elongates into the mesodermal layer. The position of the mesodermal 
condensation is maintained at the base of the plug as two layers of epithelial cells 
form the inner and outer root sheath (1RS and ORS). Subsequent proliferation almost 
completely surrounds the dermal condensate, which develops into the dermal papilla, 
with cells adjacent to this structure forming the matrix. Matrix cells proliferate 
transiently and move toward the surface with central matrix becoming pre-cortical
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cells that subsequently give rise to the cortex, medulla and cuticle of the hair shaft. 
More peripheral matrix cells form the 1RS which is in turn surrounded by ORS. Near 
the skin surface the 1RS degenerates, allowing the newly formed hair shaft to be 
pushed outward as further matrix cells differentiate (Fig. 2.7).
Follicle cycling
Once fully formed, follicles enter a cycle of active growth (anagen) regression 
(catagen) and rest (telogen) that is normally maintained throughout postnatal life. It 
is only the lower half of the hair follicle that undergoes change, with cells for follicle 
renewal residing in the bulge region at the base of the permanent portion. At the end 
of anagen matrix cells lose their proliferative capacity and the lower part of the 
follicle regresses bringing the dermal papilla closer to the bulge region (Fig. 2.7 
Catagen). At the telogen/anagen transition a signal, which is perhaps from the 
dermal papilla, triggers proliferation of a few stem cells that produce new matrix and 
ORS that differentiate and move downward(Fig. 2.7 Anagen I). When the lower half 
of the follicle is reformed once more, further proliferation becomes restricted to the 
matrix cells that are in contact with the dermal papilla as the follicle progresses 
through a new cycle (Fig. 2.7 Anagen IV-VI).
2.3.6 Whole mount X-gal staining of the developing hair follicles in Sox2P̂ °̂'̂ '̂  
embryos.
From 12dpc small spots of X-gal staining in the hair germs of the vibrissae 
begin to appear in Sox2^^^°''^ embryos. This coincides with the first morphological 
signs of induction of these follicles (Fig. 2.2d). Vibrissae form in rows lateral to the 
nostrils and just a few hours after the first induction is observed the X-gal staining
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Figure 2.7 The stages of hair follicle formation and cycling.
Cartoon indicating the key stages in hair follicle induction and cycling. Morphogenesis 
occurs only once in the lifetime o f an animal but the cycle o f growth, regression and 
moulting occurs many times over.
Epithelium (Epi), Bulge region (Br), Hair shaft (Hs), Dermal sheath (Ds), Inner root 
sheath (1rs), Hair shaft precursors (Hs Prec.), Matrix (M), Dermal papilla (Dp).
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pattern becomes more extensive as the follicles develop and additional populations of 
cells in each begin to express figeo. At 13.5dpc the induction of this hair type is 
complete and X-gal staining marks all the vibrissae formed including those above the 
eye and on the cheek (Fig. 2.2g,h). Also at 13.5dpc is the first appearance of the 
pelage follicles with a few spots of figeo expression detectable over the lateral aspect 
of the abdomen (Fig. 2.2g). By 15.5dpc X-gal reveals a fairly evenly spaced, 
uniformly stained set of spots over most of the surface of the embryo. This 
corresponds to the completion of the first wave of pelage follicle induction (Fig. 
2.8a). Follicles induced in this round of induction will produce monotrick hairs that 
are the longest hair type in the adult coat (Dry, 1926; Hardy, 1969). At 17.5dpc 
extensive staining of the large whisker follicles is observed and a similar, although 
smaller, version of this staining is seen in the monotrick pelage follicles. Shortly 
after the primary spate of pelage follicle formation a second wave of induction 
produces the placodes of the outer coat that contains the hair types awls and auchines. 
Once again the figeo spots appear in a roughly hexagonal array in between the sites of 
monotrick induction (Fig. 2.8d). Just before birth, there have been two rounds of 
pelage hair follicle induction in the skin and it is clear that all the follicles formed by 
this point show X-gal staining in the Sox2-̂ ^̂ °'̂ '̂ embryos. By 17.5dpc strong blue 
staining of the entire dermal sheath of the developing vibrissae give a “comma” like 
appearance to these well established hair follicles (Fig. 2.8d).
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Figure 2.8 X-gal staining of Sox2!̂ ^̂ °''̂  embryos marks Sox2 expression in the hair
follicles.
(a). By 15.5dpc the first wave o f pelage hair follicle induction is almost complete, figal 
expression reveals a fairly evenly spaced pattern o f dermal papilla that belong to follicles 
that will give rise to the largest hairs in the mouse pelage, the guard hairs or monotricks.
(b). At 17.5dpc two populations o f pelage follicles can be seen, the larger spots mark 
those ones developed from the first wave o f induction with smaller spots indicating follicles 
formed in a second wave.
(c). Higher magnification view o f the head o f the embryo in b showing the lines o f 
vibrissal follicles that have formed lateral to the nostrils. These follicles are no longer 
marked by just a spot o f expression but have many cells staining blue.
(d). Higher magnification view o f the 17.5dpc skin showing follicles induced over two 
rounds. The larger first round monotrick follicles have a similar expression pattern to 
those o f the vibrissae but are smaller.
Bar is 1mm for a,b and c, and SOOgimfor d.
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2.3.7 Sectioning reveals the detail of Sox2 expression pattern in individual hair 
follicles
The staining pattern of individual follicles broadens as they develop and this 
is highlighted in histological sections of X-gal stained samples and by
section immunohistochemistry with a S0X2 antibody.
S0X2 immunohistochemistry confirms that the protein appears at the initial 
stages of hair induction in both vibrissae and pelage follicles in an identical pattern to 
that of figeo in embryos (Fig. 2.9a-f). SOX2 is detected from the earliest
stages of follicle development in the nuclei of cells that have responded to the second 
inductive signal. All dermal condensations are marked by S0X2 expression soon 
after the adjacent epithelial placodes begin to thicken (Fig. 2.9a,d)- This cluster of 
cells maintains S0X2 expression as the epithelial component of the follicle 
proliferates forming the first inner and outer root sheath cells (Fig. 2.9b,e). Once 
created the dermal condensation and subsequently the dermal papilla is believed to 
direct the overlying epithelial cells to form the highly organised follicle structure 
containing six concentric cylinders of cells each synthesising its own distinctive set of 
proteins. More developed follicles display further staining around the in vagin ating 
follicular epithelium. These are the mesodermally derived dermal sheath that show 
X-gal (Fig. 2.9k) as well as immunohistochemical staining for S0X2 (data not 
shown). They have many dermal papilla properties and have been proposed to 
repopulate it throughout the life of the animal (Reynolds et al., 1999).
Further characteristic expression of S0X2 appears to be limited to vibrissae and the 
first follicles to develop on the torso that give rise to monotrichs. In these follicles
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Figure 2.9 Sox2 expression in developing hair follicles.
This series o f images shows how the expression o f S0X2 closely matches that o f figeo 
expression from the earliest stages o f hair follicle development. Bar is 20p,m in all 
pictures.
(a)-(c). X-Gal staining o f early stage hair follicles in Sox2f^^°*'' embryos, a stage 0-1, b 
stage 2, c stage 3a.
(d)-(f). S0X2 localization in early stage hair follicles, following staining in the condensed 
mesenchyme (arrow head). Occasional staining o f epidermal cells can be detected in later 
stage follicles, (arrow), d stage 0-1, e stage 2, f  stage 3a.
(g). Representative pre-immune serum control. This particular serial section equivalent to 
e
(h). Detection o f Sox2 RNA in 13.5dpc vibrissae by radioactive in situ hybridization 
(J.Collignon).
(i). Detection ofSox2 RNA in the developing feather buds o f stage 34 chick skin.
(j). X-gal staining in the skin o f a 16.5dpc Sox2f^^°^' embryo. The second component o f 
staining is seen in the more mature follicle (centre). Note the similarity with figure F.
(k). A stage 5 vibrissal follicle which indicates the three components to S0X2 expression 
in this structure. The dermal papilla (dp), the dermal sheath (ds) and the epithelial cells 
that may be Merkel cells (br) these reside within the 'bulge region’ o f the hair follicle 
(arrow head). The dotted line marks the boundary between the epidermis and dermis.
(I). X-gal stained adult hair follicles. In this section a catagen phase hair follicle shows 
staining o f the dermal papilla (dp) and a cluster o f cells, just below characteristic cells of^ 
the sebaceous gland (sg), that is referred to as the bulge region (br).
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s 0X2 positive cells are first detected in the ORS from stage 3c onwards (Fig. 2.9f). 
In whole mount they are seen as an incomplete ring of cells close to the surface of the 
skin (Fig. 2.9j). At later stages most stained cells are found in the bulge region with 
fewer detected in other parts of the isthmus (Fig. 2.9k). This ‘horseshoe’ pattern is 
reminiscent of the expression of mouse atonal homologue-1 (MATHl) that marks 
Merkel cells in the developing hair follicle (Ben-Arie et al., 2000). Merkel cells are 
mesodermally derived slowly adapting mechanoreceptors that are activated by steady 
skin indentation (Szeder et al., 2003). Stem cells, that support the cyclical growth 
and regression of the fully formed hair follicle, are also thought to reside in the bulge 
region and their behaviour may be influenced by the Merkel cells (Moll et al., 1996; 
Oshima et al., 2001).
2.3.8 Sox2 expression in adult leveling^ follicles.
All three components of the staining pattern persist in anaphase monotrick or 
vibrissae hair follicles from adult animals. Regressing or resting stage follicles 
appear to only maintain Sox2 expression in the dermal papilla and in cells in the 
bulge region that lies next to the characteristically large cells of the sebaceous gland 
(Fig. 2.91). No expression of the most closely related SoxBl genes Soxl and Sox3 
was detected in any of the stages of follicle development.
2.3.9 Expression of Sox2 in feather buds in chick embryos.
The first stages of feather formation are very similar to that of hair with 
interaction between cell layers forming a epithelial placode and an underlying 
mesodermal condensation. Cell proliferation as well as recruitment of mesodermal 
cells produces a feather bud that first protrudes out of the skin surface before
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invaginating inward to form a feather follicle. The mesodermal component forms the 
dermal papilla and is surrounded by the collar, which equates to the matrix region of 
a hair follicle, and is the region where new epithelial cells are added to the growing 
feather. The characteristic shape of the mature feather is achieved by complex 
combination of epithelial invagination, fusion and cell death that gives rise to feather 
barbs and barbules. Sox2 is expressed in murine epithelial appendages but it is 
unclear as to whether this is a conserved site of expression in diverse species. To test 
this, mRNA in situ hybridisation was performed on the initial stages of feather bud 
formation in chick embryos with preliminary analysis indicating the presence of Sox2 
transcripts (Fig. 2.9i).
The signal is first detected in patches of dorsal skin of stage 33 chick embryos 
(Hamburger and Hamilton, 1951) just before there is any morphological sign of 
feather bud induction (Jung et al., 1998). As feather bud development progresses the 
signal becomes slightly more widespread with Sox2 appearing to be expressed in all 
the mesodermal cells within the protruding feather bud. The results show that in the 
initial stages of epithelial appendage formation Sox2 is expressed in equivalent 




The comprehensive examination of expression patterns provides invaluable 
information with regard to understanding the role a particular gene has to play during 
development. An expression pattern may mark seemingly diverse sites that are 
linked by a particular property. Expression data could therefore provide clues to the 
role and possibly mechanism of action of any given gene.
Previous examination of SoxB gene expression including Sox2 has focussed 
on stages prior to midgestation with the exception of a few specific sites (Chapter 1). 
During these stages Sox2 expression is generally limited to relatively undifferentiated 
cells such as the epiblast, neuroepithelium of the CNS and gut endoderm. A further 
examination of Sox2 was undertaken primarily to investigate the possibility of 
uncategorised sites of expression in the second half of embryogenesis and to identify 
sites of expression that might be interesting to study by the conditional null mutation 
of Sox2.
This investigation also provided the opportunity to describe Sox2 expression 
at later developmental stages and confirmed that the expression of figeo, from the 
targeted allele Sox2-^^ '̂’, is a reliable indicator for the expression of Sox2. Having 
established this, Sox2̂ ^̂ °'̂ '  ̂ tissue may be used to isolate pure populations of Sox2 
expressing cells for in vitro experimentation, either by antibiotic selection or by 
fluorescence activated cell sorting (Li et al., 1998; Zappone et al., 2000). One use for 
Sox2 expressing cells from diverse sites may be in identifying common targets or co­
regulators by comparative analysis of expressed genes. In this instance it is important
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to know exactly which cells are expressing the selectable marker so that particular 
populations may be isolated.
After midgestation S0X2 expression is maintained in many of the tissues 
where it is first detected at earlier stages in development (Chapterl), (Wood and 
Episkopou, 1999). In the CNS Sox2 continues to be expressed predominantly in sites 
of neurogenesis for example in the ventricular and sub-ventricular zones of the 
developing forebrain. In these areas Sox2 shares expression with its closest relatives 
Soxl and Sox3. S0X2 is also detected, along with SOXl and S0X3, in many of the 
cells contributing to the olfactory tubercle although SOXl staining does appear a 
little more extensive in this region. The null mutation of Soxl produces a severe 
disruption of olfactory tubercle development, but there is no obvious consequence to 
its absence in other areas of the developing CNS (Chapter 1) (Malas et al., 2003). 
This suggests that functional similarities with the other SoxBl genes may be 
sufficient to compensate for the loss of SOXl in many cells where there is 
overlapping expression, but there may be some unique role for SOXl in olfactory 
tubercle development. Similar unique roles may be revealed upon conditional 
disruption of Sox2 or Sox3 in the developing CNS. Where there is overlapping 
expression and functional compensation, multiple null alleles may have to be 
introduced before phenotypes are exhibited and the role of these genes in these cells 
deciphered (Chapter 5).
Sox2 has a broader expression pattern than either Soxl or Sox3 with the most 
extensive sites of overlapping expression limited to the developing CNS. At early 
stages there is also overlapping expression of Sox2 and Sox3 in the sensory placodes
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of the nose and ear but by 13.5dpc Sox3 is no longer co-expressed in these tissues 
where Sox2 only is observed (Fig. 2.4m,n & Fig. 2.5i,j). In the developing lens Soxl 
and Sox2 initially have overlapping expression but Sox2 is down regulated so that by 
12.5dpc only Soxl is expressed. This is the same stage at which lens abnormalities 
appear in SoxX^'^' animals indicating that in the lens, up until this stage, functional 
compensation by Sox2 is sufficient for normal formation (Nishiguchi et al., 1998). 
Similar compensation may also occur at other sites of overlapping expression. If this 
is the case then null mutation may be expected to cause the most severe phenotypes 
in tissues where there is unique expression or where overlapping expression of close 
relatives has ceased. This information may be critically important when attempting 
to link the phenotypes of uncategorised mouse mutants with a specific gene.
The initial stages of inner ear formation are marked by overlapping expression 
of Sox2 and Sox3, but Sox3 expression is soon down regulated leaving Sox2 as the 
only SoxBl gene expressed in this region (Fig. 2.5i,j) (Uchikawa et al., 1999; Wood 
and Episkopou, 1999). Sox2 marks sensory placode cells from the outset of inner ear 
formation (Wood and Episkopou, 1999) and expression in the neuroepithelium 
persists as the major elements of this complex structure are formed. Three 
dimensional reconstruction shows Sox2 in the ventral half of the otic vesicle at 9.5dpc 
and it persists in cells of the prospective sensory epithelium as the structure of the 
inner ear develops (Fig. 2.5c-e). By 14.5dpc S0X2, but not SOXl or S0X3, is 
detected in the prospective sensory cells along one side of the cochlea and in 
vestibular neuroepithelium (Fig. 2.5h,i,j).
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SoxBl expression in chick differs slightly in that all three genes are detected 
during inner ear formation (Uchikawa et ah, 1999). Sox2 and Sox3 are detected from 
stage 9-10 (~8.5dpc mouse) in the otic placode whilst Soxl appears slightly later, just 
before stage 18 (~9.5dpc mouse). Stage 28 chick embryos (~12.5dpc mouse) have 
strong and uniform expression of Sox2 in all the sensory neuroepithelial patches of 
the inner ear, Soxl is strong in the cristae but weak in other sensory patches and Sox3 
is detectable in the cristae only. These observations indicate a degree of regulatory 
conservation between these two species and differences may simply reflect the 
alternative evolution of regulatory elements where there was once functional 
redundancy. Perhaps a more interesting possibility is that these alternative patterns 
represent the evolutionary fine tuning of an ancestral inner ear structure that has 
produced differences in the relative levels of these transcription factors in the 
respective species. Even slight differences in activity may have favoured the 
conservation of an individual gene’s expression during the evolution of an optimal 
regulatory architecture. This possibility may be investigated to some degree by 
targeted exchange of the coding region of these genes and is discussed further in 
chapter 5.
Sox2 expression in vibrissal and pelage hair follicles was described for the 
first time in this study with staining observed in more than one component of the 
developing follicle. Detection of S0X2 in precursors of receptor cells correlates well 
with expression in the other sensory organs, the tongue and perhaps in the lining of 
the gut and lung. In these locations S0X2 may have some role in determining the 
identity of specialised cells required for detecting and transducing changes in their 
environment. Other Sox2 expressing cells in the hair follicle have a completely
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different function. From the earliest stages of hair follicle development S0X2 is 
detected in dermal condensations that form in response to an epithelial signal, 
possibly involving the Wnt signalling pathway and platelet derived growth factor-A 
(PDGF-A) (DasGupta and Fuchs, 1999; Millar, 2002). Once initiated, Sox2 
expression is maintained in this group of cells into adulthood with no expression of 
either Soxl or Sox3 ever detected here. S0X2 is also observed in the dermal papilla 
during feather formation indicating that this is an evolutionarily conserved site of 
expression. In both species this group of cells directs the correct formation of 
overlying epithelium, both initially and during successive rounds of growth and 
regression. Cross talk between opposing cell layers is a common theme throughout 
development and epithelial-mesenchymal interactions have been demonstrated to 
regulate chick cSox2 in both the developing gut and lung (Ishii et al., 1998). Similar 
interactions may also be working to pattern these structures in the mouse. The 
dermal papilla is critical in the complex reciprocal signalling between juxtaposed cell 
layers and grafting experiments indicate that there is a defined progression of 
signalling in epithelial appendage development (Fig. 2.6) (Hardy, 1992).
There is also overlapping expression with the SoxF gene Soxl8 and this 
perhaps further indicates conserved regulatory functions in epithelial appendage 
formation (Olsson et al., 2001; Pennisi et al., 2000b). Interestingly the null mutation 
of Soxl 8 in mice only has minor effects on hair formation but the expression of a 
truncated form produces far more significant phenotypes (Pennisi et al., 2000a). The 
authors suggest that this is due to a trans-dominant negative effect disrupting the 
contribution to the regulatory network of multiple Soxes and may indicate a more 
significant role for Sox2 in this site. This is discussed further in chapter 4.
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The diversity of the Sox family means that there are very few tissues where 
there is unique expression of any single member and this may be key to aspects of the 
regulatory role these genes have to play. There are several examples of tissues where 
the initial expression of a particular Sox gene is augmented or replaced by that of 
another family member as cells become increasingly committed to a particular fate. 
Whilst cooperative binding ensures certain targets will be regulated exclusively by 
one Sox gene or another, a subset of targets may be differentially regulated in the 
presence of various combinations of Soxes and their partners. Where the closest 
relatives of a family have overlapping expression questions regarding shared function 
arise. Overlapping expression with more diverse relatives might indicate a degree of 
antagonism or cooperation that is critical for the optimal function of that cell.
Expression of nearly half of all the Sox genes has been detected in the 
developing CNS. The SoxC genes Sox4 and So xll have a more dynamic expression 
pattern than the SoxBl members and tend to be in regions containing differentiating 
neurons and glia (Cheung et al., 2000). At 16.5dpc in the dorsal telencephalon Soxll 
expression overlaps with that of the SoxBl genes and is highest in the sub-ventricular 
zone where there are late generated neuronal and glial precursor cells. Sox4 is not 
found here, but is strongly expressed in dorsal cortical plate that at this stage is made 
up of early generated cortical neurons. In vitro all these genes have the capacity to 
differentially regulate expression via identical target sequences in combination with a 
variety of POU domain cofactors (Chapter 1) (Wiebe et al., 2003). It would therefore 
be interesting to see if the same phenomena occurs in vivo and what the consequences 
are of adjusting the relative amounts of these factors in certain cell types.
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Several members of the Sox family are also detected in the early stages of 
inner ear development. The SoxE gene Sox9 is expressed uniformly throughout the 
otic placode similar to Sox2, but by 9.5dpc expression is resolved to the dorsal half 
the otic vesicle, opposite to that of Sox2 (Ng et al., 1997). Also at 9.5dpc the SoxD 
gene Sox6 is expressed by cells of the inner layer of otic epithelium and is then down 
regulated (Murakami et al., 2001). Another SoxD gene Soxl3  is expressed at 13.5dpc 
in the maculae (utricle and sacculae) but not in other structures (Roose et al., 1998). 
In vivo, different combinations of these (and other) factors in a single cell may result 
in competition for a subset of common targets and could result in a wide range of 
expression profiles that may trigger particular fate decisions.
The Sox genes employ a number of strategies to promote appropriate target 
specification and regulation. However, given that some Sox genes, even from 
different subgroups, are capable of differentially regulating common targets, optimal 
expression of a subset of genes may rely on a particular combination of related 
transcription factors (Kamachi et al., 1995; Wiebe et al., 2003). The idea that a cell’s 
fate may be dictated by the balance between the activities of Sox subgroup members 
has been suggested previously (Uchikawa et al., 1999). The existence of a more 
general regulatory strategy where diverse combinations of Sox genes and other 
factors regulate common targets in vivo is a point worthy of further investigation. In 
this way a relatively small number of similar regulatory factors has the potential to 
create the diversity of expression required for the development of complex 
organisms.
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The diverse pattern of Sox2 expression may be useful in identifying candidate 
targets or regulatory partners important for its function during development. In 
mouse Sox2 expression is matched to some extent by the mammalian hairy and 
enhancer-of-^lit homologues Hesl and Hes5. During CNS development these basic 
helix-loop-helix transcription factors share sites of expression with Sox2 in the 
olfactory bulb, cerebellum and the neuroepithelial lining of the ventricles (Akazawa 
et al., 1992). Similar expression is also observed in the developing sense organs and 
in the bulge region of vibrissal and monotrick hair follicles (Can et al., 2000; Hojo et 
al., 2000; Leonard et al., 2002; Zheng et al., 2000). Targeted disruption of these 
genes indicates that they inhibit neuronal differentiation by mediating notch  
signalling and mutation is most severe in embryos simultaneously null for both of 
these genes (Ohtsuka et al., 1999). In the cochlea, null mutation of H esl and Hes5 
results in supernumerary inner and outer hair cells respectively (Zine et al., 2001). 
Sox2 has also been implicated in maintaining an undifferentiated state and as such 
may have some role in the expression or function of the Hes genes (Avilion et al., 
2003; Graham et al., 2003; Li et al., 1998)..
This study extends the current description of Sox2 expression and shows that 
it is present in a variety of tissues during the development of the mouse embryo. 
Because of this diversity it is difficult to assign a particular role to Sox2 although it is 
possible that common regulatory mechanisms exist and so information gleaned in one 
system may aid understanding in a seemingly unrelated tissue. Examining the role of 
Sox2 in the developing mouse CNS by genetic manipulation may be very difficult as 
integrity of this structure is a requirement for successful breeding and maintainance 
of mouse lines. The disruption or the complete absence of the inner ear or the hair
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follicle, however, is unlikely to lead to lethality. These sites therefore offer discrete 
model systems where the effects of modifying Sox gene expression in vivo may be 
relatively easily assessed.
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Chapter 3 Conditional mutation of Sox2 in ES cells.
3.2 Introduction.
The examination and comparison of gene expression patterns is critical in 
order to formulate hypotheses about which cells and systems may require the action 
of a particular gene product. Experimental strategies can then be created in order to 
test these theories and provide evidence of the actual function of a particular gene. 
One of the most commonly employed methods is to examine the consequences of 
modifying the amount of a particular gene product within a cell, tissue or even whole 
animal.
Transcription factors play key roles in the regulatory networks that dictate the 
overall profile of gene expression in a particular cell type. If the amount of a 
transcription factor can either be raised or lowered then clues to its place in the 
regulatory network may be recovered. A favourite approach to achieve this in mice is 
to study the effect of removing a particular gene by the null mutation of one or both 
of its alleles.
The study of gene function by null mutation has become a standard method in 
many organisms. In mouse, null mutants can be created in a random fashion or in a 
defined, targeted way. Random loss of function mutants may be produced when the 
gene of interest is unknown. Speculative mutation of the whole mouse genome by 
chemical or radioactive means produces mouse models that are selected on the basis 
of some measurable phenotype in a tissue of interest. This is followed by 
identification of the mutation responsible and which gene or genes are affected. 
Targeted modification of DNA sequence in the mouse adopts the reverse strategy
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whereby a known gene is modified and then there is a search for phenotypes that 
result from this modification. This method is far more refined and relies heavily on 
the careful design and production of a suitable targeting vector to facilitate the 
introduction of a specific genetic mutation and is followed by detailed phenotypic 
analysis. In essence the targeting vector is a mutated version of a particular allele and 
is produced by manipulating DNA sequences in vitro. This modified version of the 
allele of interest can be used to specifically alter its genomic counterpart in mice 
(Smithies and Powers, 1986; Thomas and Capecchi, 1987) (reviewed by (Muller, 
1999). This is done by taking advantage of the pluripotent characteristics of 
embryonic stem cells (ES cells). ES cells are derived from the inner cell mass of 
blastocyst stage mouse embryos and can be readily manipulated in tissue culture, but 
also have the ability to contribute to all tissues of a developing embryo, producing 
chimeric mice, when injected into the cavity of a host blastocyst (Evans and 
Kaufman, 1981). In this way a mutation introduced in tissue culture can be passed 
though the germline of chimeric mice to produce lines of animals that carry the 
engineered modification.
In order to work successfully the targeting vector must contain certain critical 
components. The desired mutation should be flanked by DNA sequence homologous 
to the allele to be modified so that recombination with the target region can occur. 
The modification itself must contain a selectable marker so that, once produced, the 
few ES cells carrying the mutant allele may be separated from the majority that do 
not. Once constructed this version of the allele can then be transfected into ES cells 
in culture and will occasionally replace the normal allele by the process of 
homologous recombination. After selection and confirmation that the DNA sequence
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of a particular ES cell clone has been altered correctly, ES cells can be taken and used 
to produce mouse lines by injecting them into host blastocysts. Colonization of the 
host by ES cells will then, hopefully, create a mouse in which manipulated cells are 
represented in each tissue and in particular contribute toward the germ line. If the 
modification is able to pass through the germ line then lines of mice may be created 
that carry the altered allele in each cell. In this manner a specific gene can be 
modified or removed followed by the examination of any resulting phenotype. The 
modification most often adopted is the complete or partial removal of the coding 
sequence so that no functional gene product can ever be produced from that allele.
By using the original replacement method a targeted modification is carried 
by every cell from the earliest stages of development. Animals harbouring lethal 
mutations can only be studied up until the point at which the specific alteration is 
lethal and the earlier this lethality is the fewer the sites are that can be studied. The 
null mutation of Sox2 {Sox2^^X^^^ produced in ES cells by replacing 3.5kb of DNA, 
including the entire coding region of Sox2, with the reporter/selection cassette figeo. 
These cells were then introduced into blastocysts to produce mouse lines (Avilion et 
al., 2003). Since mice carrying a homozygous null mutation of Sox2 die at the peri- 
implantation stage due to a failure of the epiblast this model can not provide 
information about the role of Sox2 in other sites later in development (Avilion et al., 
2003).
Sox2 is expressed in a variety of tissues throughout embryonic development 
as well as in the adult mouse and so a mutation strategy avoiding early lethality 
would enable an examination of its contribution at later stages (Chapter 2). Ideally
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such a strategy allows the removal of Sox2 in a spatially and temporally restricted 
manner leaving other sites with normal levels of expression. This can be achieved by 
using the crelloxP site-specific recombination system (Gu et ah, 1993). This method 
relies upon the ability of the PI bacteriophage protein ere to catalyse recombination 
between two 34bp loxP (locus of ‘x’ over in PI) sequences placed anywhere in the 
genome. If a targeted modification produces a region flanked by loxP sites, arranged 
in the same orientation (floxed), intervening DNA may be looped out and 
consequently removed upon the introduction of ere recombinase (Fig. 3.1). Targeting 
vectors are therefore designed in order to produce functional but floxed regions of 
DNA in mice generated from ES cells. Conditional removal of the floxed sequence 
can subsequently be achieved by introducing ere either by transfection or breeding 
(Reviewed by Lewandoski, 2001).
If the floxed sequence contains all or part of the coding sequence of a gene 
then a null mutation may be produced upon the introduction of ere. This technology 
therefore provides an enormous advance in precision and flexibility when studying 
gene function by null mutation. There is a growing resource of mouse lines available 
that express the ere protein in a variety of tissues at numerous developmental and 
adult stages (http://www.m shri.on.ca/nagy/Cre-pub.htm l). By breeding ere 
expressing mouse lines against those carrying particular floxed alleles specific null 
mutations can be produced at any stage in virtually any tissue.
The aim of this experiment was to examine the role of Sox2, by null mutation, 
in some of its diverse sites of expression during the development of the mouse 
embryo. In order to facilitate this a strategy was devised in order to introduce loxP
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Figure 3.1 crelloxP site specific recombination system.
(a). An allele is produced so that a region o f interest is flanked by loxP ere recognition 
sites (floxed).
(b). The presence o f ere recombinase catalyses association and recombination between 
the two loxP sequences
(c). The two loxP sites recombine, looping out the intervening DNA sequence, which will 
eventually degrade or be deleted as cells divide. The allele o f interest is left without the 
intervening DNA sequence and a single loxP at the site o f recombination. This reaction 
may also occur in the reverse direction but as the two loxP sites are no longer close to 







sites into the Sox2 allele so that its coding sequence can be removed upon the 
introduction of cre recombinase.
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3.3 Results.
3.3.1 Targeting strategy using pDBlS
The initial strategy employed to produce a floxed Sox2 allele utilised the 
targeting vector pDB13 that carries a promotorless selection cassette just upstream of 
the initiator codon of the Sox2 coding sequence. Sox2 is expressed in ES cells and by 
hijacking the natural Sox2 promoter this vector would confer resistance to the 
antibiotic G418 only when correct targeting of one of the Sox2 alleles has occurred or 
in the rare event of random integration next to another promoter also expressed in ES 
cells. This strategy is in essence the same as that used to produce the Sox2P^^°mx\\ 
allele, which was very efficient as it increased the proportion of correctly targeted ES 
cell clones after antibiotic selection (Fig. 3.2d) (Chapter 1), (Avilion et al., 2003). 
The selection cassette itself was flanked by FRT QFlp recognition target) sites (flrted) 
that are the recognition sequences of the Saccharomyces cerevisiae site-specific 
recombinase Flp. The Flp/F7?r system works in a way that is analogous to crelloxP 
and was employed so that the selection cassette can be removed once correct 
targeting had been achieved, either by introducing Flp recombinase into cells in vitro 
or by the pronuclear injection of zygotes with a FR T  expressing construct (Fig. 
3.2d,e). Removal of the selection cassette would then leave a floxed Sox2 gene that is 
fully functional. The addition of cre recombinase will remove the loxP-flanked Sox2 
gene (Fig. 3.2e,f). The loxP sites that flanked the Sox2 coding sequences were placed 
within the untranslated region (UTR) of the gene in an attempt to minimise the risk of 
introducing an unintentional mutation that might affect the regulation of Sox2 (Fig. 
3.5).
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Figure 3.1 Conditional targeting strategy using pDB13.
Figure summarising the key features o f the targeting strategy using pDB13. A more 
detailed description o f the production o f this vector is given in materials and methods.
(a). The targeting vector used to produce the Sox2^^^° allele. The selection cassette figeo 
replaces approximately 3.5kb o f the Sox2 gene including the entire coding region.
(b). The Sox2 locus showing regions o f homology, where recombination may occur, with 
both the Sox2f^^° vector and pDB13.
(c). The targeting vector pDB13. The selection cassette is placed so that it inserts at the 
same point as in the Sox2^^^° allele but the Sox2 coding sequence and downstream DNA is 
left intact. The selection cassette is flrted to facilitate its removal once targeting has been 
achieved.
(d). A representation o f the Sox2^°^ allele once homologous recombination has taken place.
(e). After the introduction o f Flp recombinase recombination between the FRT sites results 
in the removal o f the figeo selection cassette. A functional but floxed Sox2 allele remains 
along with a single FRT site.
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3.3.2 Transfection and screening of ES cells with pDB13
The targeting construct pDB13 (Fig. 3.2c) was made as described in materials 
and methods and used to transfect CCE ES cells, followed by G418 antibiotic 
selection. Initially two transfections (4x10^ cells) were performed (materials and 
methods) and from these there were fifteen colonies of a suitable size to be expanded 
further for screening. This number was low even for a promoterless targeting vector. 
Only one of the colonies showed the expected morphology of a correctly selected 
clone and this was also the only one positive for the targeting vector as judged by 
PCR (materials and methods). Southern analysis of DNA from this colony reveals 
that cells were indeed correctly targeted but the modified Sox2 allele did not contain 
the second (3’) loxP site (data not shown). When these cells were stained for figeo 
activity it revealed a spotty staining pattern where each ES cell showed a very 
localized spot of colour that seemed to be located at the edge of the nucleus (Fig. 
3.3). This indicates that the selection cassette was not performing effectively for 
some reason but was still capable of producing a protein that could convey some 
resistance to G418 and catalyse the reaction with X-gal. A further two transfections 
were carried out where the concentration of antibiotic used in the selection step was 
reduced to lOOpg/ml in an attempt to encourage the expansion of targeted clones 
expressing an inefficient version of the selectable marker. This strategy however 
produced no further suitable ES cell clones and was therefore abandoned in favour of 
constructing a new vector.
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Figure 3.3 X-gal staining of the single clone isolated from pDB13 targeting.
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pDBlJ done /
3.3.3 Targeting strategy using pDB37.
A second targeting vector (pDB37) was designed using an alternative strategy 
to facilitate the conditional disruption of Sox2. The second strategy is more 
conservative than the first in order to increase the chance of success but it required 
the incorporation of certain components that could potentially interfere with the aim 
of the experiment! The new strategy abandoned the promoterless selection cassette in 
favour of using a neomycin gene (neo) expressed under the control of the 
ubiquitously expressing phosphoglycerate kinase (PGK) promoter (PGKneo). The 
function of this selection cassette had already been tested in other targeting 
experiments but there are potential problems associated with its promoter. The PGK 
promoter is able to influence the regulation of genes in the vicinity of its insertion site 
and so unexpected phenotypes my arise from its use (reviewed by Muller, 1999). To 
minimise any potential interference during the targeting and selection steps the PGK 
driven selectable marker was placed in the opposite orientation, downstream of the 
coding region of interest. Subsequent interference may be avoided as the entire 
cassette is flrted and so can be removed when no longer required (Fig. 3.4d,e). Upon 
the introduction of Flp recombinase only a single loxP and an FRT  site remain and 
are not likely to cause any significant problems (Fig. 3.4e).
Suitable insertion sites for the selection cassette and distant loxP sequence 
were carefully identified so as to minimise the possibility of interference with the 
normal function of the modified allele. A search was carried out for regions of 
homology between mouse and the human genomic sequence available at the time in 
the vicinity of the Sox2 coding sequence. Regions that were highly conserved
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Figure 3.3 Conditional targeting strategy using pDB37.
Figure summarising the key features o f the targeting strategy using pDB37. A more 
detailed description o f the production o f this vector is given in materials and methods.
(a). The targeting vector used to produce the Sox2P̂ °̂ allele. The selection cassette figeo 
replaces approximately 3.5kb o f the Sox2 gene including the entire coding region.
(b). The Sox2 locus showing regions o f homology, where recombination may occur, with 
both the Sox2^^^° vector and pDB37.
(c). The targeting vector pDB37. The flrted selection cassette was placed downstream 
and in the opposite orientation to Sox2. The second loxP site was placed some distance 
upstream, avoiding possible regulatory sequences.
(d). The initial Sox2 allele that should result from a correct targeting using pDB37.
(e). Upon the introduction o f Flp recombinase the selection cassette should be removed 
leaving a single FRT and a single loxP site downstream o f the using coding sequence.
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between the species might have some function and so were avoided. Other regions 
that showed DNase hypersensitivity and so might be involved in gene regulation were 
also avoided (Zappone et al., 2000). The selection cassette (and first loxP) was 
placed just downstream (50bp) of the transcribed region of Sox2 in a stretch of 
relatively unconserved sequence (Fig. 3.5). Using the same criteria the most suitable 
site for the flanking loxP was considered to be about 4.5kb away from the selection 
cassette upstream of the initiating codon of Sox2.
Regions of DNase hypersensitivity have subsequently been refined to more 
specific sequences that are involved in the regulation of Sox2 expression (Tomioka et 
al., 2002). The more complete genomic sequence available at the time of writing 
shows extensive identity between human, mouse and chicken sequence both upstream 
and downstream of the Sox2 open reading frame (Uchikawa et al., 2003). The 
insertion sites for the selection cassette and the second loxP site, however, remain in 
relatively unconserved regions (Fig. 3.5).
The choices made during the design of pDB37 are likely to produce a fully 
functional, floxed Sox2 allele but at the expense of a low efficiency targeting and 
selection step. Firstly far more antibiotic resistant clones are produced by using a 
ubiquitously expressed selectable marker with most being random integrants and 
therefore not useful. Secondly the distance between the two loxP sites increases the 
chance that when targeting does occur, homologous recombination will exclude the 
second loxP as there is no selection pressure favouring its presence. In an attempt to 
increase targeting efficiency a longer stretch of homologous sequence was used than
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Figure 3.4 Summary of Sox2 allele with insertion sites and published hotspots.
A diagram relating the targeting constructs pDBlS and PDB37 to the Sox2 locus. Vista 
a l i g n m e n t  ( V i s u a l i z a t i o n  Too l s  f o r  A l i g n m e n t , http://www- 
gsd.lbl.gOv/vistalVISTAdownload2.html) highlights identity between mouse and human 
genomic sequence once repetitive sequence has been removed. Top bar adjacent to ying- 
yang represents human chromosome three with red bar indicating position o f comparison. 
Identity greater than 50% over a lOObp window is shown with identity greater than 75% 
highlighted in pink. Regions where sequence is significantly conserved may have an 
important function and are best avoided when targeting the locus. The deletion caused by 
the Sox2/̂ ^̂ ° vector removes the Sox2 coding sequence but also one o f the S0X 20T  exons. 
Regulatory sequences srrl and srr2, described by Tomioka et al, are also shown and 
indicate just two o f regulatory sites best avoided in a conditional strategy (Tomioka et al., 
2002).
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with pDB13 (Fig. 3.5), even so many colonies still needed to be screened in order to 
isolate those with the complete modification.
The targeting vector pDB37 was transfected into ABl ES cells (kind gift R 
Behringer) and after exposure to G418 antibiotic, twelve hundred colonies were 
selected for expansion and screening. Out of the twelve hundred, fourteen colonies 
were deemed as correctly targeted by Southern blot, using a 3’ probe, external to the 
targeting vector (Fig. 3.6a,b). Out of those fourteen only two had the desired 
recombination events with the second loxP site also being present (Fig. 3.6c). These 
two clones (8B9 and 10D6) were further characterised before being used for the 
production of chimeras.
The clones selected for injection grew normally in culture and in total twenty- 
six chimeras were produced from their injection into C57B1/6 host blastocysts. 
Generally there was a good contribution from both ES cell clones with eight (30%) of 
the chimeras produced having greater than ninety percent ES cell contribution as 
judged by agouti coat colour (Table 3.1). There was also a sex ratio distortion in 
mice derived from these cells with twenty-two of the chimeras produced being male. 
This gave a percentage ratio of 85:15 male to female rather than equal numbers of 
each.
Sex ratio distortion and ES cell quality.
The sex ratio distortion suggests that some of the animals derived from XX 
host blastocysts had been converted to males due to the contribution of the XY ES 
cells injected into them. If the proportion of XY ES cell derived cells in the 
developing gonad is high enough then the chimera will be phenotypically male.
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Figure 3.5 Screening of ES cell clones derived from transfection with pDB37.
(a). Diagram representing a Sox2 allele correctly targeted after homologous 
recombination with pDB37. Restriction enzyme sites shown are those useful for screening 
purposes with ‘̂ ’indicating those sites that would be introduced by modification o f the 
endogenous Sox2 allele. Blue arrows indicate the ends o f homologous sequence in the 
pDB37 construct. Southern blots were performed by digesting genomic DNA with EcoRl. 
The fragmant indicated in red is not contained within the targeting construct and could 
redily detect wildtype or targeted Sox2 alleles which were 15kb or 7kb respectively. PCR 
screening o f positive samples with the oligonucleotide pairs ODB55/56 and ODB55/57 
was used to ensure that loxP site distant from the selection cassette had also been 
encorporated.
(b). ES cell genomic DNA digested with EcoRI and probed with a fragment external to the 
targeting construct pDB37 can clearly distinguish between wildtype and targeted allele. 
Here eight staggered lanes are shown. Only the lane with 10D6 DNA has 15kb and 7kb 
bands characteristic o f a wildtype and a targeted allele respectively.
(c)i. PCR was utilised to screen targeted ES cell clones for the loxP site distant from the 
selection cassette. Two alternative pairs o f oligonucleotides could each be used to discern 
between wildtype (wt) and targeted alleles.
(c)ii. ES cell clones deemed correctly targeted by Southern blotting using a 3 ’ probe were 
screened with PCR to establish if homologous recombination had also included the distant 
loxP site. Two o f these clones showed characteristic double bands indicating complete 
targeting. Enzymatic digestion o f the PCR products supports the existance o f the intended 
mutation. Marker DNA is Ikb ladder from Boehringer Mannheim.
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although it is actually a mixture of XX and XY cells. In both phenotypically 
and genotypically female or genotypically male chimeric gonads, gametes may arise 
from cells that are either derived from the host blastocyst or the XY ES cells, giving 
black or agouti pups respectively. In a chimera which is phenotypically male, due to 
a large XY ES cell contribution, but derived from a genotypically female host 
blastocyst, wild type XX cells are not able to give rise to viable male gametes and so 
any functional sperm in these animals must be derived from the initial ES cell 
contribution. The fertility of these mice will therefore depend entirely on the quality 
of the ES cells used to produce them and so will be either infertile or give rise only to 
agouti pups.
Breeding o f chimeras.
The chimeric mice, made from the two independently targeted ES cell clones, 
were bred against MFl animals (albino). Coat colour was examined in the offspring 
of chimeras, with agouti pups indicating a transmission of ES cell derived genetic 
material. Out of 974 pups produced by the chimeras none had agouti coat colour and 
litter sizes were normal (Table 3.1). Also five male chimeras, (which may represent 
sex converted ones), were not able to make MFl dams pregnant despite evidence of 
normal mating. These results suggest that the ES cell clones used to generate the 
chimeras are unable to contribute to the germ cells.
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Table 3.1 Chimeric mice and offspring created.
Chimeric mice produced by the injection o f targeted ES cells into host blastocysts were 
selected on the basis o f coat colour. The proportion o f agouti fur indicates the degree of 
contribution o f ES cell derivatives in these animals. Chimeric mice were then bred against 
wild-type animals with the hope that the targeted allele would pass through the germline. 
In the event o f germline transmission offspring should have a completely agouti coat.
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Line ID number %Chimerism Sex
Total
Offspring Total Agouti
8B9 11 90 Male 0 0
8B9 14 85 Male 0 0
8B9 19 65 Male 41 0
8B9 13 60 Male 34 0
8B9 18 60 Male 39 0
8B9 15 45 Male 54 0
8B9 12 30 Male 66 0
8B9 16 20 Male 38 0
8B9 17 20 Male 30 0
8B9 20 20 Male 50 0
8B9 23 20 Female 9 0
8B9 22 15 Female 16 0
8B9 21 5 Female 9 0
10D6 7 95 Male 37 0
10D6 8 95 Male 82 0
10D6 24 95 Male 27 0
10D6 25 95 Male 27 0
10D6 26 95 Male 0 0
10D6 2 90 Male 0 0
10D6 5 90 Male 35 0
10D6 9 70 Male 91 0
10D6 1 30 Male 101 0
10D6 4 15 Male 113 0
10D6 6 10 Male 75 0
10D6 3 5 Female 0 0




The expression study (Chapter 2) indicates that Sox2 plays a significant role in 
a number of tissues of the developing mouse embryo after the point at which the 
existing homozygous null mutants die. Production of a conditional null mutation 
would therefore offer a valuable resource with which to study the role of Sox2 
throughout murine developmental and adult stages. The results of this chapter 
demonstrate that although gene targeting techniques promise a powerful method by 
which gene function can be studied these approaches can be fraught with technical 
difficulties. Ultimately, however, it is worth pursuing such strategies since they offer 
precise ways of manipulating the mouse genome in order to create in vivo models.
In the initial strategy pDBlS was designed to maximise targeting efficiency 
whilst minimising the chance of the required modifications causing aberrant 
phenotypes. The promotorless strategy used here is very similar to that employed to 
produce the Sox2^^^° allele, which had a very good targeting efficiency. In the 
Sox2/̂ ^̂ ° targeting experiment forty G418 resistant ES cell colonies were selected for 
expansion and screening yielding seven correctly targeted clones so it was.peculiar 
that the pDBlB strategy was so unsuccessful. pDBlB was able to modify the Sox2 
allele since the only colony to survive was indeed targeted correctly although there 
was an unusual figeo staining pattern. The extremely low targeting efficiency and 
lack of G418 resistant colonies arising due to random integration suggests that there 
is a problem with the activity of the selection cassette. There could be a number of 
possible explanations for this including mutation, misregulation or a disruption of 
proper transcription or translation of the selectable marker. Observations suggest
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that both components of the selection cassette do indeed work, at least to some extent, 
since one colony was blue and G418 resistant. The site of the selection cassette 
within the targeting vector should permit figeo expression in ES cells as it did not 
differ from the original Sox2^^^° targeting construct and so there is not likely to be a 
problem with the promoterless strategy. The location of the second loxP site is also 
unlikely be problematic since it lies within the 3’UTR of Sox2 and therefore is 
probably separate from any Sox2 regulatory elements required for the expression of 
the selectable marker in ES cells. Additionally the exclusion of this region of the 
UTR in the previous Sox2-^^ '̂* targeting experiment had no adverse affect on 
expression of the selectable marker in ES cell culture.
The most notable difference between the conditional targeting construct and 
the original is that pDB13 contains a pair of recombinase recognition sites just before 
the start codon of the figeo cassette. The sequence of the recombinase recognition 
sites include repeats of core recognition sequences. Although these have been placed 
individually in the transcribed region of other genes, without affecting correct 
expression, placing both the loxP and FRT sequences next to each other may have the 
effect of interfering with efficient transcription or translation of the selection cassette. 
Anecdotally this idea is supported by the lack of random integrants produced in the 
four transfections attempted with this construct when they should represent a 
majority. Even dramatically reducing the concentration of G418 to encourage the 
growth of clones with a low level of antibiotic resistance had no effect.
Although both the figal and the neo components of the selection cassette had 
some function and homologous regions were able to direct the modified gene to one
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of the Sox2 alleles it was not practicable to pursue the pDB13 strategy. The 
experimental aim was to investigate the role of Sox2 using a conditional mutation, it 
was therefore most efficient to design and construct an entirely new targeting vector.
The second strategy, using pDB37, was successful and was designed 
primarily to create a fully functional floxed gene whilst compromising a little on 
targeting efficiency. The ubiquitous expression of the selectable marker meant that a 
far greater number of random integrants were produced than would have been with a 
successful promoterless strategy. Although many ES cell colonies had to be screened 
the targeting did yield fourteen clones where homologous recombination had taken 
place and the Sox2 gene had been targeted. Great care was taken to avoid possible 
regulatory elements but this introduced further inefficiency due to the distance 
between the selection cassette and the second loxP sequence. Complete targeting was 
therefore a rare event with correctly modified clones occurring at an overall rate of 
about one in six hundred. This is not necessarily a problem but for an ideal 
experiment both clones needed to colonise the germline of chimeric mice and 
unfortunately they did not.
The two ES cell clones deemed to be correctly targeted both produced high 
percentage chimeras and this was an indication that the ES cell derived cells of the 
adult mice are able to contribute and behave normally in many of the tissues of these 
animals. Extensive breeding, however, did not yield any live animals that carried the 
floxed Sox2 allele. The fact that the chimeras produced no ES cell derived agouti 
pups is an indication that ES cell derived gametes give rise to non-viable embryos or 
that ES cells were not contributing to a functional germ cell population.
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Chimeric animals can support cells with otherwise lethal mutations because of 
clonal expansion or non-cell autonomous effects of wild-type cells (Bi et al., 1999). 
Also ES cells injected into host blastocysts do not contribute to extra embryonic 
components and so mutations affecting these tissues would not become apparent until 
the next generation is produced. Once all cells of the developing embryo carry a 
mutation lethal effects can no longer be compensated. In this instance this could 
explain the lack of agouti pups from chimeric animals but litter sizes were normal 
perhaps suggesting a problem with fertility rather than lethality of a proportion of 
embryos.
The majority of chimeras were fertile because of gamete production from 
cells derived from the host blastocyst. Any gametes produced from this population 
would produce black pups. It is possible that offspring carrying the targeted gene 
died in utero due to a dominant effect of the mutated allele. Since many high 
percentage chimeras were bom and these animals produced litters of normal size it is 
more likely that failure to transmit the floxed Sox2 allele is due to the failure of these 
cells to colonize the germ line. There was a proportion of male chimeras that 
appeared infertile and may have represented XX/XY animals in which no gametes 
could be produced either by the wild type XX C57B1/6 or the XY ES cells. There 
may have been no viable gamete production at all in these phenotypically male 
animals as judged by breeding although they might have been able to contribute 
enough functional cells to the gonad to sex reverse the chimeras. SOX2 and S0X3 
have been detected during stages of male meiosis (Shanthi Mahadaviah and James 
Turner unpublished data) and although a single null Sox2 allele should not affect this
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process, mis-expression, caused by regulatory interference, could potentially 
confound normal gamete production.
It is possible that these ES cell clones are not able to contribute to the 
germline for reasons that are entirely unrelated to the targeted allele. ES cells are 
notoriously vulnerable to slight changes in their preferred culture conditions and 
usually several independently targeted clones are injected to produce chimeric mice 
with the expectation that not all will be able to contribute to the germ line. In this 
instance the low efficiency of complete targeting yielded only two clones suitable for 
expansion and injection into host blastocysts. Since the two clones selected as 
properly targeted were derived from different plates after electroporation they must 
represent independent clones. It is therefore unlikely that they carry the same 
spontaneous mutation that might have arisen from experimental procedure. All tissue 
culture was carried out meticulously and cells used to produce chimeras were shown 
to be negative for mycoplasma, a common tissue culture contaminant that is known to 
interfere with germline transmission (Robertson, 1989). The number of passages in 
culture was also kept to a minimum since it is known that increased passage number 
reduces the ability of these cells to contribute to the germ line (Fedorov et al., 1997) . 
It is possible that there was some problem with the ES cell stock before targeting 
Sox2, however, cells were shown to transmit to the germline in previous experiments 
in our lab and elsewhere (Bi et al., 1999; Rizzoti et al., 2004). Problems of this 
nature could be overcome by further transfections with the same construct and 
injection of newly targeted clones in order to produce mice.
119
If there is a problem associated with the targeted allele then either Sox2 or 
some other gene may be affected by the engineered mutation. This effect is most 
likely to be mediated by up-regulation of a gene or genes in the vicinity since animals 
heterozygous for the Sox2^^^° null mutation, in which this region of DNA is absent, 
are viable and able to breed. The Sox2P̂ '̂' mutation not only removes the entire 
coding sequence of Sox2 but also a further 2.7kb downstream which includes the 
second exon of a recently identified gene Sox20T  (Fantes et al., 2003).
The discovery of Sox20T  emphasises the importance of creating the minimal 
amount of disruption when engineering the genome. Sox20T  does not appear to be 
translated but transcripts are highly conserved between mouse and human and it is 
suggested to play a role in gene regulation (Fantes et al., 2003). Inadvertently 
disrupting the function of this or any another gene is a major risk associated with 
gene targeting and is why both pDB13 and pDB37 were devised to minimise such 
potential effects both before and after the introduction of ere. It is not known if this 
gene might have some role in germ cell development but it is possible that its 
regulation is affected by the presence of the PGK promoter and this is why the 
targeted ES cells are unable to contribute to the germline.
Correct targeting with the vector pDB37 leaves this entire region intact, 
inserting DNA at only two points flanking the Sox2 coding region. If there is an 
inappropriate regulation of Sox2 or one of the nearby genes, preventing germline 
transmission, then this is most likely mediated by the presence of the PGKneo  
cassette. There are several examples where placement of the PGKneo cassette in 
intronic, 5 ’ or 3’ flanking or in untranslated regions interferes with the normal
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function of genes in its vicinity (Lewandoski, 2001; Muller, 1999). Sox2 is required 
to maintain the pluripotency of cells in the early embryo and for the derivation of ES 
cells but the existence of Sox2^^^°'^  ̂mice demonstrates that a single null allele is not 
usually lethal (Avilion et al., 2003). Constitutive expression of Sox2 in ES cells, 
however, results in extensive cell death (Mitsui et al., 2003). In this instance targeted 
ES cell clones appear completely normal in vitro and they are able to make a 
significant contribution to chimeric animals. This is a strong indication that targeted 
clones are able to maintain their pluripotent behaviour and that, at least during early 
stages, adequate and not excessive amounts of Sox2 are expressed from engineered 
cells.
Potential interference could be overcome by removing the PGKneo cassette. 
pDB37 was constructed incorporating a PGKneo cassette flanked by FRT sequences 
so that it can be removed after correct targeting if necessary. Targeted clones can be 
transfected with Flp recombinase in vitro with loss of their antibiotic resistance 
indicating that the selection cassette has been successfully removed (Fig. 3.4e). 
These ES cell clones should then be checked by Southern analysis to confirm that 
they have a copy of Sox2 flanked by loxP sites but lack the selection cassette. Floxed 
ES cell clones could then be injected into blastocysts to produce chimeras and would 
hopefully facilitate germline transmission of the targeted allele. This would leave an 
allele that differs from the wild type by the addition of two loxP sites and a single 
stretch of FRT sequence representing a total of less than one hundred bases. The 
majority of this lies within unconserved sequence that is removed completely in the 
Sox2!̂ ^̂ ° allele and, unless it separates critical regulatory elements, it should hopefully 
not cause a problem to the normal function of the locus before the introduction of ere.
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The decision to inject ES cell clones without first removing the selection 
cassette was made for two main reasons. Firstly, the chances of germline 
transmission are considered to be better when cells have had a minimum number of 
passages in culture. Secondly, some degree of interference from the neo cassette 
might have produced a hypomorphic allele that, in combination with the null and wild 
type, could have been very informative (Nagy et al., 1998). Since Sox2 heterozygous 
null animals are viable it is reasonable to assume that, if the selection cassette has the 
effect of inhibiting the correct expression of this gene to some degree, mice should 
still be viable. By removing the selection cassette only once a mouse line had been 
created, an allelic series could be produced including the floxed gene with interfering 
selection cassette present, a floxed gene and an allele null for the gene of interest 
(Fig. 3.4d-f).
Compromises made whilst designing pDB37 means that recombination 
between the two loxP  sites deletes 4.5kb of genomic DNA including the entire 
transcribed region of Sox2 but avoids any Sox20T  exons. Although it is formerly 
possible that part of this sequence is necessary for non-Sox2 function this likelihood 
was considered slight although should remain a consideration when examining any 
null phenotypes.
Once the difficulty of early lethality is circumvented by the production of a 
floxed Sox2 allele tremendous prospects toward the study of the role of this gene in a 
wide variety of embryonic and adult tissues are opened up. Mutations could involve 
removal of Sox2 from a very restricted set of cells or tissues thus focusing upon 
discrete developmental questions. The targeting of a suitable mutation to the Sox2
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allele should be fairly straight forward. After introducing ere, lines carrying a floxed 
Sox2 gene would need to be bred to the second filial generation (F2) in order to 
produce animals that completely lack a functional Sox2 allele in a particular organ or 
tissue. In order to speed up this process, as well as providing a useful marker for 
Sox2 expression, animals carrying a Sox2^^^° allele as well as the ere allele could be 
used. By breeding animals against Sox2P^^°'^ !̂ere (tissue X) about half
the offspring created would be useful, as they would lack a functional Sox2 allele in 
tissue X and would express figeo in cells that otherwise should be expressing Sox2.
Analysis shows that Sox2 is expressed in a range of tissues throughout mouse 
development. These sites can be broadly divided into two categories, those with 
overlapping expression of Sox2 's closest family members Soxl and Sox3 and those in 
which its expression is unique amongst the group B genes. It is possible that Sox2 
contributes similarly towards the regulatory network in all the sites in which it is 
expressed, although the outcome of this activity may be distinctly different. The 
disruption of Sox2 in sites where there is no overlapping expression with either of the 
other SoxBl genes may reveal its role in the development of these tissues but also 
facilitate the understanding of more general molecular mechanisms that would be 
difficult to reveal in cells where there may be functional compensation by other 
genes. There are a number of tissues where the expression of Sox2 appears to be 
unique with respect to its closest relatives, for instance in the early sensory placodes, 
dermal papilla, endoderm or in preimplantation development. Cre lines allowing the 
removal of Sox2 in these specific sites could be produced.
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A unique role of Sox2 may also be investigated in the earliest populations of 
cells of the developing embryo. The mechanisms by which embryonic progenitor 
cells maintain their pluripotency is poorly understood and it has not been possible to 
fully investigate these mechanisms using the original Sox2 null mutant. The ZP3-cre 
mouse (Lewandoski et al., 1997), which expresses cre in the developing oocyte, 
could be used to produce pre-implantation embryos that have no maternal 
contribution of Sox2. This experiment would unmask any previously unobserved 
early function of S0X2 in vivo that is extremely difficult to achieve with traditional 
null mutations. It will also be possible to produce ES cell lines that are homozygous 
for the floxed allele and thence study Sox2 function in cells from the earliest stages of 
development in vitro.
The most significant site of Sox2 expression is in the developing CNS. There 
is a considerable overlap of expression in this tissue with that of many members of 
the Sox family, and in particular with those of group B, posing the question of 
whether there is any functional overlap between these genes. It is possible that subtle 
differences between these genes means that the activity of each one compared to the 
others in any given cell type might elicit a unique response. Consequently 
appropriate cell function may rely upon the presence of the correct proportion of 
these proteins. The perturbation of these proportions could lead to a modification of 
cell fate. Rather than disrupting multiple genes throughout a tissue as significant and 
as critical as the CNS, mutation may be limited to a particular region for example part 
of the  h in db ra in .  For  e xa m p l e  the K ro x 2 0 -c re  mouse 
(http://www.mshri.on.ca/nagy/Cre-pub.html) could be used to remove Sox2 from 
rhombomeres 3 and 5. In this manner the phenotypic consequences would be
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restricted allowing groups of mutant cells to be studied in the context of a normally 
developing embryo.
Another question to address is whether Sox2 performs slightly different 
functions in the regulatory networks that exist in early CNS progenitor cells and cells 
of the more developed embryonic or adult CNS where it is also expressed. 
Temporally specific disruption of Sox2 offers the possibility of examining this over 
several stages of development. For instance Sox2 is expressed in pluripotent 
progenitors of the CNS at the earliest stages of nervous system development but also 
in a similar population of cells lining the ventricles of the brain in late gestation 
embryos. Although its presence might be a requirement for these cells at each of 
these stages Sox2 is not necessarily performing exactly the same function. The 
disruption of Sox2 at these different stages using a tissue specific inducible cre may 
therefore expose distinct regulatory functions. This will give insights into how Sox2 
affects the proliferation, migration and differentiation of neural cells in the 
developing nervous system and the developed brain.
Many possibilities are offered by a floxed Sox2 allele that justify the laborious 
nature of its production. In particular this type of genomic manipulation allows 
subtle modifications to be achieved in vivo facilitating the design and execution of 
increasingly refined experiments.
125
Chapter 4 M ouse mutants Lee and Ysb help to uncover functions of Sox2  
at late stages in embryonic development.
4.2 Introduction
The conditional null mutation of Sox2 would provide an ideal method by 
which to study, in a highly defined way, its role in the regulatory networks of 
particular tissues in the developing mouse embryo. However, other methods of 
answering questions about the role of Sox2 in murine development are also available. 
Whilst creating a conditional null mutant, these methods can be employed to provide 
further information from a different perspective hence increasing the overall 
understanding of this gene’s function.
Many mouse mutants have been created either by deliberate mutagenesis 
induced by chemicals or radiation, or due to the random integration of transgenes, 
often as the serendipitous by-product of other experiments. By their nature these 
random mutations are difficult to characterise but an increasing list of mutant 
pheno t yp es  is appear ing  in the l i t e r a t u r e  (eg SHIRPA 
http://www.mgu.har.mrc.ac.uk/mut.html). Diverse phenotypes can arise from 
mutations affecting different genes but some also affect only distinct aspects of a 
single gene’s function. These may range from those that simply remove a gene by 
rearrangement, to single base pair mutations that modify function due to codon 
change. Codon changes can result in premature truncation of a protein or perhaps 
alter its activity. The action of these methods of mutagenesis is not however 
restricted to those parts of a gene that encode the functional protein. Regulatory 
elements can be disrupted producing, mice that lack the expression of a particular
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gene, but only in a limited range of its expression sites. This is somewhat similar to 
the conditional knockout strategy. These mutants can be particularly useful when 
complete removal of the gene, results in early embryonic lethality.
Targeted mutagenesis requires that the gene is known before the phenotype 
can be ascertained but random mutagenesis relies on identifying phenotypes and then 
looking for the causative gene. However, finding the disruptions that are responsible 
for causing the phenotype can be a laborious process. Key data acquired from 
expression pattern and physical mapping studies, however, can facilitate the 
identification of the genes affected by speculative or fortuitous mutation. Once the 
particular gene or genes affected in such mouse models are identified they can 
provide valuable information critical to the understanding of gene function.
Often mutant mouse strains are initially recognised on the basis of easily 
identifiable phenotypes that readily set them apart from the many animals being 
handled in a standard colony or screen. Malformations of hair follicles or the inner 
ear produce such phenotypes. Mutation of either of these structures is not likely to be 
lethal, often displaying overt phenotypes and so many mouse models harbouring 
mutations in these structures have been identified, although animals carrying 
mutations affecting both hair and inner ear formation are much rarer.
The mouse mutants yellow submarine (Ysb) and light coat and circling (Lee) 
were both isolated on the basis of a recessive circling phenotype and a non­
segregating semi-dominant coat colour that made these animals appear more yellow 
than their wild type littermates (Dong et al., 2002). Both mutant strains are bom with 
the expected Mendelian frequencies from heterozygous matings and homozygotes are
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viable and often fertile. In these mutants recessive circling behaviour and head 
tossing indicates an abnormality in the structure or function of the vestibular 
component of the inner ear, resulting in balance problems. Further investigation 
confirmed vestibular abnormalities but also shows that these mice have cochlear 
defects resulting in deafness.
Coat abnormalities or colour differences are often recognised in screens. The 
lightness observed here appears to be the result of some disruption in the way a 
normal agouti coat is formed (Lamoreux et al., 2001). Agouti, a coat with a brownish 
appearance, is the wild-type coat colour of mice. It results from melanocytes in the 
base of the growing hair switching melanin production between the two pigments 
eumelanin (brown to black) and phaeomelanin (red to yellow) as the hair elongates. 
Two genes are involved in melanin switching: extension and agouti. Extension 
encodes the melanocortin 1 receptor (Mclr) that is able to bind to the a-melanocyte 
stimulating hormone (a-MSH), thus transducing the signal to produce eumelanin. 
The agouti protein antagonises the interaction of a-MSH with M clr resulting in a 
switch from eumelanin to phaeomelanin production. Transient expression of agouti 
between days four and six of the hair cycle results in black hairs with the 
characteristic subapical yellow band. Differences, not only in the relative amounts of 
pigment and their distribution in single hairs, but also in the proportion of 
alternatively coloured hairs can give rise to a wide variety of apparent coat colours in 
the mouse. Normally about eighty percent of the coat is comprised of zigzag type 
underhairs but auchenes, awls and monotrichs (guard) have a greater influence on the 
overall coat colour because they are longer and lie over the top of the zigzags.
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The Ysb mutant arose by the random integration of a C o lla i-figal reporter 
transgene in a promoter analysis experiment. There is a complex mutation associated 
with this mutant which involves at least two integration sites, close to each other, 
towards the centromeric end of chromosome 3 and a deletion of about twenty 
kilobases in between these integration sites (Dong et al., 2002).
When stained with X-gal, embryos show a B-gal expression pattern broader 
than expected for C olla i and that found in other lines of mice carrying the same 
transgene. This indicates that the reporter has integrated in a site which is under the 
influence of an endogenous promoter (Keith Leung and Anna Tang unpublished 
data). At 9.5 dpc, embryos display additional staining in the hindbrain and a few 
days later a spotty pattern of expression appears that marks the developing hair 
follicles. Analysis of embryos homozygous for the Ysb allele show that not only are 
the sensory cells of the inner ear severely disrupted but also the innervation of the ear 
is abnormal (Keith Leung and Anna Tang unpublished data).
The mouse mutant Lee was isolated at Harwell during an X-ray mutagenesis 
screen (Lyon et al., 1979) and although the phenotypes exhibited are similar to Ysb 
they appeared to be more severe, i.e. a more yellow coat and more frequent/violent 
circling. The Lee mutation maps to chromosome three and G-banding analysis 
reveals that there is an inversion between B and E l at the centromeric end of this 
chromosome. Heterozygous Lee mice do not have a circling phenotype, but their 
coat does appear slightly more yellow when compared to their wild type littermates. 
(Dong et al., 2002).
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Phenotypic similarities between these Ysb and Lee mutant indicates that their 
mutations might be affecting the same gene or genes. When heterozygous animals 
from each line are bred together, Lec^''IYsb^'' offspring are yellow and circling (Dong 
et al., 2002) (Fig. 4.1). Since Lee and Ysb fail to complement each other in this 
breeding assay and have also been mapped to the same region of chromosome three it 
is likely that the mutations are indeed allelic.
Close examination shows that the severity of inner ear defect varies 
depending on the genotype of the mice. The gross structure of the inner ear can be 
visualised by filling the lumen of embryonic inner ears, at 16.5 dpc, with latex paint 
(Amy Kiernan et al., manuscript submitted (after Martin and Swanson, 1993)). 
Although both Lee and Ysb heterozygotes have an essentially normal ear structure, 
the homozygotes and compound heterozygotes display a range of abnormal inner ear 
formation (Fig. 4.2a,b,d,e). Lee homozygotes have the most severe phenotype, with 
many of the vestibular and cochlear components missing (Fig. 4.2e). The form the 
latex paint acquires in these samples shows that the channels of all three semicircular 
canals are completely malformed and there are only remnants of the utricular and 
saccular components where cells that transduce movement into nerve signals should 
reside. The cochlea, which is responsible for detecting sound, normally forms a 
coiled structure with one and a half turns. In Lee homozygotes, however, this 
structure only just manages half a turn and electron microscopy reveals that the 
normal cellular arrangement of sensory cells is completely missing (Amy Kiernan et 
al., manuscript submitted). Lec^''IYsb^'' have the next most severe abnormality 
followed by YsblYsb embryos (Fig. 4.2d). The variety in the inner ear structure
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Figure 4.1 Light coat colour of circling LcC''/Ysb*'' mice.
Figure showing the typical yellow coat colour o f Lcc'^'lYsb^'' animals. Matings between 
the Lee and Ysb mouse lines produce offspring with a mixed background but compound 
heterozygotes are readily detected amongst littermates that have normal coat 
pigmentation. Animals from stock strains show the dramatic colour contrast between 
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indicates that, although the alleles Ysb and Lee probably affect the same gene (or 
genes), the influence that these disruptions have is not identical.
Chromosomal abnormalities of the Lee and Ysb alleles were not the same but 
there was a region of overlap that is likely to contain the core components critical for 
proper ear and hair formation. Core components may be influenced by chromosomal 
abnormalities unique to the respective alleles and hence a range of abnormalities were 
seen that depended upon the exact genotype.
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4.3 Results
In order to explain the phenotypes of the Ysb and Lee mutants it is useful to 
know the actual gene or genes being affected. Since the precise nature of the 
mutation in these animals is unknown a candidate approach was employed, based 
upon the approximate physical position of the two mutations and the structures that 
are affected in these strains. Of all the genes that have been mapped to the 
centromeric end of chromosome 3 Sox2 appears to be one of the best candidates in 
the vicinity of the region disrupted in the Ysb and Lee mutants. Apart from physically 
mapping to the same approximate chromosomal location, expression data shows that 
Sox2 is expressed in the same tissues that are affected by the Lee and Ysb mutations 
(Chapter 2).
4.3.1 Breeding with Sox2P̂ °̂'̂ '̂  shows that Sox2 is allelic to both Ysb and Lee.
An initial investigation to establish if there is any disruption in the coding 
region of Sox2 was carried out by examining genomic DNA from the Lee and Ysb 
mutants by Southern blot. This analysis reveals that the coding region of Sox2 and 
the DNA immediately surrounding it did not have any major deletions, insertions or 
rearrangements (Anna Felling, unpublished data). Although the coding region of 
Sox2 appears intact it still remains a good candidate since the Lee and Ysb alleles 
could be harbouring mutations affecting the regulation of Sox2 expression rather than 
the function of the protein. The Sox2̂ ^̂ °'̂ '̂  mutation is precisely known and therefore 
it can be used to decipher the involvement of the Lee and Ysb mutations in the 
expression of S0X2. In order to test whether the Lee and Ysb mutations are allelic to
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s 0x2 , heterozygotes from each strain were bred against Sox2P̂ °̂'̂  ̂ and offspring 
examined for phenotypes including inner ear and coat abnormalities.
Matings were set up between Sox2/̂ ^̂ °''̂  and Ysb'^"  ̂ or Lcc/Lcc animals. 
Initially 16.5 dpc embryos were harvested in order to examine the formation of their 
inner ear. These have a normal structure in all embryos except those that carry one of 
each of the mutant alleles from their parents. Lcc'̂ '̂/Sox2!̂ ^̂ °'̂ '̂  samples have an 
abnormality similar in form and comparable in severity to the Lee homozygotes and 
the Sox2P^^°' '̂ /̂Ysb '̂’ inner ears have a structure that is most similar to the Lee^ '̂/Ysb^ '̂ 
samples that were examined previously (Fig. 4.2c-f Amy Kiernan unpublished data). 
Paint fill experiments show that the architecture of the inner ear is severely disrupted 
apparently due to malformation of vestibular and cochlear sensory epithelium where 
Sox2 expression is found. This confirms that Sox2 is indeed one of the genes, if not 
the only gene, being affected by the Lee and Ysb mutant alleles because the extent 
and severity of abnormality is not normally observed in animals heterozygous for any 
of these alleles.
Compound heterozygotes have eoat eolour abnormalities.
The second characteristic phenotype of Lee, Ysb homozygotes or Lee'^^IYsb'^^ 
compound heterozygotes is a distinctly yellow coat colour when compared to their 
littermates. This phenotype might also be attributable to lack of S0X2. To test this, 
Sox2!̂ ^̂ °'̂  ̂ mice were bred against either Ysb or Lee heterozygotes and pregnant 
females were allowed to litter down. The litters produced were weaned and 
genotyped by PCR from a tail biopsy (materials and methods). No Lee^ '̂!Sox2P^^°'^  ̂
pups were ever recovered and it can be assumed that these animals die at or shortly
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Figure 1.2 The inner ear structure of mutants carrying Lee. Ysb and alleles
The inner ear structure o f mutants carrying Lee, Ysb and Sox2f^^° alleles was visualized by 
filling the lumen o f the inner ear from 16.5dpe embryos with paint (Amy Kiernan 
unpublished data). Bar in g is 100pm and applies to a -f also.
(a). Embryos carrying a single allele show an inner ear with normal structure, here 
represented by Ysb/+.
(b). Embryos that are homozygous for Ysb display show malformation o f the semicircular 
canals and maculae. The cochlea is also slightly malformed with less turns than the 
heterozygote.
(c). The compound heterozygote Sox2!^^^°'' /̂Ysb^ '̂ has a similar but more severe phenotype 
to that ofh.
(d). The compound heterozygote Ysb '̂'VLee '̂'' has an inner ear structure almost identical to
(e). Lee homozygotes show one o f the most severe phenotypes with severe ablation o f the 
vestibular components o f the inner ear. The cochlea hardly manages to complete a single 
turn.
(f). A very similar phenotype to e is observed in the inner ears o f Sox2/̂ ^̂ °'^̂ /Lee^̂ ' embryos.
(g). The normal inner ear structure o f a wild type 17dpc embryo. The inset is a view o f a 
normal cochlea that makes one and a half turns by this stage o f development (Morsli et al..
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after birth and are rapidly cannibalised. YslA''ISox2f^^°''^ animals, however, do 
survive and show the circling behaviour expected due to the inner ear abnormalities 
observed in embryos with the same genotype. Ysh^''ISox2f^^°''^ animals are bom at 
the expected Mendelian frequency indicating that this genotype does not affect 
viability. Of the compound heterozygotes bom, most, but not all display circling 
behaviour. The coat of these mice is also more yellow than their littermates although 
a few were pure black. Parents of litters with black pups carry recessive alleles that 
prevent the production of pheomelanin and so a proportion of black circling pups was 
expected and represents the animals that are homozygous for this allele. Plucking of 
hairs and their microscopic examination reveals that, not only is there a difference in 
ratios of hair type in yellow compound heterozygotes when compared to wild-type 
littermates, but also in the extent of the pheomelanin band (Keith Leung unpublished 
data), both of which aspects contribute to the yellow appearance of the coat. These 
hair phenotypes are similar to those observed in the pure Lee or Ysb lines (Dong et 
al., 2002).
These breeding data suggest that both Ysb and Lee are allelic to Sox2 and 
since the phenotypes are complemented by a Sox2 null allele they must cause a 
reduction or abolition of expression in particular cell types. Such a reduction in the 
levels of expression is most likely to be a consequence of some disruption in its 
normal regulation. Promoter sequences responsible for regulating gene expression 
are generally modular with several distinct DNA sequences required to ensure that 
the overall pattem of a particular gene’s expression is achieved. There can be a 
considerable physical distance between all the regulatory modules and the gene they 
control so mutations may only affect gene expression in a subset of tissues at
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particular developmental stages. Mutations of this sort can effect gene expression 
spatially, temporally or in the levels of the gene that is expressed. In this case, both 
Lee and Ysb alleles cause a reduction in the amount of expression but only in a subset 
of the sites in which it is normally expressed. The effects of the Lee allele appear to 
be equivalent to that of in compound heterozygotes and so may mediate a
complete abolition of Sox2 in the developing inner ear and hair follicle. The Ysb 
allele produces slightly less severe phenotypes in compound heterozygotes and so 
either it may not completely abolish Sox2 expression from this allele or it may cause 
an abolition over a shorter developmental period that results in a milder phenotype. 
Mutations that abolish or reduce Sox2 expression in only a subset of tissues, mediated 
by Lee and Ysb alleles, would explain why homozygous Lee and Ysb animals are 
viable while the homozygous null of Sox2 is lethal at the peri-implantation stage. In 
situ hybridisation subsequently showed that there was greatly reduced expression of 
Sox2 in the otic vesicles of 9.5dpc Ysb homozygotes and no Sox2 RNA or protein 
could be detected in the inner ear structures of Lee homozygotes at 9.5dpc and 
16.5dpc respectively (Amy Kiernan et al., manuscript submitted).
4.3.2 A hair phenotype can be seen in heterozygous Sox2!^^ °̂'^ ÎC2Yi mice.
Production of Lee!Sox2P^ °̂' '̂  ̂ or Ysb/Sox2P̂ °̂'̂ '̂  mutant embryos and mice 
shows that Sox2 is most likely to be allelic to these mutations and that the overall 
nature of these disruptions is loss of function. Since Lee and Ysb both involve 
complex disruptions of chromosome 3 that could affect more than one gene, however, 
it is not possible to conclude that these mutations are only affecting Sox2 or indeed 
directly affecting Sox2 on the basis of this evidence. If some aspect of the Lee or Ysb
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phenotype could be recapitulated in animals in which the Sox2 mutation is precisely 
known, then this would suggest that Sox2 is the most significant, if not the only, gene 
affected by these alleles. Sox2/̂ ^̂ °'̂ ' embryos die at the peri-implantation stage but 
Sox2P̂ °̂'̂ '̂  mice ^re viable and so these animals were examined for semi-dominant 
phenotypes similar to Lee or Ysh heterozygotes that would further implicate Sox2 as 
the major gene affected by these mutations and thus having a critical role in both 
inner ear and hair follicle development.
Of the two predominant phenotypes displayed by animals carrying a single 
Lee or Ysb allele coat colour differences could most readily be detected and measured 
(Dong et al., 2002). Lee homozygotes clearly have a yellow coat and the 
heterozygotes, although less yellow, can still be discerned from their wild-type 
littermates on the basis of coat colour. If no Sox2 expression in the hair follicle is 
produced from the Lee allele then it follows that a Sox2^^ °̂' '̂  ̂mouse should also be 
discernible from its littermates on the basis of coat colour. The fur of Sox2f^^°'^  ̂mice 
was therefore examined to see if there is a coat phenotype similar to that observed in 
the Lee or Ysb heterozygotes (Dong et al., 2002).
Sox2f^^°''  ̂ mice are maintained on two different backgrounds: I29SvEv and 
M Fl. MFl is albino and so on this background no coat colour phenotype can be 
seen. I29SvEv mice have an agouti coat colour but carry the ehinehilla allele (c^ )̂. 
Chinehilla encodes a tyrosinase that interferes with the production of pheomelanin 
(yellow/red) more than it does with eumelanin (brown/black), resulting in a slightly 
darker appearance that masks yellow coat phenotypes to some extent (Lamoreux et 
al., 2001). Lee mutants show a coat colour phenotype when maintained on a C3H/He
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background so a congenic breeding regime was therefore set up to change the 
background of the Sox2^^^°''^!MF\ animals to C3H/He. Changing the genetic 
background of a mouse is quite a laborious procedure and normally it takes more than 
ten generations in a congenic breeding scheme to become 99.8% identical across the 
entire genome, although 94% identity can be achieved in five generations (Silver, 
1995). After just two out-breeding generations about 75% of the genome should be 
isogenic with the new background and at this point Sox2P^̂ °’'^C2>YilY{dnlf2 mice are 
discernible from their littermates on the basis of coat colour and are almost equivalent 
in colour to the Lee heterozygous animals (Fig. 4.3a). This is the first indication that 
Sox2 alone is affected in the Lee and Ysb mutants (at least for coat colour) since in 
these Sox2^^^°'*C?>Y{IYidnli2 animals only 3.5kb including the coding sequence is 
absent.
4.3.3 Hair samples reveal a Sox2^^^°''  ̂ coat phenotype.
To investigate the hair phenotype more carefully hair plucks were taken from 
5<9x2̂ ^̂ "’'^^C3H/He/nlf2 mice and wild-type littermate controls in a manner standard 
for this type of experiment (materials and methods and (Pennisi et al., 2000b). 
Briefly three mice for each genotype were selected for analysis and hairs from three 
mid-dorsal plucks per animal were taken and microscopically examined. In the first 
comparison, hairs were sorted into types and then relative frequency calculated (Fig. 
4.3b). Statistical analysis shows that there is a significant difference in the relative 
frequencies of hair types present in the samples although there is no difference in the 
total amount of hairs recovered from the standard plucks. Significant differences are 
noted only in awl and zigzag hair types between the wild-type and Sox2f^^°''^ samples.
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Figure 4.3 The coat phenotype of C3WYiQ animals
(a). The appearance o f the coat o f a Sox‘̂^^°'^^ mouse on the C3H/He background is 
distinctly yellow when compared to a wild type littermate.
(b). Hair type comparison o f Sox2f̂ °̂'̂ '̂  mice against wild type littermates. Hairs from  
three mid dorsum plucks from three mice o f each genotype were sorted and counted. 
Statistical analysis o f these data, using the unpaired t test, show significant differences in 
four o f the categories analysed.
(c). A Ysb^ '̂/Sox2f^^°'^  ̂mouse compared to C57BI and CBA/C57BI FI. Coat appears very 
much more yellow than wild-type counterparts and fa r  more yellow than SoxTf̂ ^̂ '̂ "̂  
animals.
(d). The length o f the agouti band was measured in two o f the hair types examined. An 
unpaired t test was then used to examine the null hypothesis that the means o f the two 
experimental populations were equal. Using this test Sox2f^^°'^  ̂awls showed significantly 
longer eumelanin band with a that those taken from their wild-type littermates (P value o f 
0.02) but no difference was seen in auchenes.
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The relative number of all awls, the most common type of over hair, is significantly 
lower in samples from animals. Sub-dividing the awls into agouti and all­
black, it is clear that there is in fact a decrease in the number of black awls and an 
increase in agouti when compared to wild-type. In a wild-type agouti coat there are 
usually almost twice as many black awls as agouti but conversely, animals carrying a 
single Sox2 null allele have approximately twice as many agouti awls compared to 
black. The wild-type mouse coat comprises about 70% zigzag underhairs but this 
number is significantly greater in Sox2P̂ °̂'̂  ̂littermates.
Three of the four hair types present in the mouse coat normally display agouti 
pigmentation: auchenes, awls and zigzags. The second analysis performed examined 
the length of the agouti band in awls and auchenes. It is notable that, although there 
is no significant difference in the eumelanin band in auchenes, awls from Sox2f^^°'^  ̂
animals have a significantly longer stretch of yellow pigment than littermate controls 
(Fig. 4.3d). These data indicate that Sox2^^ '̂''^  ̂ animals can be discerned from their 
wild-type littermates on the basis of coat colour and that the difference in hue of the 
agouti coat can be attributed to a significant increase in the proportion of agouti hairs 
formed as well as the extent of the eumelanin band in the most common outer coat 
hairs. These data did not indicate that there were extra agouti hairs being produced 
but rather there had been a category switch of some hair types.
These measurable phenotypes of the Sox2^^^°'^^ mice correspond to the 
heterozygous phenotype of both the Ysb and Lee coat (Dong et al., 2002). This is a 
strong indication that Sox2 is the primary gene contributing to the coat phenotype in 
these strains and that this due to the loss of function of Sox2. Variable phenotypes
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are observed with different combinations of the mutant alleles, strongly suggesting 
that cellular function is dependent upon a particular dose of Sox2 in these tissues.
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4.4 Discussion
The expression pattem of Sox2 indicates that it has a role in various tissues 
throughout mouse development but peri-implantation lethality of Sox2-̂ ^̂ °'̂ ' embryos 
precludes the use of the homozygous mutation after about 4.5dpc. The production of 
mice carrying a floxed Sox2 allele would provide one method by which early lethality 
may be circumvented allowing the consequences of tissue specific Sox2 dismption to 
be observed at later stages. Random or serendipitous mutations may also cause the 
desired dismption but it is difficult to characterise the specific gene or genes affected 
in models that are isolated on the basis of an interesting phenotype. By linking these 
phenotypes with particular genetic defects a great deal may be learnt about the 
molecular mechanisms underlying normal development.
The mouse mutants Ysb and Lee display abnormalities in the development of 
the sensory components of the inner ear as well as hair specification and 
pigmentation (Dong et al., 2002). A number of genes, including Sox2, share the 
approximate chromosomal location of these abnormalities but Sox2 is also expressed 
in the tissues that are most severely affected by these mutations. In order to test the 
hypothesis that normal Sox2 expression is affected by the Ysb and Lee alleles a 
complementation assay was performed. In this assay, mice heterozygous for Sox2f^^° 
and either Lee or Ysb were created in order to identify any similarities between the 
effects of these alleles. Compound heterozygotes display both inner ear and hair 
follicle phenotypes suggesting that they are caused by the loss of function of Sox2 in 
these tissues. Close examination of Ysb and Lee homozygotes reveals that although 
Sox2 expression in the developing inner ear is reduced or absent, chromosomal
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abnormalities lie some distance away from the transcribed region of Sox2, which is 
intact.
A defect limited to particular regulatory elements controlling Sox2 expression 
would explain why phenotypes are observed only in certain tissues, whereas the 
complete removal of Sox2 causes lethality. Ysb and Lee alleles may however be 
directly affecting the expression of several genes, including Sox2, with synergy 
between these defects causing hearing, balance and coat abnormalities. Lack of 
genetic complementation as well as similar phenotypes in a combination of tissues 
where Sox2 is expressed, strongly suggests that this is the key gene affected by these 
mutations. It remains possible, however, that the disruption of Sox2 alone may not 
have any of the same affects reflecting a more minor role in the development of the 
hair follicle and inner ear. In order to reinforce the evidence that it is Sox2 alone that 
is responsible for these phenotypes animals with a far more defined mutation must be 
examined. Sox2f^^°''^ mice carry such a mutation and hair specification and 
pigmentation was chosen as the most accessible phenotype to examine. When 
compared to wild-type littermates Sox2f^^°''^ animals have abnormalities comparable 
to those of Ysb and Lee heterozygotes but these are only revealed on a permissive 
background. This is a strong indication that Sox2 is important for hair formation, and 
most likely also for inner ear formation and that the Ysb and Lee alleles are a useful 
tool to examine its role in these and possibly other tissues.
The examination of hairs from the coat of Sox2f^^°''^ animals reveals that Sox2 
functions in more than one component of murine hair development. Although Sox2 is 
expressed during the initial stages of hair follicle formation, induction of follicles
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appears to be unaffected in mutant animals. A switch in hair type and pigmentation 
characteristics is observed in mutants, but both the specification of a particular hair 
type and the extension of the agouti band manifest themselves in the hair lacking 
Sox2. Of the sites where Sox2 is expressed in the developing hair follicle, 
abnormalities in the dermal papilla and dermal sheath cells are most likely to lead to 
observed phenotypes (Chapter 2).
The dermal papilla is thought to play an important role in follicular 
development as well as the cycles of hair growth and regression that occur throughout 
the life of the mouse, however, little is known about the molecular mechanisms 
underlying its function. This cluster of mesodermally derived cells directs the fate of 
the adjacent epidermis dictating what type of follicle and consequently hair should be 
produced. In the hair cycle the dermal papilla does not regress but seems to 
coordinate the formation of a new follicle, of the appropriate class, from stem cells 
located in the bulge region (Chapter 2).
Hair pigment is produced by melanocytes at the base of the developing hair 
shaft and donated, via melanosomes, to adjacent kératinocytes as the hair extends. 
Dermal papilla cells can excrete the agouti signalling peptide that antagonises the 
interaction of a-MSH with the M clr receptor on the surface of melanocytes causing 
them to switch to the production of the yellow pigment pheomelanin from black 
eumelanin (see above). When dermal papilla or dermal sheath cells are transplanted 
in vivo, not only are new follicles induced but the hairs produced show growth and 
pigmentation characteristics typical of the follicles of the donor cells rather than that 
those of the recipient tissue (Reynolds and Jahoda, 1992; Reynolds et al., 1999). It
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follows that any modification of the normal signalling network of the dermal papilla 
has the capacity to alter signals, such as agouti, that influence pigmentation patterns 
or the form of the hair that is produced.
A single null allele of Sox2 mediates effects on both the hair type and 
pigmentation characteristics of the mouse pelage. This indicates that it is likely to 
play a crucial role, in a dose dependent manner, in the signalling network of dermal 
papilla cells. If a particular quantity of Sox2 is required for wild-type function of the 
dermal papilla then further reduction in the amount of Sox2 might be expected to 
have a more pronounced phenotype and indeed the agouti Sox2P^^°''^lYsh'^ animals do 
have a much more yellow coat colour than with either allele alone (Fig. 4.3d). This 
mutant, however, may have some residual Sox2 expression sufficient to obscure a 
more dramatic function of Sox2 in the developing hair follicle as it does in the inner 
ear. Lee homozygotes display the most severe phenotypes in both ear and hair 
formation and might represent the phenotype of animals with no Sox2 expression in 
the hair follicle or the inner ear. If Sox2^^^°''~ ÎLee animals had been able to survive 
post-partum they are likely to have displayed an equally (or more) severe coat 
phenotype.
Exactly how a reduction of S0X2 results in the observed phenotypes remains 
to be shown but it may have some responsibility in regulating the expression of genes 
necessary for mediating organising signals from the dermal condensate and later the 
dermal papilla (Chapter 2). As in other tissues it is possible that the regulatory 
responsibility for certain genes is shared by different Sox proteins. Competition for 
common regulatory elements could result in differential regulation of a subset of
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target genes that in this case might determine the characteristics of the hair being 
produced. The expression of other Soxes in the same cell type might even mask the 
absolute role of this class of genes in hair follicle development where only one or 
another is removed. Neither Soxl nor Sox3 expression was ever detected in the 
developing follicles but interestingly similar but, distinct phenotypes are observed in 
the pelage of animals carrying alleles with mutations in another Sox family member, 
Soxl 8.
Soxl 8 is a member of subgroup F  and is expressed in dermal papilla and 
dermal sheath cells in a pattem very similar to that of Sox2 (Pennisi et al., 2000b). 
Null mutation of Soxl 8 shows similar but opposite coat phenotypes to that observed 
in the Sox2/̂ ^̂ °'̂ ,̂ Lee or Ysb mice. These include a decreased proportion of zigzag 
hairs and a darkening of overall coat colour due either to the reduction of size of the 
subapical pheomelanin band or its complete absence (Pennisi et al., 2000a). The 
authors were surprised at the mild phenotype of these animals, which lack any 
functional Soxl8, as they had already established that the classical mouse mutant 
ragged carries missense mutations in the Soxl 8 gene which leads to a severe 
disruption of hair follicle formation and a homozygote that is practically nude 
(Downes and Koopman, 2001; Pennisi et al., 2000b; Slee, 1957). The conclusion 
drawn is that ragged alleles are contributing to a trans-dominant negative effect 
mediated by mutant S0X18 proteins rather than haploinsufficiency because of the 
lack of similar phenotypes observed in the Soxl8 null mutants.
The evidence indicates a synergy between S0X2 and S0X18 as a wild-type 
coat can only be formed when normal levels of each are expressed. It is tempting to
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speculate that the proteins produced from ragged alleles are interfering with cellular 
processes that are normally regulated by a balance between SOX2 and S0X18. Null 
mutations in either gene have opposite effects on coat formation possibly indicating 
an involvement in common cellular processes. The absence of either protein results 
in fairly mild coat phenotypes suggesting that remaining factors have some 
overlapping function in the maintenance of pelage formation. Acting as a dominant 
negative ragged would perhaps prevent both S0X2 and wild-type S0X18 from 
performing their normal function, which may be why even heterozygous ragged 
phenotypes are much more severe (Pennisi et al., 2000b; Slee, 1957).
It would be interesting to examine if ragged like coat phenotypes could be 
reproduced in animals carrying combinations of Sox2 and S o x l8  null alleles. A 
severe disruption of follicle development in these animals would at least demonstrate 
a synergy between the two mutations and may provide important information as to 
whether related Sox factors regulate some of the same targets in vivo. If found it is 
possible that similar interactions are also relevant within the regulatory networks of 
other cell types, such as the gut endoderm, where a similar combination of Sox factors 
is expressed (Kanai-Azuma et al., 2002). There are many tissues where there is 
overlapping expression of Sox genes, the combination of which might determine the 
identity of particular cells. Although these related factors might regulate completely 
separate sets of genes a subset of targets may depend upon differential regulation by a 
group of related factors. The hair follicle could serve as a useful model system in 
which to investigate in vivo interactions between individual Sox genes and their 
targets. It has the additional benefit that slight changes can be readily assayed whilst
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more significant disruptions would only cause the loss of this structure without 
compromising viability.
Together Ysb and Lee form an allelic series with each of these
mutations causing a modification to the normal expression pattern of Sox2 (and 
maybe other genes as well). Breeding experiments show that the Lee and Ysb alleles 
cause a loss of function of Sox2 with the predominant phenotypes observed in the 
inner ear and the hair follicle. Ysb/Ysb, Lee/Lee and Sox2P̂ °̂'̂ '̂ IYsb'̂ '' animals are 
viable, but no Sox2^^^‘'’''yLee^^' animals were ever recovered after birth although late 
gestation embryos were recovered alive and appeared grossly normal. The reason for 
postnatal lethality of these animals was not determined but is unlikely to be caused by 
abnormalities of hair follicles or the inner ear. This indicates that there are further 
sites of Sox2 expression that are affected by the Lee allele and so it may be used to 
understand the role of Sox2 in other tissues of the developing embryo.
Survival of Lee homozygous animals post partum may be explained if there is 
a certain dose of S0X2 required for viability in whichever tissue is being affected. 
One explanation for this might be that the Lee allele is affecting a regulatory element 
responsible for maintaining Sox2 expression in certain cells after a particular 
developmental stage. In animals homozygous for the Lee allele, Sox2 would be 
expressed at normal levels until the point at which the regulatory mutation means it 
can no longer be maintained in a particular group of cells. Viability of the whole 
animal is not lost as enough S0X2 is provided by initial expression. In Sox2^^^^' 
^ /̂Lee'^ '̂ animals only half the dose of Sox2 is expressed from the outset. This is 
normally sufficient for viability, however, once Sox2 expression also ceases from the
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Lee allele, then the amount of SOX2 available in a particular group of cells may drop 
below a critical threshold and result in the death of these animals.
Expression data has proved key to the identification of Sox2 as a critical gene 
disrupted by both the Lee and Ysb mutations. Although both of these alleles have 
large and only partially characterised abnormalities, the link to Sox2 misregulation 
makes them a useful tool in the investigation of both inner ear and hair follicle 
formation as well as to elucidate functional characteristics of Sox2. Further 
investigation may yield additional tissues where Sox2 expression is disrupted and so 
facilitate the examination of further aspects of its function. Apart from this, further 
characterisation of the Lee and Ysb alleles may provide clues to the location of 
regulatory elements that would normally control the expression of Sox2. This study 
highlights the importance of this type of randomly created mutant despite the 
existence of more deliberate techniques of gene modification such as conditionally 
null Sox2 allele. Conditional inactivation of Sox2 could be use to highlight individual 
roles in the different components of the hair follicle that exhibit Sox2 expression. Cre 
constructs utilising versican regulatory elements that direct expression to the dermal 
papilla could be exploited to extend the current understanding of the role of Sox2 in 
these cells.
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Chapter 5 Sox gene redundancy addressed bv breeding and
together.
5.2 Introduction.
The idea of functional redundancy has arisen largely from the observation of 
overlapping expression patterns of related genes and their analysis by targeted null 
mutation. The lack of obvious phenotypes or malformation limited to a subset of 
expression sites when a single gene is disrupted is often explained as a result of 
compensation by a related gene (Cheung et al., 2000; Kume et al., 2000; Overton et 
al., 2002; Pennisi et al., 2000a; Solomon and Fritz, 2002). Such compensation may 
be abrogated if animals carrying multiple null alleles are created. In these compound 
null models, phenotypes are often more severe than the additive effects of the 
individual mutations and this is taken as an indication of functional redundancy 
between the respective genes. The implication that Soxl, Sox2 and Sox3 share some 
functional responsibility may be similarly addressed, in vivo. By breeding together 
mice that carry null mutations in these genes it should be possible to create animals 
lacking different doses of these genes.
At the time when this experiment was conceived, targeted disruption of all the 
SoxBl genes had been made but only Soxl and Sox2 null alleles were available in 
viable mouse lines. Although mice carrying null alleles in all three genes may be 
expected to have the severest phenotype it is important to examine the effect of all the 
possible combinations of null alleles. An experiment focussing on the effects of 
combining null alleles of Soxl {Soxl^^) and Sox2 (Sox2^^^°) was therefore carried out.
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Viability was used as the initial crude measure of the effect of these 
mutations. The two individual mutants were re-examined using this assay before 
analysing animals carrying combined mutations. If the functions of these genes are 
unrelated then the addition of their phenotypes should not decrease viability beyond 
the simple summation of that of and Sox2̂ ^̂ °'̂ '̂ . If there is an increase in
mortality above this there are two potential explanations. Firstly, there is functional 
equivalence between these two genes where it is the overall level of SoxBl protein in 
a particular cell that is important. Reduction of this total level by disrupting 
increasing numbers of alleles would be expected to result in increasingly pronounced 
phenotypes. In this model, this effect should be the same regardless of which 
combination of alleles is removed; the importance is in the absolute dose. The 
second explanation is that the two proteins are active in the same cells at the same 
time but their function is qualitatively different. In this case, one might still expect to 
see a more severe phenotype in these compound mutants but the particular 
combination of alleles removed is critical. These hypotheses can only be 
distinguished once the consequence of all possible combinations of mutations has 
been revealed.
An increase in mortality in the compound mutants would require further 
investigation in sites of overlapping expression between Soxl and Sox2. It will be 
important to analyse phenotypes in these regions to uncover the roles of the SoxBl 




5.3.1 Do single Soxl’̂  ̂or Sox2̂ ^̂ ° alleles affect viability?
Before examining the effect that compound null mutations of Soxl or Sox2 
have on mouse viability it was important to analyse what affect these alleles had on 
their own. It has already been established that the most severe effects of these alleles 
manifest themselves when there is a homozygous null mutation (Avilion et al., 2003; 
Malas et al., 2003; Nishiguchi et al., 1998) but it was important to establish the 
consequence, if any, to animals that carried a single null allele of either of these 
genes.
The Soxl'^^ mutation.
The Soxl""^ null mutation has already been described (Malas et al., 2003; 
Nishiguchi et al., 1998). Litters from heterozygous matings contain the expected 
Mendelian frequency of null alleles at birth so SOXl does not appear to be essential 
for embryonic life. The predominant phenotypes of Soxl'"^'^' mice are micropthalmia, 
spontaneous seizures and a high mortality rate in both inbred and hybrid backgrounds 
(Chapter 1). Breeding data confirmed that, although at weaning age there are less 
Soxl"^ '̂ '̂ mice present than would be expected, a significant number are able to 
survive well past this age. The numbers of heterozygotes at weaning did not give any 
indication that a single null allele has any effect on viability up to this age (Table 
5.1).
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Table 5.1 Tail biopsy data for Soxl'^  ̂heterozygote matings.
Tail biopsy data was collected over one year from maintenance breeding o f Sox 1”̂  ̂ line 
where both parents are Soxl’̂  ̂' .̂
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Weaned % of
Background Genotype (n) Total
129SvEv +/+ 23 27%
(12 litters) -/+ 50 53%
-/- 13 15%
Total 86
C57B1/6 +/+ 20 34%




The Sox2̂ ^ °̂ mutation.
As with the Soxl null mutation, homozygotes showed a far more
severe phenotype (Avilion et al., 2003). All Sox2^^ °̂' '̂ animals die at the peri- 
implantation stage and so S0X2 is an essential component for embryonic life. An 
analysis of the breeding data of the Sox2^^^° mice revealed that there was also a 
significant detrimental effect of a single null allele. This effect was observed on both 
the 129/SvEv and M Fl backgrounds although it was greater on the inbred 
background. Tail biopsy data, from over one hundred litters, created by mating 
Sox2f^^°'^  ̂males against wild-type females, indicated that at weaning age (3-4 weeks 
post-partum) there were significantly less Sox2^^^°''^ animals present than expected, 
assuming normal Mendelian inheritance. When numbers and genotypes were 
examined, forty or twenty-nine percent less Sox2f̂ °̂'̂ "̂  mice were present than would 
have been expected on the 129SvEv or MFl backgrounds respectively (Table 5.2).
In order to establish when Sox2f^^°''  ̂ animals were dying, carcasses of pre­
weaned mice found dead in cages were collected from maintenance breeding of the 
Sox2f^^°''^ lines and genotyped. Analysis revealed that almost 74% (n=23) of these 
animals were Sox2f^ '̂"''  ̂which could entirely account for the discrepancy seen at three 
to four weeks post partum. Animals tended to die either soon after birth or after 
about three weeks. No gross abnormalities were observed in the younger group of 
animals but three week old Sox2^^^°''^ pups were often, although not always, much 
smaller than their wild-type littermates.
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Table 5.2 Tail biopsy data for 5'6>x2^^ '̂'maintainence breeding.
Tail biopsy data was collected over one year from maintenance breeding o f Sox2^^^° line. 
Father is always Sox2P̂ ^̂ '̂ '̂  and mother wild-type.
The significance o f ^  analysis with five degrees o f freedom is P< 0.05 if  ̂  is greater than
11.07 and P<0.01 if  the value is greater than 15.09. "^denotes estimates made by 
normalising expected figures against the observed wild-type samples.
% Missing is calculated on the basis that wild-type numbers represent the norm.
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MFl +/+ 259 58.3%




5.3.2 Production of Soxl""fSox2!^^^°coTapoux{di null mutants.
Breeding data confirms the effects on viability to animals carrying null alleles 
of either Soxl or Sox2. A mating regime was devised in order to analyse viability in 
animals carrying combinations of these two null alleles. Mice heterozygous for the 
null mutation of either Soxl or Sox2 were mated together to produce animals that 
were heterozygous for each of these null alleles. A second round of breeding was 
then required to create litters that might carry all the possible genotypes. Offspring 
from this second round of matings were examined at a variety of stages to establish 
any effect that these null alleles might have on viability. Matings were selected to 
control against any effect of genetic background and fell into the two main 
categories; inbred (129/SvEv) or hybrid (129/SvEv X M Fl) background. The 
observed consequences of the compound null mutations were the same on both 
backgrounds, although possibly slightly more severe on the inbred background. The 
majority of data was collected from mice on the hybrid background that generally 
produced more reliable litter sizes and therefore numbers for statistical analysis.
Statistical analysis o f the breeding data.
Apart from background differences, breeding data falls into three main 
categories. First, all the embryos harvested at different stages in development. 
Second, all the (recovered) animals that were bom, including those that died before 
weaning and, lastly, those mice that survived for at least four weeks and were then 
weaned from their mother.
Expected overall Mendelian ratios were calculated allowing for the fact that 
Sox2^^^°''' is always lethal at peri-implantation stages and that litters obtained were
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derived from a variety of parental genotypes. There is also no linkage between any of 
the alleles being examined.
Embryonic data.
The effects of the two null alleles were examined during embryogenesis. 
Embryos were harvested at all stages after mid-gestation until birth and were then 
genotyped. These data indicate that all expected genotypes are represented 
throughout embryonic development and that no excessive lethality was noted (Table 
5.3). Chi squared analysis (%̂ ) confirmed that there is no significant variation from 
the expected frequencies of genotypes during embryogenesis whether the data is 
examined as a whole or as subdivisions based on age or background (data not 
shown). It was also noted that embryos harvested at all stages showed signs of life 
(heartbeat and reflex movement at later stages).
Weaned animals breeding data.
Tail biopsy data from all breedings carried out in this experiment were 
analysed to gain an insight into the genotypes that were able to survive up until 
weaning age (three to four weeks post partum). Statistical analysis of the total 
weaned animals, using Chi squared, indicates that overall there is a very significant 
deviation from the expected Mendelian ratios (Table 5.3). Analysis reveals that the 
deviation from expected frequencies is partly due to the complete absence of Soxl"' '̂ '̂ 
!Sox2P̂ °̂'̂ ,̂ but it is not obvious if the numbers of animals with other genotypes are 
also significantly different.
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Table 5.3 Observed numbers and statistical analysis of MFl offspring the Soxl'”\  Sox2!̂ ^̂ °
breeding experiment.
Breeding data is split into two categories: ‘Embryos’ recovered up to 17.5dpc and 
‘Weaned’ animals that had a tail tip biopsy.
The significance o f ^  analysis with five degrees of freedom is P< 0.05 if  ̂  is greater than
11.07 and P<0.01 if the value is greater than 15.09.
Zq is a measure (according to binomial distribution) o f the null hypothesis that observed 
equals expected. P<0.05 ifZo lies outside the interval ±1.96 and P<0.01 ifZolies outside 
the interval ±2.58.
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Statistical analysis - explanation
In this experiment, statistical analysis relies upon producing an expected value 
of animals with a particular genotype. These values are normally calculated by 
multiplying the proportion of animals expected, according to Mendelian genetics, by 
the total number of samples recovered and is useful when examining a shift from one 
genotype to another. In this experiment the total number of samples at weaning is an 
underestimate as there is a proportion of animals that die, due to their genotype with 
respect to Soxl""^ or Sox2f^^°. Many of these animals are lost as they are cannibalised 
before they can be counted and genotyped. In order to estimate the actual number of 
animals that should have survived to weaning, if there was no detrimental effect of a 
particular genotype, an expected total was extrapolated by multiplying up from the 
number of wild-type pups. A certain proportion of wild-type animals will die but this 
number ought to be equal across the respective genotypes and therefore this method 
gives a good baseline estimate.
By making these estimates for all weaning data and comparing them to actual 
values it can be shown that significantly fewer animals of all genotypes, except 
Soxl"" '̂^  ̂and wild-type, survived to weaning (Table 5.3). However, animals with the 
Soxl"' '̂ '̂ISox2^^ °̂' '̂  ̂genotype are the only ones that never survive past weaning age.
Death before weaning age.
Breeding data shows that there is a major discrepancy between animals 
expected to be present at weaning and the actual numbers observed, although all 
expected genotypes were present during embryogenesis. An analysis of animals that 
had died within four weeks post partum was therefore performed. As many dead
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Figure 5.1 The longest surviving Soxl"’"̂'''!Sox2P̂ °̂''̂  animals do not thrive.
A few mice carrying the severest expected genotype were on the hybrid background and 
survived to about three weeks old. These animas never thrived or survived being weaned 
despite being indistinguishable from their littermates at birth.
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pups as possible were collected and genotyped by PCR. It was often difficult to 
recover all the carcasses before the mother had eaten them and so it was assumed that 
these animals only represented a proportion of those that died before weaning.
The majority of all animals found dead were up to one day old (58%, n=58). 
There was another cluster of deaths at about three weeks (17% 19-23d, n=17). Of the 
twenty-one SoxI ’̂ '̂̂ 'ISoxTP̂^̂ "'̂  ̂ animals found dead only five survived past three days 
old and animals of this genotype were the only ones that all died before weaning age. 
Although there was no discernible difference in size at birth surviving Soxl'^ '̂ '̂ 
!Sox2f̂ °̂'̂ '̂  animals were always a fraction of the size and weight of their littermates at 
three weeks (Fig.5.1). No obvious physical or behavioural attributes were observed 
that could explain this difference. Other animals that were either Soxl'"^'^' or Sox2^^^°' 
although significantly more likely to die before weaning than wild-type littermates, 
did not differ greatly in size and were usually able to survive past four weeks old.
By adding together all bom animals (whether dead or alive) an estimate of the 
total bom animals can be made ( ‘*Exp.’ Table 5.4). This indicates that only about 
half of all dead pups were recovered (difference between bom ‘total’ and bom 
‘*total’) and that most of this difference is due to the absence of Soxl'^ '̂ '̂ISox2^^^°'^  ̂
animals. Since almost all of the older carcasses were genotyped it was assumed that 
most of the ‘dissappeared’ pups were lost soon after birth and entirely eaten.
Summary o f breeding data findings
Examination of all the breeding data reveals that there is a roughly equivalent 
detrimental effect to carrying a homozygous null Soxl mutation or a single null Sox2 
allele. Although embryonic viability is not affected in mice with these genotypes
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Table 5.4 Numbers of genotyped carcases and summary of animals bom during the
Soxl'"^ breeding experiment.
Breeding data is split into two categories: ‘Dead PW’ are all the post partum carcasses 
recovered before weaning and ‘B om ’ animals which is the sum o f all weaned animals plus 
post partum carcasses recovered before weaning.
The significance o f  ̂  analysis with five degrees o f freedom is P< 0.05 if  ̂  is greater than
11.07 and P<0.01 if the value is greater than 15.09.
Zq is a measure (according to binomial distribution) o f the null hypothesis that observed 
equals expected. P<0.05 ifZg lies outside the interval ±1.96 and P<0.01 ifZolies outside 
the interval ±2.58.
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animals are 30-40% more likely to die before weaning age than their wild-type (or 
littermates. Also Soxl'^^'^7Sox2^^^‘''̂ '̂ compound mutations are not 
detrimental to embryonic life but are most commonly lethal soon after birth. The few 
Soxl'^^’̂ 'ISox2'̂ "̂°'̂  ̂mice able to survive up until about three weeks post-partum were 
all on the hybrid background, clearly not thriving and never survived weaning. These 
data confirm that there is a significant disadvantage in carrying two mutant copies of 
Soxl and one of Sox2 that exceeds the additive effects of each allele alone.
5.3.3 Search for a phenotype.
As the majority of Soxl'’' '̂frSox2^^^‘''̂ '̂ animais die at or around birth it is likely 
that the combined effects of these mutations are exerting themselves during 
development when both these genes are mainly expressed. The uterus is an 
extremely supportive environment and embryos with quite major abnormalities are 
able to survive whilst inside. In the case of the Shh null mutation embryos develop 
with cyclopia and extensive skeletal abnormalities but do not die until birth 
commonly followed by the rapid cannibalisation of stillborn pups (Chiang et al., 
1996). It is for this reason that Soxl'^ '̂ '̂ISox2!^^^°'^  ̂ embryos, at various stages, were 
examined in an attempt to identify any abnormality that might be causing premature 
death post-partum.
Why look at the CNS?
Of the three SoxBl genes, Soxl has the most limited expression pattern being 
restricted almost exclusively to the developing CNS, with in vitro experiments 
confirming a role in the early steps of nervous system development (Li et al., 1998; 
Wichterle et al., 2002). Development of the vertebrate CNS relies upon the highly
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orchestrated production of a wide array of neuronal and glial cell types from multi­
potential progenitor cells. The first sign of neural progenitors is seen with the 
formation of the neural plate at around 7.5dpc that subsequently folds to form a tube 
like structure surrounding a central ventricle. After midgestation, cell proliferation 
and differentiation result in a dramatic elaboration of the basic neural tube structure 
in a process that is broadly similar from beginning to end. Throughout development 
CNS precursor cells proliferate in the ventricular zone that lines the lumen of the 
developing brain and spinal cord. Once these cells have undergone their final mitosis 
they move away from the ventricular zone and begin to differentiate into the class of 
cell appropriate to their temporal and spatial position. Early differentiating neurons 
are therefore found in the sub-ventricular zone but continue to migrate outward 
achieving terminal differentiation in more lateral regions.
Whilst many regulatory genes are expressed in the progenitors of particular 
CNS structures, members of the Sox family cross these boundaries and instead seem 
limited by more general criteria such as the level of differentiation or proliferative 
capacity (Cheung et al., 2000; Graham et al., 2003). SoxBl genes have significantly 
overlapping expression patterns in the CNS that predominantly mark cells in the 
ventricular and sub-ventricular zones throughout development (Chapter 1), (Cheung 
et al., 2000; Collignon, 1992; Wood and Episkopou, 1999). Lethality of Soxl'’"̂ '̂ ' 
ISox2^ '̂°' '̂  ̂ mice may therefore be caused by abnormalities in these populations 
leading to more widespread effects upon the developing CNS.
The majority of cells in the cortex and striatum of the forebrain develop from 
two adjacent telencephalic fields. Progenitor cells lining the ventral side of the lateral
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ventricle give rise to striatal neurons (including the dorsal striatum, nucleus 
accumbens and the olfactory tubercle). Gsh2 is necessary for the maintenance of 
striatal progenitors and in its absence striatal development is severely disrupted and 
the lateral ganglionic eminence is dramatically reduced in size (Szucsic 1997, 
Toresson 2000). The dorsal ventricular zone gives rise to cells that migrate radially 
eventually forming six cortical layers in a characteristically inside out fashion. Cells 
bom at different times between 12dpc and 16dpc normally contribute to progressively 
more superficial layers. The Pax6 mouse mutant. Small eye (Pax6^^^), produces no 
functional Pax6 causing the death of homozygotes soon after birth. Pax6 is highly 
expressed in cortical progenitors and its absence (in Pax6"̂ ^̂ "̂  ̂ embryos) causes a 
partial redistribution of metaphase cells due to an acceleration of cortical 
development (Estivill-Torrus et al., 2002). Transiently induced chemical lesions of 
cortical precursors results in thinning of the cortical plate but this is partially 
compensated for with the normal cortical arrangement and connections still being 
produced (Gillies 1993).
No explicit abnormalities have been described in the CNS of Sox2^^^°'^^ 
embryos. The Soxl"'^'^' mutation however causes a specific lesion in the olfactory 
(Piriform) cortex despite a far more widespread expression pattern. This has been 
shown to be the cause of spontaneous seizures and secondary neural defects in these 
animals between four and six weeks of age (Chapter 1), (Malas et al., 2003). The 
absence of more extensive malformation is thought to be due to functional 
compensation by other SoxBl genes. It is possible that this striatal lesion is 
exacerbated in animals that also carry a null Sox2 allele or that other malformations 
arising from the disruption of progenitors are produced. A gross survey of whole
175
embryos and brains was initially performed but attention was focussed on examining 
developing forebrain regions after midgestation.
Gross examination o f whole embryos
embryos were taken from the hybrid line and were 
examined alongside littermate controls. Where possible, litters for analysis were 
chosen containing all the expected genotypes but often did not contain a 
representative of each. For the preliminary analysis it was most important to compare 
Soxl”'̂ '̂ 'iSox2P̂ °̂'̂ '̂  samples (usually two) with a wild-type or Soxl"'^'^'^/Sox2^^''‘ normal 
control and a homozygous Soxl null as this mutation is known to cause specific CNS 
lesions and eye defects.
A gross examination of all embryos harvested at different developmental 
stages was carried out in order to identify any major defects that might result from the 
combination of disrupted alleles in Soxl’’"̂ '̂ 'ISox2!̂ ^̂ °'̂ '̂  animals. Embryos of all 
genotypes appeared normal at all stages examined and could not be identified on the 
basis of their appearance. In order to aid the gross analysis some embryos were 
stained to detect figeo activity conferred by the Sox2^^^° allele. This identifies all of 
the structures that should have been expressing Sox2 and allow a comparison between 
genotypes that carry the Sox2^^^° allele. Again there were no gross differences in the 
X-gal expression pattern of any of the embryos examined that could be attributed to 
the Soxl’̂ '̂̂ 'ISox2P̂ °̂'''̂  phenotype although micropthalmia, due to the absence of 
SOXl, was observed (Fig. 5.2 and data not shown). Stained embryos were also wax 
embedded and sectioned but no obvious differences could be determined and so a 
more thorough examination of embryonic CNS was undertaken.
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Figure 5.2 12.5dpc X-gal stained embryos from the Soxl^\ Sox2P̂ °̂ breeding experiment.
Littermates on a hybrid background were harvested and subjected to X-gal staining 
(materials and methods). No gross dijferences were observed in wholemount except a 
slightly smaller eye in embryos null for Soxl. Slight differences in staining were more 
likely to be an artefact o f the staining procedure. Bar is 1mm.
177
(a) SoxV"‘''*/Sox2'̂ '̂'‘'''̂
( h )  S oxJ'" ''^ '/Sox2-^ '‘̂ '''’'̂ ^
Gross histological analysis o f embryonic CNS.
Brains removed from the cranium of 16.5dpc embryos did not differ greatly 
between genotypes in size or shape and there were no gross abnormalities observed 
with all the major structures present (Fig. 5.3a). Samples were wax embedded and 
serial sectioned in order to allow closer histological and immunohistochemical 
analysis (materials and methods). Series of sections were stained using either 
haematoxylin and eosin or Cresol violet (to detect Nissl substance in neurons). These 
were then photographed under high power magnification and comparable sections 
compared side by side. In this analysis particular attention was paid to the main CNS 
structures and areas that derive from regions where there is expression of the SoxBl 
genes (Fig. 5.3b).
It is possible that the reduction in SoxBl genes in Soxl'^ '̂ '̂ISox2f^^°''^ embryos 
disrupts telencephalic progenitors and might produce thinning or disruption of the 
ventricular cell layers or structures derived from these areas. No lesions or atrophy of 
the ventricular zones can be seen in Soxl"" '̂ '̂ISox2f^^°'^  ̂ samples although this is where 
there is the greatest expression of Soxl, Sox2 and Sox3 in the developing CNS. A 
migration of ventricular progenitors also gives rise to the nucleus accumbens and the 
olfactory tubercle that is disrupted in Soxl null embryos. This specific lesion is 
difficult to visualise using standard histological techniques but does not appear to be 
more severely disrupted in animals carrying an additional Sox2 null allele. 
Comparison of all sections (shown) indicated that there are no gross differences in 
any of the forebrain structures at 16.5dpc. Overall, comparable sections appeared
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Figure 5.3 Gross examination of the CNS in embryos of the major genotypes being
examined.
(a). Whole brains were removed from the cranium o f 16.5dpc embryos and compared side 
by side but no gross abnormalities could be observed. Samples were also processed for  
histological analysis. The position o f coronal sections shown are depicted on the wild-type 
brain sample. Bar is 1mm.
(b). First row (plane i) cuts through the olfactory bulbs. The second series o f sections 
(plane it) shows the lateral ventricle (LV) at the level o f the olfactory tubercle (OTU) that 
is disrupted in animals carrying the Soxl"^^ '' genotype (micropthalmia is also noticeable in 
these samples). The final set o f sections (plane Hi) cuts through the posterior part o f the 
lateral ventricle showing the choroid plexus (cp), the beginnings o f the developing 
hippocampus (asterisk) and the ganglionic eminence (GE) which is made up o f the 
ventricular and sub ventricular zones. Bar is 100p,mfor all panes in this section.
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(a) Wild-type Soxl"' ‘ '̂ '/Sox2-̂ ^̂ ''"
m
extremely similar and there was no obvious difference in the dimensions or 
organisation of the CNS discernable by this type of analysis.
Immunohistochemical analysis
Histological examination of serial sections of brains did not reveal any 
obvious difference between samples carrying different combinations of null alleles. 
It was then necessary to focus any search by analysing a series of comparable serial 
sections with molecular markers that would detect more subtle changes in CNS 
structure. There is an extraordinary number of markers that could indicate anomalies 
in brain samples, but the initial choice was made as general as possible. Antibodies 
to detect SOXl, SOX2 and S0X3 were employed in order to indicate precisely 
regions of the CNS where they are expressed. When used in combination on serial 
sections a clear picture could be obtained as to which cells have overlapping 
expression of these genes and perhaps give an indication of the regions of the 
developing CNS that might be most affected in the Soxl'^ '̂^VSox2^^^°^ '̂ mimdiXs.
Sox protein expression in 11.5dpc CNS.
In wild-type ll.Sdpc samples the expression of SOXl, S0X2 and S0X3 is 
very similar and marks cells in the ventricular and sub-ventricular zones, lining the 
lumen of the developing CNS (Fig. 5.4a). In samples with the Soxl'”̂'̂ ' genotype, no 
SOXl protein was detected and the pattern of the other markers appeared unchanged 
although generally the remaining SOXB1 proteins were more difficult to detect.
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Figure 5.4 SOX B1 protein expression in the ventricular zones and neural tube of lL5dpc
and 16.5dpc embryos.
(a). 11.5dpc samples: Antibodies were used to detect SOXl, S0X2 and S0X3 in coronal 
brain sections from the three major genotypes being examined. Protein was detected in 
serial sections where possible and in comparable sections where not. Bar is 100pm.
(b). 16.5dpc samples: Antibodies were used to detect SOXl, SOX2 and S0X3 in sagittal 
brain sections from the three major genotypes being examined. Protein was detected in 
anterior and posterior regions o f the third ventricle in serial sections where possible and 
in comparable sections where not. Asterisk marks the lumen o f the lateral ventricle. 
VZ/SVZ indicates the region o f the ventricular and sub ventricular zones where SOXl, 
S0X2 and S0X3 staining is normally seen in wildtype samples. In samples from Soxl^^ '' 
!Sox2f^^°''^ embryos S0X2 and S0X3 staining is detected but the number o f positive cells 
and the intensity o f staining consistently appears to be reduced despite these layers 
appearing similar under conventional histological examination.
SOXl appears as pseudo colour yellow. S0X2 signal appears red and S0X3 is pseudo 
coloured green. Bar is 100pm.
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Immunohistochemical analysis of SOXBl proteins in the ventricular layers of 
16.5dpc samples confirmed their continued expression in the ventricular and 
subventricular zone of the lateral ventricles (Fig. 5.4b). In wild-type samples, protein 
expression is robust and can be seen in a similar pattern in Soxl^^ '' samples except 
that there is no SOXl present. Positive cells are normally detected throughout the 
ventricular zones but generally staining is strongest in cells closest to the lumen. In 
Soxl”'̂ '’'ISox2P̂ °̂''* samples, although S0X2 and SOX3 are detected, the number of 
positive cells and the intensity of staining consistently appears to be reduced despite 
these layers appearing similar under conventional histological examination (Fig. 
5.3b). Again antibody detection with the SOX2 and S0X3 antibodies was more 
difficult in samples carrying the Soxl” '̂̂ ' mutation and might indicate a disruption of 
auto/cross-regulation of these genes resulting in a reduction in dose over and above 
that attributable to the null alleles alone.
Histological examination of embryos carrying different combinations of null 
alleles for Soxl and Sox2 did not reveal any gross abnormality in the embryonic CNS, 
however, there did appear to be an alteration in SOX protein expression that only 
occurred in animals with the most severe genotype (Soxr'^'''lSox2P^^°''^). The 
difference in Sox protein expression was noticeable at later stages in development and 
suggests that a reduction in the dose of Soxl and Sox2 genes disrupts proliferating 
and/or early differentiating cells in the ventricular zones. In these samples, less cells 
stained positive for SOXBl proteins which may indicate that cells start to 
differentiate earlier or that cell cycle dynamics and/or viability may be altered. 
Markers to detect change in these aspects of cell behaviour were therefore employed.
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Analysis o f cell proliferation and programmed cell death
Cell proliferation was assayed using an antibody that detects cells in 
metaphase. The antibody used detects phosphorylated histone H3 (H3P) and begins 
binding weakly to pericentromeric heterochromatin of cells in G2 but the signal 
spreads as chromosomes condense becoming strongest during metaphase (Hendzel et 
al., 1997). Throughout brain development this signal is normally restricted to dividing 
cells at the ventricular surface but its distribution is altered where mutation interferes 
with cellular dynamics (Estivill-Torrus et al., 2002). The number and distribution of 
H3P positive cells was examined at ll.Sdpc, 14.5dpc and 16.5dpc in S o x l”̂ '̂'' 
iSoxlf^^ '̂''^ brain sections and littermate controls. No difference either in the number 
of metaphase cells marked or their distribution could be detected between these 
samples (data not shown).
TUNEL analysis.
Another reason for a reduced number of SOXBl positive cells might be that 
the null alleles cause cellular changes that compromise their viability. In order to 
detect cells that were undergoing programmed cell death TUNEL (terminal 
deoxynucleotidyl transferase dUTP nick end-labeling) analysis was carried out. This 
technique labels the ends of fragmented DNA that are produced within cells 
undergoing apoptosis (materials and methods).
Samples from the three different embryonic stages were examined (ll.Sdpc, 
14.5dpc and 16.5dpc) and in general no differences in the number of apoptotic cells 
could detected. There was, however, some localised cell death that was only 
observed in the older Soxl'^ '̂''ISox2^^^°''^ samples. In each case apoptosis occurred in
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Figure 5.5 Unique differences are revealed in Soxl^ '̂''ISox2P^ °̂''* embryos by TUNEL and
TuJl analysis.
(a),(b). TUNEL analysis was performed on 14.5 and 16.5dpc SoxT^^''jSox'2f^^°''^ embryos 
alongside littermate controls. Clusters o f TUNEL positive cells were observed in the 
undifferentiated ventricular zone where there is normally expression o f the SoxBl genes. 
Although the regions affected were not the same these clusters o f cells marked by this 
procedure were only ever observed in SoxV^ '̂''ISox2f^^°''^ samples, (a), inset shows a close 
up o f positive cells in the 14.5dpc forebrain in sagittal sections around the anterior margin 
o f the third ventricle. Bar is 500pm. (b), TUNEL positive cells in the 16.5dpc Soxl”'̂ '̂ ' 
ISoxlf^^^''^ sample were located in the ventricular zone o f the olfactory bulb. Bar is 500pm.
(c). Preliminary immunohistochemical analysis using the TuJl antibody (to detect Illfi- 
tubulin in early differentiated neurons) marks ectopic expression in the ventricular zone o f 
lateral ventricles only in Soxl^^'''/Sox'2f^^°''* samples (arrowheads). Sections are in the 





the ventricular zone but the regions affected were not in the same areas. In 
one sample a group of apoptotic cells was detected adjacent to the ventricle of one of 
the olfactory bulbs (Fig. 5.3a). In a second sample olfactory neuroepithelium 
appeared normal but there was increased apoptosis in the anterior ventricular zone of 
the third ventricle. Such localised cell death may not result in gross morphological 
differences but could compromise the circuitry of the developing CNS and therefore 
the viability of animals carrying these lesions.
Preliminary analysis with cell type specific markers.
A preliminary survey was made using antibodies to mark specific cell types. 
Antibodies directed against radial glia (RC2), early migrating cells (DCXl) and early 
neurons (TuJl) were employed to search for differences in these cell populations. In 
these initial experiments no differences attributable to the 
phenotype were observed with the RC2 or DCXl antibody, however, when using the 
TuJl antibody, which detects IIIB-tubulin, some alterations were seen. Preliminary 
analysis indicated that cells ectopically expressing this marker could be found within 
the ventricular zones only in samples. This antibody was only




Soxl, S o x l  and Sox3 are grouped together by virtue of a high degree of 
sequence similarity but they also have extensive overlap in their expression patterns 
(Chapter 1). Animals null for each of the SoxBl genes indicate the importance of 
their protein products during development but phenotypes are generally limited to 
tissues where there is unique expression of a single member of this subgroup 
(Chapterl). The limited consequence of the null mutation of a single gene (at least 
for S o x l  and Sox3) despite a broad expression pattern suggests functional 
compensation by related proteins with overlapping expression. If this is the case then 
more than one gene must be removed in order to decipher their role. Animals 
carrying various combinations of null alleles of Soxl and Soxl were therefore created 
to address the possibility of functional redundancy between these genes.
In this experiment all the expected genotypes were produced and were able to 
survive until birth but Soxl’̂ '̂ l̂Soxlf^^°'^  ̂pups always died before weaning age, most 
commonly soon after birth. The summation of the individual phenotypes observed in 
animals carrying equivalent mutations in either Soxl or Soxl can not explain the 
postnatal lethality of Soxl'^ '̂ '̂ISox2^^ °̂' '̂  ̂ animals and is an indication that there is 
synergy between these genes.
The expression of Soxl, Soxl and Sox3 in the developing CNS indicates that 
they may have a role in maintaining progenitor cell identity before they start to 
migrate away from the ventricular zones. The overlapping expression of all three 
genes is highly conserved and so is likely to be a requirement for normal 
development. The introduction of null alleles may reduce the total complement of
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these genes, but expression from the remaining wild-type SoxBl genes may broadly, 
but not completely, compensate for the loss.
Immunohistochemical analysis indicated an alteration in the extent of S0X2 
and S0X3 expression from the remaining wild-type alleles in S o x l”"̂ '̂ '!Sox2f̂ °̂'̂  ̂
samples. SoxBl proteins were also generally more difficult to detect as the number of 
null alleles present increased. This might reflect a degree of auto/crossregulation of 
these Sox genes, which has been previously suggested, exacerbating the effect of the 
null alleles present (Graham et al., 2003; Tomioka et al., 2002; Uchikawa et al., 1999; 
Wiebe et al., 2003). Assuming that S0X2 and S0X3 still mark cells of the same 
identity then the overall reduction in SoxBl expression has the effect of reducing the 
population size of this cell type. There could be a number of explanations for this 
such as a decrease in proliferation, an increase in cell death or the accelerated 
differentiation of SoxBl expressing cells. Initial analysis surveyed the forebrains of 
mutant embryos at various stages to identify any differences in cell proliferation or 
viability.
When the number and distribution of metaphase cells was examined there 
appeared to be no difference between samples. Also histological analysis did not 
indicate any obvious atrophy in comparable sections. This indicates that the stem cell 
population, present within the region marked by SoxBl expression (Pevny and Rao, 
2003), is behaving normally and does not indicate that there is a generalised decrease 
in the rate of proliferation of progenitor cells.
TUNEL analysis was employed to identify cells undergoing programmed cell 
death but no general differences were observed between samples. The only
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difference that could be attributed to the genotype was the
appearance of localised patches of TUNEL positive cells in the ventricular 
neuroepithelium of older embryonic samples.
Increased apoptosis is observed in a number of animal models when Sox 
genes are completely removed. Mice null for S o x l?  exhibit apoptosis of the 
endoderm in the foregut (Kanai-Azuma et al., 2002). Lack of any functional Sox9 
causes extensive programmed cell death in mutant limb buds although this is not true 
in animals harbouring a mixture of null and wild-type cells, indicating it is not an 
inherent property of deficient cells (Akiyama et al., 2002; Bi et al., 1999).
Increased apoptosis is also seen when the SoxE protein SOXIO is absent from 
neural crest cells, but haploinsufficiency leads to a fate change without increased 
apoptosis (Cheung and Briscoe, 2003; Paratore et al., 2001). The SoxE  relative 
SOX9 is also found in neural crest and in Xenopus appears to be required there for the 
initial expression of SoxlO. Later in development these two genes resolve a mutually 
exclusive pattern of expression and cranial neural crest development is upset, in a 
fashion similar to the null SoxlO, when expression of Sox9 is disrupted (Spokony et 
al., 2002). This suggests that some SoxE expression is required for neural crest cell 
survival but the correct amount is necessary for cells to make appropriate fate 
decisions. This is similar to the situation in animals carrying various combinations of 
null alleles of the identically expressed SoxD  genes Sox5  and Sox6 (Smits and 
Lefebvre, 2003). Increasingly severe abnormalities in notochord development are 
observed as more null alleles are introduced but widespread apoptosis is seen only 
when both genes are absent (Smits and Lefebvre, 2003). This suggests that although
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there may be some unique activity, shared functions between these two proteins 
ensures that basic structural formation can be achieved as long as some protein is 
present. Refinement of this basic structure is, however, reliant upon the expression of 
the correct quantities of these genes. This quantitative regulation will have been 
achieved through evolution. Evolution has also resulted in some unique function of 
each of these proteins so that it is not just a matter of achieving the correct absolute 
amount but some of each may be required for optimum development even in tissues 
where there is overlapping expression.
In this experiment dying cells observed in the ventricular zones of 
lSox2̂ ^̂ °'̂ '̂  samples do not occur frequently enough to account for the more general 
reduction of SoxBl positive ventricular cells. This difference may be due to the 
reduction in the overall dose of these genes affecting cell dynamics in Soxl'^ '̂ '̂ 
!Sox2P̂ °̂'̂  ̂ CNS. A reduced dose, although usually sufficient for survival, might 
trigger premature differentiation and/or the adoption of inappropriate cell fates as 
seen in the SoxlO  knockout. A general effect such as this might be the cause of 
serious neuronal defects leading to postnatal lethality when Soxl and Sox2 alleles are 
disrupted.
The mammalian hairy and enhancer o f split homologue-1 (Hesl) is a basic 
helix-loop-helix (bHLH) transcription factor that is expressed at high levels in the 
ventricular zone of the developing CNS. Homozygous disruption of Hesl causes the 
increased lethality of embryos older than 12.5dpc and no animals survive more than 
one day postpartum. Lethality is attributed to the premature and disproportionate 
differentiation of progenitors to a neuronal fate as well as increased apoptosis of
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neural precursors in the ventricular zones (Ishibashi et ah, 1995; Nakamura et ah, 
2000). Null mutation of Hes5 is not lethal under normal laboratory conditions and 
again the morphological arrangement of the forebrain appears normal (Ishibashi et 
al., 1995; Ohtsuka et al., 1999). Most Hes5 function appears to be compensated for, 
but similar accelerated differentiation is seen in the ventricular zone of the Hes5 null 
CNS. A degree of functional compensation is revealed when compound mutants are 
made lacking both H esl and Hes5 (Ohtsuka et al., 1999). The brains of these 
embryos are smaller and severely deformed; neurons appear at an even greater 
density but there are still many Nestin positive neural precursor cells present. This 
indicates that the initial stages of neurogenesis are able to proceed but that lack of 
Hes genes later disrupts the correct timing and differentiation of progenitors.
embryos continue to have expression from one wild-type 
Sox2 and one Sox3 allele (the latter due to X-inactivation. Like the individual Hes 
mutants expression from related wild-type alleles may be sufficient to maintain basic, 
although not perfect, integrity of the regulatory network and therefore CNS structure. 
In wild-type animals background differences would not cause expression levels to fall 
below a threshold critical for viability, but in mutant embryos a deficit may occur in 
certain zones. In SoxH '̂ '̂!Sox2P^ °̂' '̂  ̂ mutants the pockets of apoptotic cells may 
therefore be the result of localised background dependant differences in already 
depleted wild-type SoxBl gene expression. It is possible that the further reduction of 
SoxBl levels could lead to more significant and reproducible programmed cell death, 
but alterations in the behaviour of SoxH '̂^7Sox2f^ '̂"'^  ̂ cells may yield greater insight 
into role of these proteins. The elimination of background differences by utilising 
samples from inbred mouse lines may yeild more consistant and perhaps extensive
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areas of apoptosis. In these samples it may be easier to identify exactly which cells in 
the CNS are most sensitive to the reduction in SoxBl expression.
SoxH '̂ '̂ISox2^^^°'^  ̂embryos display some similar phenotypes to the Hesl and 
Hes5 knockouts and could potentially be involved in a similar aspects of fate 
determination. In order to test this possibility markers of downstream events in the 
differentiation pathway should be examined and might indicate accelerated 
differentiation. Subventricular zone markers such as Dlx5 (Anderson et al., 1997) or 
Svetl (Thomas and Capecchi, 1987) may be useful to detect changes in the 
arrangement of these layers. If reduction of SoxBl genes leads to premature 
differentiation of progenitors then these markers may well show an expanded domain 
of expression. As cell fate may also change, cell type specific markers may show a 
shift in the distribution and proportion of cells arising from ventricular progenitors 
such as early neuronal (Neuron-specific class III b-tubulin TuJl or microtubule 
associated protein-2 MAP2) or glial (GFAP or GLAST (astrocytes) radial glia 
(RC2)).
Preliminary analysis with the early neuron specific antibody TuJl indicated 
that there may be premature differentiation of progenitor cells in the striatal 
ventricular zones of 16.5dpc SoxH '̂ '̂!Sox2f^^°' '̂  ̂ samples. These experiments were 
preliminary as they were only carried out on a single set of samples but they do 
indicate an interesting observation that requires confirmation. In chick neural tube 
the expression of a dominant negative form of Sox2 also has the effect of accelerating 
the rate of differentiation of neuronal precursors, whilst over expression prevents 
differentiation without stimulating over proliferation (Graham et al., 2003).
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The redistribution of early neuronal cells and increased cell death are 
phenotypes remarkably similar to that seen in samples null for either of the bHLH 
genes Hesl or Hes5. This indicates a role for each of these genes around the same 
stage of neurogenesis. It is possible that one influences the expression of the other or 
that each is required for the correct regulation of a set of common targets.
To date the only common target shown to be regulated by Sox and bHLH 
factors is the fruit fly gene Slit. The function of this family of extracellular matrix 
molecules is evolutionarily conserved with repulsive activity necessary for 
appropriate axon guidance and possibly neuronal migration (Plump et al., 2002). In 
Drosophila, Slit gene regulation requires the concerted contribution of the bHLH- 
PAS gene Singleminded (Sim), the POU domain protein Drifter (Dfr) and the Sox 
gene Dichaete (Fish, Fish-hook, SOX70D, S0XB2.1) interacting directly on the Slit 
enhancer (Ma et al., 2000). Sim is an absolute requirement for the initiation of Slit 
expression whilst its interaction with 5'ox/POU complexes is necessary for 
maintenance of Slit expression (Ma et al., 2000). Interaction in this case is between 
the PAS (Per, Amt, Sim (Crews and Fan, 1999)) domain of Sim and the HMG box of 
Dichaete but differential regulation may be achieved in the presence of alternative 
Sox, POU or bHLH proteins. It is possible that a similar regulatory relationship has 
been conserved as Slitl and Slitl have overlapping expression with all three classes 
of proteins in the ventricular zones of the developing mouse forebrain (Marin et al., 
2002). It would therefore be interesting to examine the expression of Slit genes in 
embryos carrying compound mutations in Soxl and Sox2.
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The lack of obvious phenotypes in animals carrying null mutations has often 
been explained as due to ‘functional redundancy’ between closely related proteins. 
Redundancy is defined as ‘the state or fact of not being or no longer being needed’ 
that in this context suggests an unnecessary excess of a particular activity. The 
lethality of mice carrying compound null mutations might be taken to reflect 
redundancy between these related genes, but experiments in vivo and in vitro indicate 
that some function may not be compensated for even by very similar proteins.
The subgroup members of the vertebrate Sox family are thought to have 
arisen by duplication of ancestral genes. Initially, pairs of identical genes would 
rapidly accumulate mutations (within a few million years) refining activity and/or 
expression levels close to what is actually required. These alleles become fixed in the 
population when further mutation is detrimental to the host. The SoxBl proteins are 
extremely well conserved even between species where the closest ancestor occurred 
nearly two hundred million years ago and some functional conservation can even be 
demonstrated between mouse and fly Sox genes (Chapterl), (Ma et al., 2000; Soriano 
and Russell, 1998). Differences between these genes may in certain contexts confer 
different activities and the combination of common and unique activities may be the 
strength behind their contribution to the regulatory network. This combination will 
be a function both of expression pattern and protein activity and so a full complement 
is likely to be critical for optimal fitness. This is perhaps why even a single null Sox 
allele can cause developmental changes despite overlapping expression of a related 
protein (Smits and Lefebvre, 2003; Sock et al., 2001). Close examination may reveal 
the contribution of a single allele but minor developmental changes may have no
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consequence to the behaviour or viability of the mollycoddled laboratory mouse and 
so might appear, on the face of it, insignificant or indeed redundant.
Several null mutations may be required before any obvious effect occurs in a 
tissue of interest, not due to redundancy per se, but due to the reduced relative 
contribution of a single allele. For example in the ventricular zones, Soxl, Sox2 and 
Sox3 are expressed giving a total of 5 expressed alleles (Sox3 is known to be subject 
to X-inactivation (Rizzoti et al., 2004). Assuming that function and expression from 
each allele is equivalent then SoxH^’̂ ' would only remove two fifths of the necessary 
protein in sites where there is overlapping expression. Introduction of further null 
alleles, as in SoxH '̂ '̂!Sox2f^^°'^^ mutants, would remove slightly more than half. This 
is equivalent to haploinsufficiency (or worse) that is capable of causing phenotypes 
such as increased postnatal lethality or hair follicle dysgenesis in Sox2f^^°'^  ̂ animals. 
As mentioned above this effect may be exacerbated further if the correct levels of Sox 
genes are also required for auto or cross regulation.
Although a phenotype was observed in cells where there is overlapping 
expression of Soxl, Sox2 and Sox3 it is not possible to conclude that this is the cause 
of postnatal lethality of SoxH^'^lSox2f^^°'^^ animals. The cause of death may actually 
be due to defects in other parts of the CNS or quite separate phenotypes that 
synergistically result in the death of animals in this experiment.
The creation of a conditionally null Sox2 allele and using it in the place of 
Sox2̂ "̂°'̂ '̂  would allow a more refined reduction or elimination of SoxB l genes. 
Restricting gene disruption to certain parts of the CNS would make it easier to 
analyse the role of these genes in cells where there is overlapping expression. The
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further introduction of the conditionally null allele of Sox3 may make it possible to 
completely ablate the normal expression of all three SoxBl genes. It would also 
provide the opportunity to examine the relative importance of these proteins by 
creating animals lacking different combinations of SoxBl genes.
Whilst the cumulative importance of this subgroup of genes may be examined 
in this way it is unable to provide information about the unique functions of these 
genes that have evolved. In order to examine the role that functional compensation 
might play between close relatives, such as Soxl, Sox2 and Sox3, in vivo the coding 
region of one gene may be swapped for another by gene targeting. In this case total 
dose with respect to equivalent function would remain unchanged and unique roles 
would be exposed as the replacement gene would be unable to compensate.
A mouse model attempting to answer this question has already been produced 
where the coding sequence of Sox2 replaces its closest relative Sox3 (Sox3̂ '"''̂ ). 
Offspring display none of the severe deformities attributed to a null Sox3 allele 
demonstrating major, although perhaps not complete, functional compensation by 
S0X2 (Silvia Brunelli unpublished data), (Parsons, 1997). A second targeted 
replacement where Sox2 coding sequence is exchanged by that of Soxl {Sox2^°''^) has 
also been created (Vasso Episkopou unpublished data). This model is homozygous 
lethal at the same stage as Sox2^^^°' '̂ but the removal of critical regulatory sequence, 
preventing proper expression of the replacement gene early in development, negates 
drawing any conclusions about potential functional compensation. However, this 
model may still be useful as part of allelic series with the Sox2 regulatory mutants 
Ysb and Lee (Chapter 4). By creating animals carrying one each of Sox2^‘""‘̂  and Lac
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or Ysb the degree of functional compensation by Soxl may be examined in the 
development of the inner ear and the hair follicle. A range of phenotypes might be 
observed depending on the level of functional compensation Soxl is able to provide 
in the place of Sox2 and opens up screening possibilities to discover differentially 
expressed targets.
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Chapter 6 Final Discussion
One of the most interesting aspects of Sox2 is its relationship to other 
members both within its subgroup and to the rest of the family. Its closest relatives 
Soxl and Sox3 share considerable homology throughout their sequence suggesting 
very similar functional characteristics. Experimental evidence reinforces this idea as 
well as revealing considerable overlapping expression. This has led to the suggestion 
that the overall dosage of these proteins is more important than any distinct function. 
Members of the other Sox subgroups share similarity within the HMG box with other 
domains being more diverse. Since target specification is fundamentally dependant 
upon DNA binding via the HMG domain one could imagine that this would allow 
any SOX protein to regulate the same target. Whilst similarities might permit certain 
targets to be regulated in a comparable way differences provide the means to regulate 
other targets differentially. This could result in certain SOX proteins having 
antagonistic effects.
SOXl, S0X 2 and S0X3 are unequivocally very similar physically, 
functionally and in terms of expression pattern. The results presented in chapter five 
demonstrate that in regions where there is overlapping expression of the SoxBl genes 
obvious phenotypes are only revealed by the disruption of multiple subgroup 
members. A fundamental role in the ventricular zone was uncovered by the creation 
of Soxl"^ '̂''!Sox2f^^°' '̂  ̂ mutants. Whilst the gross morphology of the CNS in these 
samples appeared normal, immunohistochemistry revealed changes in cell viability 
and perhaps premature differentiation. These data indicate a basic role in the 
dynamics of the progenitor cell population and further analysis of these mutants may
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help to explain the mechanisms more precisely. Initial investigations should focus on 
describing further characteristics of cells in the mutant ventricles especially with 
respect to differentiation markers. A more comprehensive survey of changes in the 
expression profile could be made by utilising microarray technology. It is possible 
that further phenotypes in samples as well as those in other
genotypes are masked to some extent because all the cells carry the same mutation. 
A more reliable (and comparable) assay of any functional differences might be 
achieved by examining mutant cells in the context of a wild-type environment. This 
could be accomplished in vitro by culturing wild-type embryonic brain slices onto 
which labelled experimental cells could be placed and monitored. The experimental 
cells would include wild-type as well as cells carrying combinations of all the 
available mutant alleles. Each brain slice could accommodate differently labelled 
cells harvested from the ventricular zone that would then be monitored in real time. 
This would allow the direct comparison of cell behaviour between wild-type and 
mutant samples in the same environment and would permit the analysis of mutant 
cells beyond that achievable in vivo.
Although Soxl'̂ '̂̂ 'ISox2!̂ ^̂ °'̂  ̂embryos provide useful material to study the role 
of SoxBl in the ventricular zone, extra information could be gained by disrupting 
further alleles. The conditional disruption of Sox2 would allow its complete removal 
in the ventricular zone and similarly with the Sox3 conditional knockout. The 
advantage of a conditional strategy is that one is not observing secondary effects. 
These experiments could be carried out in vivo by the unilateral introduction of ere 
into the ventricular layer by in utero electroporation. By adopting this method Soxl, 
Sox2 and Sox3 could all be removed in a localised cell population. This is likely to
202
produce the most severe phenotype and give a definite insight into the role of SoxBl 
genes/proteins in sites of overlapping expression.
Currently there is evidence that the activity of Soxl, Sox2 and Sox3 is very 
similar, however, equivalent function is not consistent with evolutionary selection 
pressures. The conservation of overlapping patterns of expression and variations in 
protein structure over a long period of evolutionary time strongly supports a selective 
advantage in maintaining subtle differences. Transcription factors with similar but 
not identical activities offer a sophisticated strategy to refine the expression 
characteristics of a cell. Therefore it is important to distinguish between functional 
equivalence and functional similarity. Conventional approaches make it very tricky 
to differentiate between these possibilities because of the difficulty in speculatively 
screening large numbers of potential targets for subtle differences. Microarray 
technology, however, offers a method by which the expression of thousands of genes 
may be analysed simultaneously and provides a quantifiable method for the 
comparison of different samples. Expression analysis demonstrates the overlapping 
expression of SoxBl genes in the ventricular zone of the developing CNS that is 
conserved between mouse and chicken. Microarray analysis of the expression profile 
of these cells using mutants heterozygous for Soxl, Sox2 and Sox3 and comparing to 
wild-type may reveal both the targets of these genes as well as subtle differences in 
their activity. It is precisely these subtle differences that are likely to have permitted 
increased complexity in the developing vertebrate CNS.
Whereas the similarity between SoxBl genes is likely to contribute to a subtle 
refinement of the regulatory network more dramatic differences may be brought
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about by members of other subgroups. One advantage of conserving the core DNA 
binding domain across a large family of genes is that it allows diverse regulatory 
possibilities. Even in the most primitive animals there is a representative of each Sox 
subgroup and these have varying degrees of overlapping expression. This prompts 
the suggestion that certain regulatory processes might critically rely upon the 
antagonistic behaviour of related proteins and that these fundamental relationships 
have been crucial over a long period of time.
The mouse mutants Lee and Ysb were used along with Sox2P^^° to demonstrate 
the requirement of Sox2 for the correct development of the inner ear and the hair 
follicle. In the hair follicle relatively mild phenotypes were seen but what is most 
striking is the similarity of phenotypes observed after the null mutation of the group F 
gene Soxl8. Hair type and pigmentation characteristics were altered in both instances 
but the effects in each case were opposite to each other. This is intriguing because it 
suggests that the appearance of the mouse coat is dependent upon a balance between 
these related factors and it is possible that they may regulate some common targets.
Furthermore dominant negative forms of Soxl 8 expressed by ragged alleles 
cause far more severe coat abnormalities revealing significant roles for Sox factors in 
hair follicle development. So far apart from Sox2 and Soxl 8 no other Sox gene 
expression has been described during hair follicle development and so the ragged 
phenotype could be solely due to a disruption of their regulatory responsibilities. It 
would therefore be interesting to reduce the amount of both these genes in the same 
animal by breeding together the null mutants to see if a ragged-\fk& phenotype can be 
reproduced. If the coat phenotype of Sox2/Soxl8 null animals is not the same then
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further Sox genes, susceptible to interference by ragged protein, are likely to be 
responsible for vital aspects of follicle development. However, the replication of a 
ragged-Vik& phenotype confirms that the correct expression of these genes is critically 
important but also suggests that whilst they regulate some targets antagonistically 
others may respond in a similar way. An insight into the molecular mechanisms 
underlying these processes may be revealed by comparison of follicular material 
using the multi-gene screening techniques discussed above. It is even possible that 
this could represent a common regulatory strategy in many of the sites where there is 
overlapping expression of related transcription factors. If this is the case then the hair 
follicle may be used as a convenient model system in which to examine this 
phenomenon. Phenotypes arising from genetic manipulations are readily assayed and 
severe disruptions, unlike those in the CNS, are unlikely to compromise viability. By 
exploiting this system the mechanisms of regulation by the SOX proteins could be 
studied in vivo allowing functional differences between them to be examined. For 
example the over-expression of Sox2 in the dermal papilla could lead to phenotypes 
similar to those of the Soxl8 null by altering the balance between their two proteins. 
The expression of other members of the Sox family may reveal how their activity 
compares in the same context and could go some way towards explaining the 
regulatory consequences of expressing different combinations of these transcription 
factors in vivo.
Analysis of further mutant alleles is likely to be of key importance in 
understanding the kind of regulatory interactions described above. The creation of 
conditionally null mutants provides the means with which to analyse function whilst 
avoiding many of the pitfalls associated with traditional gene disruptions such as
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early lethality and secondary phenotypes. However, although general roles are 
revealed by the complete disruption of specific alleles the dissection of an individual 
gene’s activity in an in vivo context is likely to require the isolation or production of 
even more subtle mutations. For example the targeted replacement of one subgroup 
member by another may reveal the how slight physical differences contribute to 
optimal function, especially in sites where there is normally overlapping expression.
Sox2 is clearly crucial for many aspects during mouse embryogenesis as well 
as postnatal development. This thesis aimed to clarify the regions of Sox2 expression 
in the second half of gestation and highlights novel sites including the hair follicle 
and inner ear. These areas have no overlapping expression of other SoxBl genes and 
this enabled the study of S0X2 function alone. The investigation of compound 
mutants revealed phenotypes that suggest the SOXB1 proteins work together during 
neurogenesis in the CNS. It is therefore important not to consider each one alone 
whilst still being aware of the potential for distinct functions. The advent of new 
technology along with the generation of more sophisticated mouse mutants will aid 
the unravelling of these complex regulatory interactions.
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Chapter 7 Materials and Methods
Standard molecular biology techniques were carried out essentially as 
described in Molecular Cloning, A Laboratory Manual and Current Protocols in 
Molecular Biology (Ausubel, 1999; Sambrook, 1989) and reagents used as per 
manufacturers recommendations unless otherwise stated.
7.2 Screening of transgenic mice
Standard PCR was performed using Perkin Elmer amplitaq as per the 
manufacturers recommendations. Long PCR was performed using the Boehringer 
Mannheim Expand long PCR kit.
7.2.1 PCR analysis of alleles.
The detection of Ysb alleles was carried out as detailed in Dong et.al., 2002.
7.2.2 Maintenance and screening of Lee mouse lines.
Lee mouse lines were screened by test breeding each mouse. Heterozygote 
animals do not have circling behaviour, but produce circling offspring at a normal 
Mendelian ratio when bred together, thus confirming parental genotype. A number of 
homozygote males (circling) proved to be fertile and were used, particularly in 
compound breeding experiments, to guarantee the presence of an Lee allele.
7.2.3 PCR analysis of Soxl null allele.
A cocktail of primers was used to detect the null and wild type allele of Soxl. 
NE02 (5 ’ CTT ccT CGT GCT TTA CGG TAT CGC 3 ’)  (mutant allele) SXIS'R (5 ’tg a  tg c  a t t  ttg  
GGG GTA TCT CTC 3 ’)  (wild type allele) and SXSFnew ( s ’tta  ctt  cc c  gcc  a g c  tc t  tc  3 ')
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(common antisense oligo) gave bands of 480bp for the null allele and 373bp for the 
wild type allele.
7.2.4 PCR analysis of Sox2 null allele.
The primer pair S0X2 2BS (5 ’c a c  a c t  c c t  g g c  c g g  g c c  g a g  g  3 ’)  and 
LACZPZ4A (GTA GAT GGG CGC ATC GTA ACC GTG c) was used to detect the null allele of 
Sox2 and gives a band of 336bp. Screening of cells targeted with pDB13 was carried 
out using the above primer set and then oligos ODB25 (5'CAT c g c  c t t  c t a  t c g  c c t  t c t  
TGA 3 ’)  and ODB28 (5 ’c a a  g c c  c c t  t c c  t t g  t t c  c t  3 ’)  were used for long PCR analysis. 
Control reactions were performed using Sox2^^^°' '̂', 129/Sv genomic DNA and no 
DNA.
7.3 Method for taking and examining hair samples
Three hair samples were taken from each mouse in the mid dorsal region just 
posterior to the shoulder blades. Each hair pluck was carried out in a single 
movement using a pair of Millipore hybridisation forceps (smooth). All samples 
were then counted blind before collation.
7.4 Targeting and screening of Sox2 in ES cells.
7.4.1 Construction of the vectors used in targeting experiments.
The Sox2 conditional knockout targeting vectors were constructed using 
genomic DNA from a male 129SvEv mouse lambda library.
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7.4.2 Phosphorylation and annealing of complementary oligonucleotide pairs used in
cloning.
All oligonucleotides were synthesised and HPLC purified by MWG Biotech. 
Pairs used for cloning were diluted in ligase buffer (New England Biolabs) and 
phosphorylated by the addition of T4 polynucleotide kinase (PNK (New England 
Biolabs)). PNK was then inactivated by incubating at 75°C for ten minutes and 
annealing of the oligonucleotides was then carried out directly by raising the 
temperature to 95°C for one minute then allowing the reaction to cool to room 
temperature. Where pairs were to be ligated an approximately equal molar quantity 
of phosphorylated and annealed oligonucleotide pair and vector was used in the 
reaction.
7.4.3 Production of the first targeting vector pDB13.
The oligonucleotide pair ODB1 ( s ’ggc  cgc  a t a  a c t  tcg  t a t  a g c  a t a  ca t  ta t  acg
AAG TTA TGA AGT TCC TAT TCC GAA GTT CCT ATT CTC TAG AAA GTA TAG GAA CTT C 3’) and ODB2 
(5 ’GGC CGA AGT TCC TAT ACT TTC TAG AG A ATA GGA ACT TCG GAA TAG GAA CTT CAT A AC TTC GTA TA A 
TGT ATG CTA TAC GAA GTT ATG c  3’) was ligated with the plasmid that contained the beta- 
galactosidase, neomycin fusion gene pSABGEO (Friedrich, 1991) which had been cut 
with Notl and then dephosphorylated with calf alkaline phosphatase(CIP (Roche)). 
This step introduced the ere and flp recombinase recognition sites, loxP (Smith, 1995) 
m d fr t  (O'Gorman, 1991) 5’ of the selection cassette producing pDB4 (Fig. 7.1a). A 
single/r^ site was then introduced, using the oligonucleotide pair ODB5 ( s ’g a a g t t c c t
ATT CCG AAG TTC CTA TTC TCT AGA AAG TAT AGG AAC TTC GGC CG 3’) and ODB6 (S ’CGG CCG AAG 
TTC CTA TAC TTT CTA GAG AAT AGG AAC TTC GGA ATA GGA ACT TCG TAC 3’). ThiS
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oligonucleotide pair was ligated into pDB4 that had been cut with Kpnl and 
dephosphorylated with CIP to produce the plasmid pDB6 (Fig. 7.1b). The adenovirus 
splice acceptor site was then removed by cutting pDB6 with Spel/Hindlll, endfilling 
with DNA polymerase I (large Klenow fragment) followed by religation to produce 
the plasmid pDB6ASA (Fig. 7.1c).
pDB3 was cut with Xbal, and dephosphorylated using CIP. The 
oligonucleotide pair 0DB3 (5 ’cta  g c a  t a a  ctt cgt a t a  g c a  t a c  a t t  a t a  cg a  a g t  ta t  3 ’)  
and ODB4 (5 ’cta  gcc  ta g  g at  a a c  rrc gta  t a a  tgt  a t g  cta  t a c  g a a  gtt a t g  3’) was ligated 
into the pre-prepared pDB3 vector to produce the plasmid pDB5 (Fig. 7.Id). This 
step introduced a single loxP site 3' of the coding region of Sox2. A  600bp piece of 
Sox2 genomic DNA was isolated by gel purification of the clone SN5 that had been 
cut with Xbal. This fragment was then ligated into pDB5 that had been cut with Xbal 
and dephosphorylated with CIP to produce pDBlO (Fig. 7. le). pDBlO was cut with 
Notl and dephosphorylated. The loxPlfrt flanked selection cassette was released from 
pDB6ASA by a partial Eagl digestion that produces sticky ends compatible with 
Notl. Gel purification produced a 3.9 kilobase (kb) fragment that was then ligated 
into the Notl cut pDBlO vector to produce plasmid pD B ll (Fig. 7. If). pD B ll was 
cut with Notl and a 5.7kb genomic DNA fragment from SN5 was introduced 5' to the 
coding region of Sox2, to produce the final targeting construct pDB13 (Fig. 7.1g). 
For electroporation into ES cells pDB13 was linearised with Kpnl.
7.4.4 Production of the second targeting vector (pDB371
SB 158 was digested with the restriction enzymes BamHI and Hindlll. 
Digested DNA was end filled with T4 DNA polymerase (Roche) and the 2kb
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fragment, containing the PGKneo selection cassette, flanked by frt sites and followed 
by a loxP site, was gel purified. This fragment was then ligated into SN5 plasmid 
DNA that had previously been linearised with SphI, endfilled with T4 DNA 
polymerase (Roche) and dephosphorylated with CIP (Roche) producing pDB36 (Fig. 
7.2a,b).
To introduce the second loxP  site into the targeting vector a pair of 
complementary oligonucleotides was designed containing the loxP sequence flanked 
by Mlul sites (ODB53 (5 ’cgc  gta  cta  g ta  ta a  ctt  cgt a t a  g c a  ta c  a t t  a t a  c g a  a g t  ta t3 ’) 
ODB54 (5 ’CGC GAT AAC TTC GTA TAA TGT ATG CTA TAC GAA GTT ATA CTA GTA3 ’ ) .  
Oligonucleotides were ligated into pDB36 that had been linearised with Mlul and 
dephosphorylated with CIP (Roche) (Fig. 7.2c). Promising clones of the completed 
construct were sequenced to confirm the presence of a single loxP site in the correct 
orientation. pDB37 was linearised using BamHI (Fig. 7.2c) before electroporating 
into ES cells.
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7.4.5 Culture of ES cells.
Embryonic stem cell lines used were either CCE (Bradley 1984) or ABl (kind 
gift R Behringher). Both lines were derived from XY 129Sv/Ev pre-implantation 
mouse embryos. This mouse strain carries the agouti coat colour marker. ES cells 
were grown in Dulbecco’s modified Eagles’ medium (DMEM) (Sigma) 
supplemented with 2mM L-glutamine (Gibco), lOOunits/ml penicillin (Gibco), 
lOOpg/ml streptomycin (Gibco), 90pM B-mercaptoethanol (Sigma), 15% ES 
qualified foetal calf serum (ECS)(Globefarm), at 37°C in a humidified incubator with 
5%C02. Media for ABl ES cells also contained 1000 units/ml of leukaemia 
inhibitory factor (LIE) (Gibco). Cells were passaged by removing the media and 
washing in PBS (without calcium and magnesium) (PBS™)(Gibco). Just enough IX 
Trypsin-EDTA solution (Gibco) was added to cover the cells, which were then 
incubated for five minutes at 37°C, until cells had lifted off the plate. An equal 
volume of media was added to the cell suspension, which was then centrifuged at 
1000 rpm for five minutes to pellet the cells. The supernatant was aspirated off, cells 
resuspended in media and plated at the desired concentration.
ES cells were plated on top of a feeder layer of mitomycinC treated, neomycin 
resistant fibroblast cells (STO(N)) (Robertson 1987) to prevent differentiation. These 
were produced by incubating STO(N) cells in media supplemented with Ipg/ml 
mitomycinC (Sigma) for two hours. Cells were washed three times in PBS*^^, 
trypsinised and plated onto gelatinised plates at a concentration of 3.8x10^ cells/cm^. 
Media was changed daily on ES cell cultures.
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7.4.6 Transfection of ES cells by electroporation.
Targeting vectors were linearised, phenol/chloroform extracted, ethanol 
precipitated and resuspended at a concentration of about Ipg/ml. ES cells were 
trypsinised and resuspended in PBS^^ at a concentration of 3.33x10^ cells/ml. 2x10^ 
cells (0.6ml) were placed in a 0.4cm electrode Gene Puiser® curvette (BioRad) and 
electroporated at 960pF at 0.2 Volts. After electroporation cells were added to 10ml 
fresh media and split between five 10cm plates of STO(N) feeder cells. A control 
sample was processed in exactly the same way except no DNA was added.
7.4.7 Selection of transfected cells with antibiotic.
Electroporated ES cells were allowed to recover for two days, being 
maintained on plain ES cell media. On the third day after electroporation media was 
supplemented with 250pg/ml of the antibiotic G418 (Sigma). Selection media was 
used usually for about ten days and was regarded as sufficient when no ES cells 
remained on the control plates. By this time discrete, G418 resistant ES cell colonies 
were present on experimental plates and were of sufficient size to pick and culture 
separately. This was achieved by replacing media with PBS®^^ and picking 
individual colonies up with a Gilson pipette and sterile filter tips. Colonies were 
transferred, in a minimum volume, to a round bottomed, ninety-six well tissue culture 
plate that contained 50pl IX Trypsin-EDTA (Gibco) in each well. Plates were 
transferred to 37°C for five minutes. 150pl fresh media was then added and the 
suspension was pipetted up and down several times to disperse cells. Cells were then 
transferred to a fresh ninety-six well plate and cultured. Once the majority of wells in 
a plate were confluent cells were passaged, one third of each to two ninety-six well
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feeder plates for freezing and the final third divided onto two gelatinised ninety-six 
well plates to recover DNA for screening.
7.4.8 Freezing of ES cells in 96 well plates.
ES cell clones were frozen in ninety-six well plates, after aspirating the media 
and washing the cells with 200//1 PBSCMF. 50/d IX Trypsin-EDTA (Gibco) was 
added to each well and plates were incubated at 37°C for five minutes. 200/d 
freezing media (40% ESQ ECS, 20% dimethyl sulphoxide (DMSG)) was added to 
each well and cells were pipetted gently to ensure a single cell suspension. Each well 
was overlaid with 100//1 light paraffin oil before sealing them with parafilm, 
wrapping in several layers of paper towels and placing at -80°C.
7.4.9 DNA isolation from ES cells
DNA was isolated from ES cells grown on gelatinised 96 well tissue culture 
plates. First 50//1 of lysis buffer (lOmM Tris pH7.5, lOmM EDTA pH 8.0, lOmM 
NaCl, 0.5% sarcosyl, Img/ml PK) was added to each well and incubated overnight at 
60°C in a humidified polythene bag. DNA was then precipitated by adding 100//1, 
freshly prepared, 75mM NaCl in 100% ethanol and leaving at room temperature for 
thirty minutes. Liquid was discarded, by briskly inverting the plate and the remaining 
DNA precipitate was washed three times by repeated addition and discarding of 
200/d of clean 70% ethanol. Plates were then air dried in an inverted position for 
thirty minutes before the addition of 25//1 of 0.5TE (5mM Tris pH7.5, ImM EDTA) 
to resuspend the DNA. To ensure proper resuspension of the DNA precipitate the 
plates were placed in a humidified bag at 37°C overnight.
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7.4.10 Southern blotting
25jÂ 2X enzyme mix (2X buffer 2mM spermidine (Sigma), 200//g/ml BSA 
and 20-30U enzyme and 10/^g RNase A (Sigma)) was added to each well containing 
isolated and resuspended ES cell DNA. Plates were then incubated overnight in a 
humidified polythene bag at 37°C. Samples were cut again by adding \Q]A IX 
enzyme mix (IX buffer ImM spermidine (Sigma), lOO/^g/ml BSA and lOU enzyme), 
followed by a further incubation, in a humidified bag, for two hours.
Samples were loaded onto a 0.7% (w/v) TAE (40mM Tris-acetate, pH8.0, 
ImM EDTA) agarose gel containing 0.2//g/ml ethidium bromide, alongside a Ikb 
ladder (Gibco) and electrophoresed at 60V until samples had travelled approximately 
ten centimetres (gel 300ml 20cm x 20cm). Photographs of the gels were taken on an 
UV transilluminator next to a ruler to allow sizing of bands. Marker lanes were 
removed (to avoid contamination) before gels were depurinated for eight minutes in a 
freshly prepared 2.5% (0.28M) HCl solution with agitation. Gels were then washed 
briefly in ddH20 before denaturing for twelve minutes in fresh 0.4M NaOH. DNA 
from the gels was then capillary blotted overnight onto Hybond N  ̂nylon membrane 
(Amersham) in 0.4M NaOH. Membranes were washed briefly in 2XSSC and stored 
wet at -20°C until hybridisation.
7.4.11 Hybridisation.
Membranes were prehybridised in an appropriate hybridisation tube (Hybaid) 
in 20ml of hybridisation buffer (6XSSC, 0.5%SDS, 5X Denharts solution (0.02% 
(w/v) Ficoll (type 400 Pharmacia), 0.02% (w/v) polyvinylpyrrolidone, 0.02% (w/v) 
bovine serum albumin) and 100//g/ml sheared and boiled salmon sperm DNA).
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Hybridisation steps were performed in a Hybaid rôtisserie oven at 65°C. DNA probes 
were labelled with ^^P-dCTP (Amersham) using the DNA Megaprime kit 
(Amersham), following the manufacturers instructions. Unincorporated nucleotides 
were removed by passing the probe through 1ml Sephadex G-50 (Pharmacia) and 
probe labelling quantified by scintillation counting. Probe was denatured at 100°C 
for three minutes before adding it directly to the prehybridisation solution already 
covering the membrane. Membranes were hybridised overnight at 65°C before being 
washed. Membranes were rinsed briefly in the tube with 2X SSC/0.5% SDS and then 
for five minutes in 11 of the same solution at 65°C with agitation. Wash solution was 
replaced with 11 IX SSC/0.5% SDS and agitated at 65°C for twenty-five minutes. 
This solution was then replaced with 11 of 0.5X SSC/0.5% SDS and agitated for 15 
minutes at 65°C. Membranes were then sealed in polythene bags and exposed 
overnight to a phosphorimaging screen (Molecular Dynamics). Screens were then 
processed using Molecular Dynamics Storm phospho-imaging screens and reader 
with Image Quant V software.
7.4.12 PCR screening of targeted clones.
ES cell clones that were deemed to be correctly targeted by southern blotting 
using a 3’ external probe were then subjected to PCR analysis to determine the 
presence of the loxP site distant from the selection cassette. Oligo pairs 
ODB55/ODB56 and ODB55/ODB57 were used for this analysis, yielding products of 
520 and 776bp respectively where the loxP site was present and 27bp less in each 
case where it was absent.
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7.5 Production and initial treatments of wax embedded samples.
Staged mouse embryos were harvested and fixed overnight in 100% methanol 
at 4°C. Fixed embryos were wax embedded by standard methods (Kaufman, 1992) 
and then sectioned to 7pm. Wax sections were heated to 60°C for fifteen minutes 
prior to dewaxing in toluene. They were then taken to PBS through an ethanol 
gradient (100% 2 min x2, 90% Imin x l, 70% Imin x l, 50% Imin x l, 30% Imin x l 
(dilutions in ddH20 and finally PBS 5min x2) before immunohistochemical detection 
or TUNEL assay.
7.6 Immunohistochemistrv
7.6.1 Enzyme linked antibody detection (bright field!
S0X2 immunohistochemistry was performed with a polyclonal antibody that 
had been raised in rabbit against the C terminal region of mouse SOX2 (excluding the 
HMG box) (Kamachi 1995) (see Avilion 2003). For control reactions the pre- 
immune serum was used at an equivalent concentration to the antibody.
1% H2 O2  in H 2 O was used for a fifteen-minute incubation, to block any 
endogenous peroxidase activity, followed by rinsing in water and two washes in PBS 
(5min each). Sections were placed in a humidified chamber and incubated with 
blocking solution (10% heat inactivated sheep serum in PB ST), for 30min at room 
temperature.
Blocking solution was removed and replaced by a 1:500 dilution of the S0X2 
antibody (or pre-immune serum) in blocking solution, and incubated overnight in a 
humid chamber at 4°C.
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The antibody solution was removed and sections were washed twice for five 
minutes each in PBTX (0.02%tween-20 in PBS) before incubating with the secondary 
antibody. 1:200 biotinylated anti-rabbit IgG (Vector Labs) in PBTX with 5% sheep 
serum. Slides were then washed in PBTX (two times 5 min each) and signal detected 
using the Vector labs ABC kit and AEC coloured substrate for peroxidase (Sigma) as 
per the manufacturers recommendations. Samples were subsequently counterstained 
with methyl green (0.15% in HgO) (Sigma) and coverslipped using glycerol gelatin 
solution (Sigma).
7.6.2 Fluorescence antibodv detection.
Sections were incubated in a humidified chamber with blocking solution (3% 
heat inactivated sheep serum (ss) in PB ST (0.1% TXlOO)) for at least an hour but 
usually overnight. Blocking solution was tapped off and replaced by primary 
antibody, at the appropriate dilution in blocking solution, coverslipped and incubated 
for one hour at room temperature in a humidified chamber. Sections were then 
washed three times for five minutes each in PBS, before diluted secondary antibody 
was applied. Sections were coverslipped and incubated with the appropriate 
secondary antibody for one hour at room temperature before being washed three 
times in PBS. Sections were mounted using Vector shield containing DAPI and 
antibody was visualised using epifluorescence. Samples were recorded using 
Delta vision™ and images analysed with Softworks™ and Adobe Photoshop™ 7.0.
Primary antibodies:
Rabbit Anti-mouse S0X2 (fb46) 1:50
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Rabbit Anti-chicken S0X3 (Brunelli et al., 2003; Wilson et al., 2001) 1:100 
Rabbit Anti-mouse SOXl (fb43, fb44) 1:200 of each.
Rabbit Anti-phospho-histone H3 (Upstate) 1:100 
TuJl anti-neuronal class III 13-tubulin (Covance) 1:1000 
Secondary Antibodies:
Anti rabbitCY3 (Cambridge Bioscience) 1:500 
Anti mouse Alexa488 (Molecular Probes) 1:500.
7.6.3 Simultaneous detection of more than one antibody on sections.
Where two primary antibodies, which have been raised in different species, 
have been used on the same sections both have been applied, at an appropriate 
concentration simultaneously. Similarly with secondary antibodies.
Where two primary antibodies, raised in the same species, have been used on 
the same sections one is processed first followed by detection and photography. 
Slides were placed in a microwave oven (850W) on full power for five minutes in 
500ml of PBS followed by processing with the second primary antibody in the 
normal way. Appropriate controls were carried out to ensure no residual signal could 
be detected after microwave treatment. Photographs were then overlaid using Adobe 
Photoshop™ 7.0.
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7.7 Beta-galactosidase staining of embryos.
Staged embryos were harvested into PBS on ice and fixed in 4% 
paraformaldehyde (PFA) solution (4%PFA in PBS), at 4°C, for 5-60 minutes, 
depending on their age. Fixed embryos were washed in embryo rinse (5mM EGTA, 
0.01% Deoxycholate, 0.02% NP-40, 2mM MgCl2 , in PBS) three times for at least ten 
minutes each and then placed in staining solution (5mM KgFeCCN) ,̂ 5mM 
K4 Fe(CN)6 , 5mM EGTA, 0.01% Deoxycholate, 0.02% NP-40, 2mM MgCl2  and 
1 mg/ml X-Gal (5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside), in PBS) at 
37°C overnight. Stained embryos were post-fixed in 4%PFA solution at 4°C 
overnight. Embryos were either wax embedded by standard methods (Kaufman, 
1992) and sectioned to 7pm or cleared in a glycerol series before photographs were 
taken. Some sections were lightly stained with eosin for histological clarity.
7.8 TUNEL assay for detection of apoptotic cells on wax sections.
Cell death kit was used as per manufacturers instructions. Briefly, wax 
sections were produced and rehydrated as described, section 7.3. Permeabilisation 
solution (0.1% TXlOO, 0.1% sodium citrate) was applied to samples for eight 
minutes, then slides were washed twice in PBS for two minutes each. Sections were 
covered in TUNEL reaction mixture and coverslipped before incubating in a 
humidified box, in the dark at 37°C for one hour. Slides were then rinsed in PBS 
mounted and visualised or processed for immunohistochemistry.
7.9 Production of 3D models from serially sectioned X-gal stained material
Samples were processed for X-gal staining, wax embeded and serial 
sectioned at 7-8pm. Slides were dewaxed slides and coverslipped without
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counterstaining. Openlab software was used to digitally capture all sections in bright 
field with subsequent alignments and manipulations carried out using Adobe 
Photoshop 7.0. Series of digital images were processed though Velocity! on a 
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